0001493152-23-027727.txt : 20230811 0001493152-23-027727.hdr.sgml : 20230811 20230811075346 ACCESSION NUMBER: 0001493152-23-027727 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 83 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vislink Technologies, Inc. CENTRAL INDEX KEY: 0001565228 STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATIONS EQUIPMENT, NEC [3669] IRS NUMBER: 205856795 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35988 FILM NUMBER: 231161579 BUSINESS ADDRESS: STREET 1: 350 CLARK DRIVE STREET 2: SUITE 125 CITY: MT. OLIVE STATE: NJ ZIP: 07828 BUSINESS PHONE: 941 953 9035 MAIL ADDRESS: STREET 1: 350 CLARK DRIVE STREET 2: SUITE 125 CITY: MT. OLIVE STATE: NJ ZIP: 07828 FORMER COMPANY: FORMER CONFORMED NAME: xG TECHNOLOGY, INC. DATE OF NAME CHANGE: 20121220 10-Q 1 form10-q.htm
0001565228 false Q2 --12-31 10000 0001565228 2023-01-01 2023-06-30 0001565228 2023-08-11 0001565228 2023-06-30 0001565228 2022-12-31 0001565228 us-gaap:SeriesAPreferredStockMember 2023-06-30 0001565228 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001565228 2023-04-01 2023-06-30 0001565228 2022-04-01 2022-06-30 0001565228 2022-01-01 2022-06-30 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-03-31 0001565228 us-gaap:CommonStockMember 2023-03-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001565228 us-gaap:TreasuryStockCommonMember 2023-03-31 0001565228 us-gaap:RetainedEarningsMember 2023-03-31 0001565228 2023-03-31 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001565228 us-gaap:CommonStockMember 2022-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001565228 us-gaap:TreasuryStockCommonMember 2022-12-31 0001565228 us-gaap:RetainedEarningsMember 2022-12-31 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-03-31 0001565228 us-gaap:CommonStockMember 2022-03-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001565228 us-gaap:TreasuryStockCommonMember 2022-03-31 0001565228 us-gaap:RetainedEarningsMember 2022-03-31 0001565228 2022-03-31 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001565228 us-gaap:CommonStockMember 2021-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001565228 us-gaap:TreasuryStockCommonMember 2021-12-31 0001565228 us-gaap:RetainedEarningsMember 2021-12-31 0001565228 2021-12-31 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-04-01 2023-06-30 0001565228 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001565228 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001565228 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0001565228 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-06-30 0001565228 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001565228 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001565228 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-06-30 0001565228 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-04-01 2022-06-30 0001565228 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001565228 us-gaap:TreasuryStockCommonMember 2022-04-01 2022-06-30 0001565228 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-06-30 0001565228 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001565228 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-06-30 0001565228 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-06-30 0001565228 us-gaap:CommonStockMember 2023-06-30 0001565228 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001565228 us-gaap:TreasuryStockCommonMember 2023-06-30 0001565228 us-gaap:RetainedEarningsMember 2023-06-30 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-06-30 0001565228 us-gaap:CommonStockMember 2022-06-30 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001565228 us-gaap:TreasuryStockCommonMember 2022-06-30 0001565228 us-gaap:RetainedEarningsMember 2022-06-30 0001565228 2022-06-30 0001565228 VISL:FederalBondsMember 2023-03-31 0001565228 VISL:FederalBackedMutualFundMember 2023-03-31 0001565228 us-gaap:StockOptionMember 2023-01-01 2023-06-30 0001565228 us-gaap:StockOptionMember 2022-01-01 2022-06-30 0001565228 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001565228 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001565228 VISL:GBPMember VISL:GBPToUSDMember 2023-06-30 0001565228 VISL:GBPToUSDMember 2023-06-30 0001565228 VISL:EuroMember VISL:EuroToGBPMember 2023-06-30 0001565228 VISL:GBPMember VISL:EuroToGBPMember 2023-06-30 0001565228 VISL:GBPMember VISL:GBPToUSDMember 2022-06-30 0001565228 VISL:GBPToUSDMember 2022-06-30 0001565228 VISL:EuroMember VISL:EuroToGBPMember 2022-06-30 0001565228 VISL:GBPMember VISL:EuroToGBPMember 2022-06-30 0001565228 2023-01-23 0001565228 2023-01-22 2023-01-23 0001565228 2023-02-01 0001565228 2023-02-01 2023-02-01 0001565228 VISL:FederalHomeLoanBanksMember 2023-06-30 0001565228 2023-02-28 0001565228 2023-02-27 2023-02-28 0001565228 VISL:FederalNationalMortgageAssociationMember 2023-06-30 0001565228 us-gaap:FairValueInputsLevel1Member VISL:FederalBondsMember 2023-06-30 0001565228 us-gaap:FairValueInputsLevel2Member VISL:FederalBondsMember 2023-06-30 0001565228 us-gaap:FairValueInputsLevel3Member VISL:FederalBondsMember 2023-06-30 0001565228 VISL:FederalBondsMember 2023-06-30 0001565228 us-gaap:FairValueInputsLevel1Member 2023-06-30 0001565228 us-gaap:FairValueInputsLevel2Member 2023-06-30 0001565228 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001565228 VISL:FederalBackedMutualFundMember 2023-06-30 0001565228 VISL:FederalBackedMutualFundMember 2023-01-01 2023-06-30 0001565228 VISL:ProprietaryTechnologyMember 2022-12-31 0001565228 VISL:PatentsAndLicensesMember 2022-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2022-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2022-12-31 0001565228 VISL:ProprietaryTechnologyMember 2023-01-01 2023-06-30 0001565228 VISL:PatentsAndLicensesMember 2023-01-01 2023-06-30 0001565228 VISL:TradeNamesAndTechnologyMember 2023-01-01 2023-06-30 0001565228 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-06-30 0001565228 VISL:ProprietaryTechnologyMember 2023-06-30 0001565228 VISL:PatentsAndLicensesMember 2023-06-30 0001565228 VISL:TradeNamesAndTechnologyMember 2023-06-30 0001565228 us-gaap:CustomerRelationshipsMember 2023-06-30 0001565228 VISL:ProprietaryTechnologyMember srt:MinimumMember 2023-06-30 0001565228 VISL:ProprietaryTechnologyMember srt:MaximumMember 2023-06-30 0001565228 VISL:PatentsAndLicensesMember srt:MinimumMember 2023-06-30 0001565228 VISL:PatentsAndLicensesMember srt:MaximumMember 2023-06-30 0001565228 VISL:TradeNamesAndTechnologyMember srt:MinimumMember 2023-06-30 0001565228 VISL:TradeNamesAndTechnologyMember srt:MaximumMember 2023-06-30 0001565228 VISL:ProprietaryTechnologyMember 2023-04-01 2023-06-30 0001565228 VISL:ProprietaryTechnologyMember 2022-04-01 2022-06-30 0001565228 VISL:ProprietaryTechnologyMember 2022-01-01 2022-06-30 0001565228 VISL:PatentsAndLicensesMember 2023-04-01 2023-06-30 0001565228 VISL:PatentsAndLicensesMember 2022-04-01 2022-06-30 0001565228 VISL:PatentsAndLicensesMember 2022-01-01 2022-06-30 0001565228 VISL:TradeNamesAndTechnologyMember 2023-04-01 2023-06-30 0001565228 VISL:TradeNamesAndTechnologyMember 2022-04-01 2022-06-30 0001565228 VISL:TradeNamesAndTechnologyMember 2022-01-01 2022-06-30 0001565228 us-gaap:CustomerRelationshipsMember 2023-04-01 2023-06-30 0001565228 us-gaap:CustomerRelationshipsMember 2022-04-01 2022-06-30 0001565228 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-06-30 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableOneMember 2022-04-05 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableOneMember 2022-04-04 2022-04-05 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableOneMember 2023-04-01 2023-06-30 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableOneMember 2023-01-01 2023-06-30 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableOneMember 2022-04-01 2022-06-30 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableOneMember 2022-01-01 2022-06-30 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableTwoMember 2023-04-05 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableTwoMember 2023-04-04 2023-04-05 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableTwoMember 2023-04-01 2023-06-30 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableTwoMember 2023-01-01 2023-06-30 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableTwoMember 2022-04-01 2022-06-30 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableTwoMember 2022-01-01 2022-06-30 0001565228 VISL:NotesPayableOneMember 2023-06-30 0001565228 VISL:NotesPayableOneMember 2022-12-31 0001565228 VISL:NotesPayableTwoMember 2023-06-30 0001565228 VISL:LutonUKMember 2023-01-01 2023-06-30 0001565228 VISL:LutonUKMember 2023-06-30 0001565228 VISL:ColchesterUKWatersideHouseMember 2023-06-30 0001565228 VISL:ColchesterUKWatersideHouseMember 2023-01-01 2023-06-30 0001565228 country:SG 2023-06-30 0001565228 country:SG 2023-01-01 2023-06-30 0001565228 VISL:BillericaMaMember 2023-06-30 0001565228 VISL:BillericaMaMember 2023-01-01 2023-06-30 0001565228 VISL:HemelUKMember 2023-06-30 0001565228 VISL:HemelUKMember 2023-01-01 2023-06-30 0001565228 VISL:MountOliveNJMember 2023-06-30 0001565228 VISL:MountOliveNJMember 2023-01-01 2023-06-30 0001565228 us-gaap:SeriesAPreferredStockMember 2023-03-22 0001565228 us-gaap:SeriesAPreferredStockMember 2023-03-31 0001565228 2022-05-20 0001565228 2023-01-10 2023-01-10 0001565228 2023-01-11 2023-01-11 0001565228 2023-05-01 2023-05-01 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001565228 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001565228 VISL:CommonStockWarrantsMember 2023-01-01 2023-06-30 0001565228 VISL:CommonStockWarrantsMember 2023-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2023-04-01 2023-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2022-04-01 2022-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2023-04-01 2023-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2022-04-01 2022-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2023-04-01 2023-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2022-04-01 2022-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2023-01-01 2023-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2022-01-01 2022-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2023-04-01 2023-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2022-04-01 2022-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2023-04-01 2023-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2022-04-01 2022-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2022-12-31 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2021-12-31 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2022-12-31 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2021-12-31 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2023-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2022-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2023-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2022-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember srt:MinimumMember 2023-01-01 2023-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember srt:MaximumMember 2023-01-01 2023-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember srt:MinimumMember 2022-01-01 2022-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember srt:MaximumMember 2022-01-01 2022-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember srt:MinimumMember 2023-01-01 2023-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember srt:MaximumMember 2023-01-01 2023-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember srt:MinimumMember 2022-01-01 2022-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember srt:MaximumMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementAwardsMember 2022-12-31 0001565228 VISL:PerformanceBasedStockOptionInducementAwardsMember 2021-12-31 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2022-12-31 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2021-12-31 0001565228 VISL:PerformanceBasedStockOptionInducementAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementAwardsMember 2023-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementAwardsMember 2022-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2023-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2022-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsOneMember 2023-01-01 2023-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsTwoMember 2023-01-01 2023-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsOneMember 2022-01-01 2022-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsTwoMember 2022-01-01 2022-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember srt:MinimumMember 2023-01-01 2023-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember srt:MaximumMember 2023-01-01 2023-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember srt:MinimumMember 2022-01-01 2022-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember srt:MaximumMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2022-12-31 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2021-12-31 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2023-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2022-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsOneMember 2023-01-01 2023-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsTwoMember 2023-01-01 2023-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsOneMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsTwoMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember srt:MinimumMember 2023-01-01 2023-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember srt:MaximumMember 2023-01-01 2023-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember srt:MinimumMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember srt:MaximumMember 2022-01-01 2022-06-30 0001565228 VISL:GroupPersonalPensionPlanUKMember 2023-04-01 2023-06-30 0001565228 VISL:GroupPersonalPensionPlanUKMember 2022-04-01 2022-06-30 0001565228 VISL:GroupPersonalPensionPlanUKMember 2023-01-01 2023-06-30 0001565228 VISL:GroupPersonalPensionPlanUKMember 2022-01-01 2022-06-30 0001565228 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember VISL:CustomerTwoMember 2022-04-01 2022-06-30 0001565228 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember VISL:CustomerTwoMember 2022-01-01 2022-06-30 0001565228 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember VISL:CustomerOneMember 2023-01-01 2023-06-30 0001565228 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember VISL:CustomerTwoMember 2023-01-01 2023-06-30 0001565228 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember VISL:CustomerOneMember 2022-01-01 2022-06-30 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:OneVendorMember 2023-06-30 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:VendorTwoMember 2023-06-30 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:VendorOneMember 2023-04-01 2023-06-30 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:VendorTwoMember 2023-01-01 2023-06-30 0001565228 VISL:PurchaseMember us-gaap:SupplierConcentrationRiskMember VISL:VendorOneMember 2023-01-01 2023-06-30 0001565228 VISL:PurchaseMember us-gaap:SupplierConcentrationRiskMember VISL:VendorTwoMember 2023-01-01 2023-06-30 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:VendorOneMember 2023-06-30 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:VendorOneMember 2023-01-01 2023-06-30 0001565228 srt:NorthAmericaMember 2023-04-01 2023-06-30 0001565228 srt:NorthAmericaMember 2022-04-01 2022-06-30 0001565228 srt:NorthAmericaMember 2023-01-01 2023-06-30 0001565228 srt:NorthAmericaMember 2022-01-01 2022-06-30 0001565228 srt:SouthAmericaMember 2023-04-01 2023-06-30 0001565228 srt:SouthAmericaMember 2022-04-01 2022-06-30 0001565228 srt:SouthAmericaMember 2023-01-01 2023-06-30 0001565228 srt:SouthAmericaMember 2022-01-01 2022-06-30 0001565228 srt:EuropeMember 2023-04-01 2023-06-30 0001565228 srt:EuropeMember 2022-04-01 2022-06-30 0001565228 srt:EuropeMember 2023-01-01 2023-06-30 0001565228 srt:EuropeMember 2022-01-01 2022-06-30 0001565228 srt:AsiaMember 2023-04-01 2023-06-30 0001565228 srt:AsiaMember 2022-04-01 2022-06-30 0001565228 srt:AsiaMember 2023-01-01 2023-06-30 0001565228 srt:AsiaMember 2022-01-01 2022-06-30 0001565228 VISL:RestOfWorldMember 2023-04-01 2023-06-30 0001565228 VISL:RestOfWorldMember 2022-04-01 2022-06-30 0001565228 VISL:RestOfWorldMember 2023-01-01 2023-06-30 0001565228 VISL:RestOfWorldMember 2022-01-01 2022-06-30 0001565228 VISL:EquipmentSalesMember 2023-04-01 2023-06-30 0001565228 VISL:EquipmentSalesMember 2022-04-01 2022-06-30 0001565228 VISL:EquipmentSalesMember 2023-01-01 2023-06-30 0001565228 VISL:EquipmentSalesMember 2022-01-01 2022-06-30 0001565228 VISL:InstallationIntegrationAndRepairsMember 2023-04-01 2023-06-30 0001565228 VISL:InstallationIntegrationAndRepairsMember 2022-04-01 2022-06-30 0001565228 VISL:InstallationIntegrationAndRepairsMember 2023-01-01 2023-06-30 0001565228 VISL:InstallationIntegrationAndRepairsMember 2022-01-01 2022-06-30 0001565228 VISL:WarrantiesMember 2023-04-01 2023-06-30 0001565228 VISL:WarrantiesMember 2022-04-01 2022-06-30 0001565228 VISL:WarrantiesMember 2023-01-01 2023-06-30 0001565228 VISL:WarrantiesMember 2022-01-01 2022-06-30 0001565228 country:US 2023-06-30 0001565228 country:US 2022-06-30 0001565228 country:NL 2023-06-30 0001565228 country:NL 2022-06-30 0001565228 country:GB 2023-06-30 0001565228 country:GB 2022-06-30 0001565228 VISL:UKSubsidiaryMember 2023-04-01 2023-06-30 0001565228 VISL:UKSubsidiaryMember 2022-04-01 2022-06-30 0001565228 VISL:UKSubsidiaryMember 2023-01-01 2023-06-30 0001565228 VISL:UKSubsidiaryMember 2022-01-01 2022-06-30 0001565228 VISL:GBPToUSDMember 2023-01-01 2023-03-31 0001565228 VISL:GBPToUSDMember 2022-01-01 2022-12-31 0001565228 us-gaap:SubsequentEventMember VISL:DIFXMember 2023-07-03 0001565228 us-gaap:SubsequentEventMember VISL:DIFXMember 2023-07-03 2023-07-03 0001565228 srt:ScenarioForecastMember 2023-09-01 2023-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:GBP utr:sqft iso4217:AED iso4217:EUR xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2023

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________to _______________.

 

Commission File Number: 001-35988

 

Vislink Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   20-5856795

(State or other jurisdiction

of incorporation or organization)

 

(IRS Employer

Identification No.)

 

350 Clark Drive, Suite 125,

Mt. Olive, NJ 07828

(Address of Principal Executive Offices)

 

(908) 852-3700

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock par value $0.00001 per share   VISL   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such a shorter period than the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such a shorter period than the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer   Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by a checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

As of August 11, 2023, the registrant’s common stock shares are 2,377,362.

 

 

 

   

 

 

VISLINK TECHNOLOGIES, INC.

QUARTERLY REPORT ON FORM 10-Q

For the six months ended June 30, 2023

 

  Page
Number
PART I: FINANCIAL INFORMATION  
Item 1. Financial Statements 1
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 23
Item 3. Quantitative and Qualitative Disclosures About Market Risk 29
Item 4. Controls and Procedures 29
   
PART II. OTHER INFORMATION  
Item 1. Legal Proceedings 30
Item 1A. Risk Factors 30
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 31
Item 3. Defaults Upon Senior Securities 31
Item 4. Mine Safety Disclosures 31
Item 5. Other Information 31
Item 6. Exhibits 31
SIGNATURES 32

 

   

 

 

PART I: FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Index to Condensed Consolidated Financial Statements

 

Condensed Consolidated Balance Sheets as of June 30, 2023 (unaudited) and December 31, 2022 3
Unaudited Condensed Consolidated Statements of Operations and Other Comprehensive Loss Income for the three and six months ended June 30, 2023, and 2022 4
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and six months ended June 30, 2023 5
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and six months ended June 30, 2022 6
Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2023, and 2022 7
Notes to Unaudited Condensed Consolidated Financial Statements 9

 

 1 

 

 

FORWARD-LOOKING INFORMATION

 

This Quarterly Report on Form 10-Q (including the section regarding Management’s Discussion and Analysis of Financial Condition and Results of Operations) (the “Report”) contains forward-looking statements regarding our business, financial condition, results of operations, and prospects. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and similar words and phrases are intended to identify forward-looking statements. However, this is not an all-inclusive list of words or phrases identifying forward-looking statements in this Report. Also, all information concerning future matters is forward-looking statements.

 

Although forward-looking statements in this Report reflect our management’s good faith judgment, such information is based on facts and circumstances we currently know. Forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from those discussed in or anticipated by the forward-looking statements. Without limitation, factors that could cause or contribute to such differences in results and outcomes include those discussed in this Report.

 

We file reports with the Securities and Exchange Commission (“SEC”), and those reports are available free of charge on our website (www.vislinktechnologies.com) under “About/Investor Information/SEC Filings.” The reports available include our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports, which are available as soon as reasonably practicable after we electronically file such materials or furnish them to the SEC. You can also read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, DC 20549. You can obtain additional information about the Public Reference Room’s operation by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet site (www.sec.gov) containing reports, proxies, information statements, and other information regarding issuers that file electronically with the SEC, including us.

 

We undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date of this Report. We urge you to carefully review and consider all the disclosures made in this Report.

 

REFERENCES TO VISLINK

 

In this Quarterly Report, unless otherwise stated or the context otherwise indicates, references to “VISL,” “Vislink,” “the Company,” “we,” “us,” “our,” and similar references refer to Vislink Technologies, Inc., a Delaware corporation.

 

 2 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)

 

   June 30,   December 31, 
   2023   2022 
    (unaudited)      
ASSETS          
Current assets          
Cash and cash equivalents  $10,973   $25,627 
Accounts receivable, net   5,747    6,007 
Inventories, net   13,177    12,021 
Investments held to maturity   10,837     
Prepaid expenses and other current assets   2,376    1,232 
Total current assets   43,110    44,887 
Right of use assets, operating leases   940    1,075 
Property and equipment, net   1,744    1,434 
Intangible assets, net   3,910    4,400 
Total assets  $49,704   $51,796 
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities          
Accounts payable  $3,333   $2,626 
Accrued expenses   1,436    1,568 
Notes payable   394    84 
Operating lease obligations, current   406    455 
Customer deposits and deferred revenue   1,921    1,540 
Total current liabilities   7,490    6,273 
Operating lease obligations, net of current portion   934    1,107 
Deferred tax liabilities   655    764 
Total liabilities   9,079    8,144 
           
Commitments and contingencies (See Note 12)   -    - 
Series A Preferred stock, $0.00001 par value per share: -0- shares authorized on June 30, 2023, and December 31, 2022, respectively; -0- and 47,419 shares issued and outstanding on June 30, 2023, and December 31, 2022, respectively.        
Stockholders’ equity          
Preferred stock, $0.00001 par value per share: 10,000,000 shares authorized on June 30, 2023, and December 31, 2022, respectively        
Common stock, $0.00001 par value per share, 100,000,000 shares authorized on June 30, 2023, and December 31, 2022, respectively: Common stock, 2,377,362 and 2,370,966 were issued, and 2,377,229 and 2,370,833 were outstanding on June 30, 2023, and December 31, 2022, respectively.        
Additional paid-in capital   346,822    345,365 
Accumulated other comprehensive loss   (1,037)   (1,337)
Treasury stock, at cost – 133 shares as of June 30, 2023, and December 31, 2022, respectively   (277)   (277)
Accumulated deficit   (304,883)   (300,099)
Total stockholders’ equity   40,625    43,652 
Total liabilities and stockholders’ equity  $49,704   $51,796 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 3 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND
OTHER COMPREHENSIVE LOSS
(IN THOUSANDS EXCEPT NET LOSS PER SHARE DATA)

 

   2023   2022   2023   2022 
   For the Three Months Ended   For the Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Revenue, net  $5,043   $6,766   $12,231   $13,626 
Cost of revenue and operating expenses                    
Cost of components and personnel   2,361    3,186    5,675    6,609 
Inventory valuation adjustments   175    101    304    197 
General and administrative expenses   4,679    4,439    9,707    9,349 
Research and development expenses   908    1,151    1,675    2,269 
Amortization and depreciation   304    465    602    922 
Total cost of revenue and operating expenses   8,427    9,342    17,963    19,346 
Loss from operations   (3,384)   (2,576)   (5,732)   (5,720)
Other income (expense)                    
Unrealized loss on investments held to maturity   (35)       (63)    
Gain on settlement of debt       9        9 
Other income   (11)   (10)   330    316 
Dividend income   128        219     
Interest income, net   220    (5)   353    (5)
Total other income (expense)   302    (6)   839    320 
Net loss before income taxes   (3,082)   (2,582)   (4,893)   (5,400)
Income taxes                    
Deferred tax benefits   54    56    109    107 
Net loss   (3,028)   (2,526)   (4,784)   (5,293)
                     
Basic and diluted loss per share  $(1.27)  $(1.10)  $(2.02)  $(2.30)
Weighted average number of shares outstanding:                    
Basic and diluted   2,377    2,305    2,374    2,298 
Comprehensive loss:                    
Net loss  $(3,028)  $(2,526)  $(4,784)  $(5,293)
Unrealized gain (loss) on currency translation adjustment   145    (1,407)   300    (1,139)
Comprehensive loss  $(2,883)  $(3,933)  $(4,484)  $(6,432)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 4 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023

(IN THOUSANDS, EXCEPT SHARE DATA)

 

Three months ending June 30, 2023:

 

                                     
                        Accumulated             
   Series A           Additional   Other             
  Preferred Stock   Common Stock   Paid In  Comprehensive   Treasury   Accumulated     
   Shares   Amount   Shares   Amount   Capital   Income (Loss)   Stock   Deficit   Total 
                                     
Balance, March 31, 2023*      $    2,377,362   $   $346,486   $(1,182)  $(277)  $(301,855)  $43,172 
Net loss                               (3,028)   (3,028)
Unrealized gain on currency translation adjustment                       145            145 
Stock-based compensation                   336                336 
Balance, June 30, 2023      $    2,377,362   $   $346,822   $(1,037)  $(277)  $(304,883)  $40,625 
                                              
Six months ending June 30, 2023:                              
                                              
Balance, January 1, 2023*   47,419   $    2,367,362   $   $345,365   $(1,337)  $(277)  $(300,099)  $43,652 
Net loss                               (4,784)   (4,784)
Unrealized gain on currency translation adjustment                       300            300 
Elimination of Series A Preferred Stock   (47,419)                                
Issuance of common stock in connection with:                                             
Compensation awards for services previously accrued           10,000        200                200 
Stock-based compensation                   1,257                1,257 
Balance, June 30, 2023      $    2,377,362   $   $346,822   $(1,037)  $(277)  $(304,883)  $40,625 

 

  

*In connection with the reverse stock split implemented by the Company on May 1, 2023, the company’s stock transfer agent calculated a de minimus adjustment to the opening quantity of shares issued.

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 5 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022

(IN THOUSANDS, EXCEPT SHARE DATA)

 

Three months ending June 30, 2022:

 

                       Accumulated             
               Additional   Other             
   Preferred Stock   Common Stock   Paid In   Comprehensive   Treasury   Accumulated     
   Shares   Amount   Shares   Amount   Capital   Loss   Stock   Deficit   Total 
Balance, March 31, 2022*      $    2,287,669   $   $344,493   $(565)  $(277)  $(289,306)  $54,345 
Net loss                               (2,526)   (2,526)
Unrealized gain on currency translation adjustment                       (871)           (871)
Issuance of common stock in connection with:                                             
Satisfaction of accounts payable vendor balance           1,935        31                31 
Satisfaction of withholding tax upon conversion of restricted stock units           17,889                         
Satisfaction with the conversion of restricted stock units           57,952                         
Stock-based compensation                   208                208 
Balance, June 30, 2022      $    2,365,445   $   $344,732   $(1,436)  $(277)  $(291,832)  $51,187 
                                              
Six months ending June 30, 2022:                              
                                              
Balance, January 1, 2022*      $    2,287,669   $   $343,746   $(297)  $(277)  $(286,539)  $56,633 
Net loss                               (5,293)   (5,293)
Unrealized gain on currency translation adjustment                       (1,139)           (1,139)
Satisfaction of accounts payable vendor balance           1,935        31                31 
Satisfaction of withholding tax upon conversion of restricted stock units           17,889                         
Satisfaction with the conversion of restricted stock units           57,952                         
Stock-based compensation                   955                955 
Balance, June 30, 2022      $    2,365,445   $   $344,732   $(1,436)  $(277)  $(291,832)  $51,187 

 

*In connection with the reverse stock split implemented by the Company on May 1, 2023, the company’s stock transfer agent calculated a de minimus adjustment to the opening quantity of shares issued.

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 6 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN THOUSANDS)

 

   2023   2022 
  

For the Six Months Ended

June 30,

 
   2023   2022 
         
Cash flows used in operating activities          
Net loss  $(4,784)  $(5,293)
Adjustments to reconcile net loss to net cash used in operating activities          
Gain on settlement of debt       (9)
Deferred tax benefits   (109)   (107)
Unrealized loss on the fair value of investments in bonds held to maturity   63     
Accretion of bond discount   (137)    
Stock-based compensation   1,257    955 
Stock issuance commitments       200
Provision for bad debt   38    15 
Recovery of bad debt   (6)   (38)
Inventory valuation adjustments   304    197 
Amortization of right-of-use assets, operating assets   135    104 
Depreciation and amortization   602    922 
Changes in assets and liabilities          
Accounts receivable   323    111 
Inventories   (1,196)   (3,934)
Prepaid expenses and other current assets   (619)   1,118 
Accounts payable   708    202 
Accrued expenses   68    (1,749)
Operating lease obligations   (222)   (286)
Customer deposits and deferred revenue   381    (646)
Net cash used in operating activities   (3,194)   (8,238)
Cash flows used in investing activities          
Cash used for investments held to maturity   (10,763)    
Cash used for property and equipment   (421)   (298)
Net cash used in investing activities   (11,184)   (298)
Cash flows used in financing activities          
Principal payments made on notes payable   (213)   (458)
Net cash used in financing activities   (213)   (458)
Effect of exchange rate changes on cash   (63)   (358)
Net decrease in cash and cash equivalents   (14,654)   (9,352)
Cash and cash equivalents, beginning of the period   25,627    36,231 
Cash and cash equivalents, end of the period  $10,973   $26,879 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 7 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)

(IN THOUSANDS)

 

  

For the Six Months Ended

June 30,

 
   2023   2022 
         
Supplemental disclosure of cash flow information:          
Cash paid during the period for interest  $6   $6 
Supplemental disclosure of non-cash information:          
Notes payable  $523   $943 
Common stock issued in connection with:          
Settlement of accounts payable  $   $31 
Compensation awards previously accrued  $200   $ 
ROU assets and operating lease obligations recognized (Note 6):          
Operating lease assets recognized  $   $ 
Less: non-cash changes to operating lease assets amortization  $(135)  $(104)
ROU assets and operating lease obligations recognized   (135)   (104)
Operating lease liabilities recognized  $   $ 
Less: non-cash changes to operating lease liabilities accretion   (222)   (286)
Operating lease liabilities recognized  $(222)  $(286)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 8 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Operations

 

Incorporated in Delaware in 2006, Vislink Technologies, Inc. (“Vislink”) is an innovative technology company that collects, delivers and manages real-time video from the action scene to the viewing screen. The Company designs, develops, and deploys innovative products and turnkey solutions that deliver reliable connectivity across real-time production, military, and government sectors worldwide in the most demanding environments. Vislink is a leader in designing and deploying wireless video solutions, providing customers with reliable and secure video and data transmission. The company is committed to delivering the latest technology and the highest quality products to meet its customers’ needs. Vislink provides solutions for collecting live news, sports, and entertainment events for the broadcast markets. Our Mobile Viewpoint product line offers live streaming solutions that use bonded cellular, 5G, and AI-driven technologies to automate the production of news and sports content. In addition to creating real-time video intelligence solutions, Vislink assists first responders, law enforcement agencies at all levels of government, and military organizations with increased situational awareness. Besides providing professional and technical services, Vislink employs a team of technology experts with decades of experience and applied knowledge of terrestrial microwaves, satellites, fiber optics, surveillance systems, and wireless communications systems to offer customers a wide range of services.

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated interim financial statements and these notes should be viewed in conjunction with Vislink Technologies, Inc.’s 2022 Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on March 31, 2023, which contains the audited consolidated financial statements and notes thereto as of December 31, 2022. As of December 31, 2022, a condensed consolidated balance sheet was prepared based on audited annual financial statements but did not include all of the footnote disclosures from the annual financial statements. In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of routine recurring adjustments, necessary for a fair statement of its financial position as of June 30, 2023, as well as results of operations for the three months and six months ended June 30, 2023, and 2022, as well as cash flow for the six months ended June 30, 2023, and 2022. For the six months ended June 30, 2023, the results of operations are not necessarily indicative of the results for the entire year, any other interim period, or any future period. Effective May 1, 2023, the Company effected a one-for-20 reverse stock split of the common stock. All per-share numbers reflect the one-for-20 reverse stock split. We have retroactively applied the reverse split throughout this quarterly report to all periods presented. The accounting policies of Vislink have not materially changed since December 31, 2022. Note 3 of Vislink’s 2022 annual report on Form 10-K provides detailed information about these policies.

 

Principles of Consolidation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. The Company has eliminated all intercompany accounts and transactions upon consolidating our subsidiaries.

 

Segment Reporting

 

The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the United States, United Kingdom, and the Netherlands.

 

Use of Estimates

 

The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities at the date of the unaudited condensed consolidated financial statements. These estimates also affect the reported revenues and expenses during the reporting periods. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. Actual results could differ from estimates, and any such differences may be material to our unaudited condensed consolidated financial statements.

 

 9 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Allowance for credit losses

 

Change in accounting principles

 

In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.

 

The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.

 

Recently Issued Accounting Principles

 

Recent Accounting Pronouncements

 

Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

 

NOTE 2 — LIQUIDITY AND FINANCIAL CONDITION

 

For the six months ended June 30, 2023, the Company incurred an approximate loss of $5.7 million from operations and used $3.2 million of cash for operational purposes. On June 30, 2023, the Company had $35.6 million in working capital, $304.9 million in accumulated deficits, and $11.0 million in cash.

 

During the first quarter of 2023, the Company invested approximately $10.8 million of its cash reserves in Federal bonds and $11.3 million in Federally insured money market mutual funds, primarily to increase investment income.

 

The Company’s liquidity requirements may be affected by a variety of factors. These factors include inflation, foreign exchange fluctuations, market conditions, strategic acquisitions, market strategy, research and development activities, regulatory matters, and product and technology innovations. The Company believes it will have sufficient funds to continue operations for at least twelve months from the filing date of these unaudited condensed consolidated financial statements.

 

 10 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 3 — LOSS PER SHARE

 

The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):

 

   2023   2022 
   Six months Ended 
   June 30 
   2023   2022 
Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:          
Stock options   85    29 
Warrants   456    459 
Total   541    488 

 

NOTE 4 — FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES

 

The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive income approximately as follows:

 

   2023   2022   2023   2022 
   Three months ended   Six months ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Net foreign exchange transactions:                    
(Gains) Losses  $41,000   $(21,000)  $(3,000)  $(5,000)
Accumulated comprehensive income:                    
Unrealized (gains) losses on currency translation adjustment  $10,000   $(871,000)  $(145,000)  $(1,139,000)

 

The exchange rates adopted for foreign exchange transactions are quoted on OANDA, a Canadian-based foreign exchange company. This website offers currency conversion, online retail foreign exchange trading, foreign currency transfers, and currency information through its website. Based on the following exchange rates, the Company converted amounts between British Pounds and US Dollars and Euros into British Pounds for the respective periods:

 

  As of June 30, 2023 – £1.266150 to $1.00; €1.088440 to $1.00
     
  The average exchange rate for the six months ended June 30, 2023 – £1.233240 to $1.00; €1.080655 to $1.00
     
  As of June 30, 2022 – £ 1.080655 to $1.00; €1.044949 to $1.00
     
  The average exchange rate for the six months ended June 30, 2022 – £1.298904 to $1.00; €1.091890 to $1.00
     

 

NOTE 5 — CASH AND CASH EQUIVALENTS

 

The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of unrestricted funds invested in a money market mutual fund. The following table illustrates the Company’s cash and cash equivalents:

 

   June 30,   December 31, 
   2023   2022 
         
Cash on hand   $1,542,000   $25,627,000 
Federally insured money market mutual funds    9,431,000     
Total cash and cash equivalents   $10,973,000   $25,627,000 

 

 11 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 6 — INVESTMENTS

 

The Company used cash to purchase the following debt instruments:

 

  On January 23, 2023, the Company purchased a bond, “HSBC USA INC CP,” with a face value of $5,065,789, a par value of $5,000,000, maturing October 24, 2023, a 5.1948% interest rate, at a discount of $253,289 totaling $4,812,500. The value on June 30, 2023, was $4,910,000.
     
  On February 1, 2023, the Company purchased a bond, “Federal Home Loan Banks,” with a face value of $4,999,750 and accrued interest of $25,729, a par value of $5,000,000, maturing December 22, 2023, at an interest rate of 4.750%, totaling $5,025,479. The value on June 30, 2023, was $4,981,000.
     
  On February 28, 2023, the Company purchased a bond, “Federal National Mortgage Association,” with a face and par value of $950,000, maturing February 28, 2024, at an interest rate of 5.07%, totaling $950,000. The value on June 30, 2023, was $946,000.

 

The Company identified these transactions as investments in debt security and will apply the guidance under ASC Topic 320, “Investments in debt securities,” and for interest income guidance under ASC Topic 310-20, “Receivables.” As of June 30, 2023, the abovementioned investments have a stated maturity of one year or less. Management intends to treat these investments as held to maturity.

 

The Company has determined the fair value of its investments held to maturity based on Level 1 input as of June 30, 2023:

 

   Level 1   Level 2   Level 3   Total 
                 
Federal Bonds  $   $10,837,000   $   $10,837,000 
                     
   $   $10,837,000   $   $10,837,000 

 

The Company’s investments held to maturity are as follows as of June 30, 2023:

 

   Amortized Cost   Unrealized Gains   Unrealized Losses   Fair Value 
                 
Federal Bonds  $10,900,000       $63,000   $10,837,000 
                     
   $10,900,000   $   $63,000   $10,837,000 

 

NOTE 7 — INTANGIBLE ASSETS

 

The following table illustrates finite intangible assets as of June 30, 2023:

 

   Proprietary Technology   Patents and Licenses   Trade Names & Technology   Customer Relationships     
                                     
       Accumulated       Accumulated       Accumulated       Accumulated     
   Cost   Amortization   Cost   Amortization   Cost   Amortization   Cost   Amortization   Net 
Balance, December 31, 2022  $2,132,000   $(815,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,189,000)  $5,095,000   $(3,074,000)  $4,400,000 
                                              
Amortization       (294,000)               (69,000)       (127,000)   (490,000)
Balance, June 30, 2023  $2,132,000   $(1,109,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,258,000)  $5,095,000   $(3,201,000)  $3,910,000 

 

The Company continuously monitors intangible assets for potential impairments based on operating results, events, and circumstances. As of June 30, 2023, management identified no triggering events.

 

 12 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 7 — INTANGIBLE ASSETS (continued)

 

The Company’s groups of intangible assets consist primarily of:

 

Proprietary Technology:

Generally, the Company amortizes proprietary technology over 3 to 5 years. Wireless multiplex transmitters and artificial intelligence are the proprietary technologies that MVP uses internally to produce and sell products and services to customers.

 

Patents and Licenses:

Patents and licenses filed by the Company are amortized for 18.5 to 20 years. The amortization of the costs associated with provisional patents and pending applications begins after successful review and filing.

 

Trade Name, Technology, and Customer Relationships:

Other intangible assets are amortized for 3 to 15 years. Prior IMT, Vislink, and MVP acquisitions contributed to developing these intangible assets, including trade names, technology, and customer lists.

 

The Company has recognized net capitalized intangible costs as follows:

 

   June 30,   December 31, 
   2023   2022 
Proprietary Technology  $1,025,000   $1,319,000 
Trade Names and Technology   991,000    1,060,000 
Customer Relationships   1,894,000    2,021,000 
   $3,910,000   $4,400,000 

 

The Company has recognized the amortization of intangible assets as follows:

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Proprietary Technology  $148,000   $148,000   $294,000   $293,000 
Patents and Licenses       167,000        331,000 
Trade Names and Technology   34,000    34,000    69,000    69,000 
Customer Relationships   64,000    64,000    127,000    127,000 
   $246,000   $413,000   $490,000   $820,000 

 

The weighted average remaining life of the amortization of the Company’s intangible assets is approximately 5.2 years as of June 30, 2023. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:

 

Period ending June 30,    
2024  $636,000 
2025   635,000 
2026   595,000 
2027   533,000 
2028   349,000 
Thereafter   1,162,000 
Finite-Lived Intangible Assets, Net, Total  $3,910,000 

 

 13 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 8 — NOTES PAYABLE

 

The table below represents the Company’s notes payable as of June 30, 2023, and December 31, 2022:

 

   Principal 
   June 30,
2023
   December 31,
2022
 
The Company renewed its D&O insurance policy on April 5, 2022, reducing the premium to approximately $1,037,000, less a down payment of $194,000, with the remaining balance financed. The loan’s terms are for nine months at a 2.09% annual interest rate and a monthly principal and interest payment of approximately $84,000. Accordingly, the Company recorded interest expenses of $-0- and $150 for the three and six months ended June 30, 2023, and $-0- and $2,000 for the three and six months ended June 30, 2022, respectively. As of June 30, 2023, the note has been fully repaid.   $   $84,000 
           
The Company renewed its D & O insurance policy on April 5, 2023, reducing the premium to approximately $811,000, less a down payment of $288,000, financing the remaining balance of approximately $523,000. The loan’s terms are for nine months at a 6.14% annual interest rate and a monthly principal and interest payment of approximately $67,000. Accordingly, the Company recorded interest expenses of $5,000 for the three and six months ended June 30, 2023, and $-0- for the three and six months ended June 30, 2022.    394,000      
   $394,000   $84,000 

 

NOTE 9 — LEASES

 

In addition to leasing office space, deployment sites, and storage warehouses, the Company also leases warehouse space internationally and domestically. Operating leases have various terms and provisions as of June 30, 2023, with lease terms remaining between one and four years. In certain individual leases, rent escalation clauses and lease concessions require additional rental payments in the later years of the lease term. These types of contracts are recognized on a straight-line basis over the minimum lease term.

 

The Company recorded $0.9 million in Right-Of-Use (“ROU”) assets on June 30, 2023, net of $1.3 million in accumulated amortization. Moreover, the Company recorded an operating lease liability of approximately $1.3 million, of which $0.4 million was current and $0.9 million was non-current. The weighted average remaining term of lease contracts on June 30, 2023, was 3.1 years, with maturity dates ranging between July 2023 and May 2027, in addition to a weighted-average discount rate of 9.5%.

 

There were no material adjustments to straight-line rental expenses for those periods. Most of the costs recognized for each period were reflected in cash used in operating activities. This expense primarily consisted of payments for office and warehouse base rent. In addition, the Company has the right to renew individual leases at various renewal terms, although the Company is not obligated to do so. Short-term lease costs, taxes, and variable service charges were immaterial.

 

A one-year lease for 600 square feet of administrative office space in Luton, UK, was signed on June 1, 2023, and will run through May 31, 2024, at approximately $2,100 per month.

 

 14 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 9 — LEASES (continued)

 

The following table illustrates operating lease data for the three months ending June 30, 2023, and 2022:

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Lease cost:                    
Operating lease cost  $103,000   $114,000   $206,000   $233,000 
Short-term lease cost   10,000    10,000    20,000    159,000 
Total lease cost  $113,000   $124,000   $226,000   $392,000 
Cash paid for lease liabilities:                    
Cash flows from operating leases            $325,000   $253,000 
Weighted-average remaining lease term—operating leases             3.1 years    3.8 years 
Weighted-average discount rate—operating leases             9.5%   9.4%

 

Maturities of operating lease liabilities were as follows as of June 30, 2023:

 

     
   Amount 
2024  $507,000 
2025   468,000 
2026   341,000 
2027   186,000 
2028    
Thereafter    
Total lease payments   1,502,000 
Less: imputed interest   162,000 
Present value of lease liabilities   1,340,000 
Less: Current lease liabilities   406,000 
Non-current lease liabilities  $934,000 

 

The table below lists the location and lease expiration date from 2023 through 2027:

 

Location  Square Footage   Lease-End
Date
  Approximate
Future Payments
 
Colchester, UK   16,000   Dec 2025   $554,000 
Singapore   950   July 2023   $3,000 
Billerica, MA   2,000   Dec 2026   $43,000 
Hemel, UK   12,870   Oct 2023   $367,000 
Mount Olive, NJ   7,979   Jan 2027   $535,000 

 

 15 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 10 — STOCKHOLDERS’ EQUITY

 

Preferred stock

 

On March 22, 2023, the Board of Directors of the Corporation approved a resolution to eliminate the Corporation’s Certificate of Designation, Preferences, and Rights (the “Certificate of Elimination”) of the Series A Preferred Stock, par value $0.00001 per share (the “Series A Preferred Stock”), that was filed with the Secretary of State of the State of Delaware on November 9, 2022.

 

Upon the effective filing of this Certificate of Elimination, the shares previously designated under the certificate of designation as Series A Preferred Stock shall resume the status of authorized but unissued shares of preferred stock of the Corporation. As of March 31, 2023, 47,500 shares are authorized, and no Series A Preferred Stock was issued or outstanding.

 

Common stock

 

Nasdaq compliance and reverse stock split

 

On May 20, 2022, we received notice from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of its noncompliance with Bid Price Rule by failing to maintain a minimum bid price for its common Stock on the Nasdaq Capital Market of at least $1.00 per share for 30 consecutive business days. The Company received a grace period of 180 days, or until November 16, 2022, to regain compliance with the minimum bid price requirement.

 

On November 10, 2022, the Company submitted a request to Nasdaq for an additional 180-day grace period to regain compliance with the minimum bid price requirement. On November 17, 2022, the Company received a letter from Nasdaq advising that the Company had been granted an additional 180-day grace period extension until May 15, 2023, to regain compliance with the minimum bid price requirement and all other applicable requirements for initial listing on the Nasdaq Capital Market except for the minimum bid price requirement. On May 15, 2023, the Company received a letter from the Nasdaq informing it of its return to compliance with the Bid Price Rule. Therefore, the Common Stock continues to be traded on the Nasdaq Capital Market. If the Company fails to comply with the continued listing requirements of Nasdaq, such as its corporate governance requirements or the Bid Price Rule, Nasdaq may delist the Common Stock.

 

On January 11, 2023, the Company held a special meeting of stockholders (the “Special Meeting”) whereby stockholders approved a proposal to authorize the Board of Directors of the Company (the “Board”), in its discretion but before the one-year anniversary of the date of the Special Meeting, to implement an amendment to the Company’s certificate of incorporation to effect a reverse stock split (the “Reverse Stock Split”) of all of the outstanding shares of Common Stock, of the Company, at a ratio in the range of 1-for-2 to 1-for-50.

 

On May 1, 2023, the Company effected a 1-for-20 reverse stock split. Upon effectiveness of the reverse stock split, every twenty shares of an outstanding common stock decreased to one share of common stock. We have retroactively applied the reverse split throughout this quarterly report to all periods presented.

 

Other common stock activity

 

During the six months that ended June 30, 2023, the Company:

 

  has issued 10,000 shares of common stock to specific board members as part of a commitment agreement valued at $200,000. The common stock’s value was determined on the agreement’s original date.
     
  recognized approximately $1,257,000 of stock-based compensation costs associated with outstanding stock options in general and administrative expenses offsetting additional capital investments.

 

 16 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 10 — STOCKHOLDERS’ EQUITY (continued)

 

Common stock warrants

 

In the six months ending June 30, 2023, 2,667 warrants expired. These outstanding warrants did not have an intrinsic value as of June 30, 2023. On June 30, 2023, the weighted average exercise price of warrants outstanding is $66.00, with a weighted average remaining contractual life of 2.61 years.

 

The following table sets forth common stock purchase warrants outstanding as of June 30, 2023:

 

  

Number of Warrants

(in shares)

  

Weighted

Average

Exercise

Price

 
         
Outstanding, December 31, 2022   458,747   $72.00 
Warrants granted, exercised, canceled, or expired   (2,667)    
Outstanding and exercisable, June 30, 2023   456,080   $66.00 

 

 17 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 11 — STOCK-BASED COMPENSATION

 

Long-term stock incentive plan awards:

 

The Company’s stock option plans provide options to purchase shares of common stock to officers, directors, other key employees, and consultants. The purchase price may be paid in cash or “net settled” in the Company’s common stock shares. In a net settlement of an option, the Company does not require payment of the exercise price from the holder but reduces the number of shares of common stock issued upon the exercise of the stock option by the smallest amount of whole shares that have an aggregate fair market value equal to or over the aggregate exercise price for the option shares covered by the option exercised. Options generally vest over three years from the grant date and expire ten years from the grant date.

 

Inducement Awards:

 

Time-vested options

The Company grants time-vested stock options to various employees in connection with their employment agreements. The equity awards are ten-year, non-statutory time-vested option inducement awards under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans (all subject to continued employment).

 

Performance-based stock options

The Company grants performance-based stock options to various employees in connection with their employment agreements. The equity awards are ten-year, non-statutory performance-based stock option inducement awards under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans that will vest in three equal tranches upon achievement of applicable performance conditions for each tranche (all subject to continued employment).

 

Restricted Stock Units (“RSUs”):

 

Time-based awards

The Company grants employees time-based restricted stock units (“RSUs”) subject to continued employment. The equity awards have an initial vesting between 25% and 33% on their one-year anniversary dates and will vest between 24 and 36 equal monthly periods thereafter.

 

Performance-based awards

The Company grants employees performance-based restricted stock unit awards subject to performance vesting conditions and continued employment. The equity awards will vest in three equal tranches upon reaching performance conditions for each tranche.

 

As shown in the following table, stock-based compensation expense is included in general and administrative expenses under the following plans:

 

                 
   Three months ended   Six months ended 
   June 30,   June 30, 
Equity-based plans:  2023   2022   2023   2022 
Long-term stock incentive plan awards  $   $   $   $1,000 
Time-vested option inducement awards   37,000    28,000    107,000    56,000 
Performance-based stock option inducement award   -    -        - 
Time-based restricted stock awards
   299,000    180,000    1,150,000    898,000 
Performance-based restricted stock awards                
Stock-based compensation expense  $336,000   $208,000   $1,257,000   $955,000 

 

 18 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 11 — STOCK-BASED COMPENSATION (continued) 

 

The following table illustrates supplementary data under various equity compensation plans:

 

    Six months ended     Six months ended  
    June 30,     June 30,  
    2023     2022     2023     2022  
    Quantity     Weighted Average     Quantity     Weighted Average     Quantity     Weighted Average     Quantity     Weighted Average  
    Long-term stock incentive plan awards     Time-vested option inducement awards  
Balance-January 1st, outstanding     2,250     $ 1,756       2,496     $ 1,795.80       24,721     $ 13.00       24,721     $ 20.20  
Granted, canceled, expired                                                
Forfeited     (58 )     (1,166.00 )     (171 )     (1,931.60 )                        
Balance-June 30th, outstanding     2,192     $ 1,771.40       2,325     $ 1,754.00       24,721     $ 10.00       24,721     $ 17.80  
Balance-June 30th, exercisable     2,192     $ 1,771.40       2,463     $ 1,802.00       24,721     $ 18.00       14,936     $ 29.60  
Remaining compensation expense     $       $       $212,000       $442,000  
Remaining amortization period     0.0 years       0.0 years       0.6 years       1.6 years  
Weighted average remaining contractual life – options outstanding and exercisable     4.0 years and 4.0 years       5.1 years and 5.0 years       6.6 years and 6.6 years       7.6 years and 7.6 years  
Intrinsic value per share     $       $       $       $  
Range of exercise prices     $139.20 to $1,944.00       $139.20 to $23,472.00       $19.20 to $34.20       $19.20 to $34.20  
                                                                 
      Performance-based stock option inducement awards       Time-based restricted stock awards  
Balance-January 1st, outstanding     12,500     $ 33.00       12,500     $ 33.00       140,736     $ 23.00       39,933     $ 63.40  
Granted, canceled, expired                             41,250       9.00       107,053       20.80  
Forfeited                             (19,415 )     (21.40            
Balance-June 30th, outstanding     12,500      $ 33.00       12,500      $ 33.00       162,571      $ 12.60       146,986       26.20  
Balance-June 30th, exercisable         $           $       63,098     $ 40.20       12,472     $ 100.80  
Remaining compensation expense     $414,000       $414,000       $2,049,000       $3,857,000  
Remaining amortization period     1.6 years       2.6 years       1.7 years       3.0 years  
Weighted average remaining contractual life – options outstanding and exercisable     6.6 years and 0.0 years       7.6 years and 7.6 years       2.1 years and 1.8 years       3.0 years and 4.0 years  
Intrinsic value per share     $       $       $       $  
Range of exercise prices     $34.20       $34.20       $8.00 to $72.00       $19.60 to $72.00  
                               
                                      Performance-based restricted stock awards  
Balance-January 1st, outstanding                                     71,303     $ 58.00       63,369     $ 58.80  
Granted, canceled, expired                                                 71,303       21.00  
Forfeited                                     (19,649 )     (21.00 )            
Balance-June 30th, outstanding                                     51,654     $ 22.00       134,762     $ 38.80  
Balance-June 30th, exercisable                                         $       63,369     $ 82.40  
Remaining compensation expense                                     $1,085,000       $1,498,000  
Remaining amortization period                                     2.5 years       7.7 years  
Weighted average remaining contractual life – options outstanding and exercisable                                     2.5 years and 0.0 years       4.3 years and 3.8 years  
Intrinsic value per share                                     $       $  
Range of exercise prices                                     $21.00 to $72.00       $21.00 to $72.00  

 

 19 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 12 — COMMITMENTS AND CONTINGENCIES

 

Pension:

 

The Company may make a matching contribution to its employees’ 401(k) plan. Furthermore, Vislink operates a Group Personal Plan through its UK subsidiary, investing funds with Royal London. Employees of the Company in the United Kingdom are entitled to participate in the Company’s employee benefit plan, to which varying amounts are contributed according to their status. Additionally, the Company operates a stakeholder pension plan in the United Kingdom.

 

The table below represents the Company’s matching contributions as follows:

 

   Three months ended   Six months ended 
   June 30,   June 30, 
   2022   2022   2022   2022 
Company matching contributions - Group Personal Pension Plan  $35,000   $48,000   $68,000   $97,000 

 

NOTE 13 — CONCENTRATIONS

 

Customer concentration risk

In the three and six months ended June 30, 2023, no customers exceeded 10 percent of the Company’s consolidated sales. In the three and six months ending June 30, 2022, the Company derived revenue from two customers representing more than 10% of its total consolidated sales for approximately $788,000 (12%) and $1,467,000 (11%), respectively.

 

Two customers owed the Company approximately $925,000 and 688,000, respectively, representing 16% and 12% of its consolidated net receivables on June 30, 2023. One customer owed the Company approximately $4,204,000, representing 48% of the Company’s consolidated net accounts receivable on June 30, 2022.

 

Vendor concentration risk

 

In the three months ending June 30, 2023, two vendors exceeded 10% of the Company’s consolidated purchases with approximately $465,000 and $323,000, representing 15% and 10% of the Company’s consolidated inventory purchases, respectively. In the six months ending June 30, 2023, two vendors met the criteria beyond 10% of the Company’s consolidated purchases of approximately $595,000 and $587,000, representing 10% of the Company’s consolidated inventory purchases, respectively. During the three and six months ended June 30, 2022, no vendor made purchases exceeding 10% of the Company’s total consolidated purchases.

 

As of June 30, 2023, one vendor exceeded 10% of the Company’s consolidated accounts payable of approximately $610,000 (18%). As of June 30, 2022, no vendor represented more than 10% of the Company’s accounts payable.

 

 20 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 14 – REVENUE

 

The Company has one operating segment, with the senior executive management team as the decision-making group. In the following table, the Company has disaggregated revenue by the Company’s primary geographical markets and revenue sources:

 

   Three months Ended   Six months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Primary geographical markets:                
North America  $1,721,000   $3,472,000   $4,888,000   $5,900,000 
South America   38,000    49,000    227,000    99,000 
Europe   1,593,000    2,105,000    3,436,000    4,294,000 
Asia   1,305,000    830,000    2,024,000    1,372,000 
Rest of World   386,000    310,000    1,656,000    1,961,000 
   $5,043,000   $6,766,000   $12,231,000   $13,626,000 
Primary revenue source:                    
Equipment sales  $4,279,000   $6,194,000   $10,673,000   $12,472,000 
Installation, integration, and repairs   263,000    330,000    749,000    573,000 
Warranties   501,000    242,000    809,000    581,000 
   $5,043,000   $6,766,000   $12,231,000   $13,626,000 
Long-Lived Assets:                    
United States            $2,174,000   $2,227,000 
Netherlands             23,000    28,000 
United Kingdom             4,397,000    5,471,000 
             $6,594,000   $7,726,000 

 

NOTE 15 — OTHER INCOME (REBATES)

 

The following table represents tax rebates related to the research costs incurred by our U.K. subsidiary.

 

   Three months Ended   Six months Ended 
   June 30,    June 30, 
    2023    2022    2023    2022 
Total tax rebates  $**5,000  $*(10,000)  $329,000   $284,000 

 

** An increase of $5,000 represents a strengthening in the exchange rate from British Pounds to U.S. dollars, resulting in a gain from initial recognition of $324,000 in the first quarter of fiscal 2023.
     
*   As a result of a weakening in the translation rate from British pounds to U.S. dollars, this $10,000 decrease represents a loss compared to the initially recognized $294,000 in fiscal 2022.

 

While the Company plans to continue filing rebate forms for the 2023 fiscal year, it cannot guarantee that rebates will be available at a similar level or at all in future years.

 

 21 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 16 — RECLASSIFICATION OF PRIOR YEAR PRESENTATION

 

We reclassified other income amounts from the prior year to ensure consistency with the presentation of the current year’s condensed consolidated statement of operations. For the three and six months ended June 30, 2022, adjustments have been made to the condensed consolidated statements of operations and comprehensive loss. Tax rebates related to research costs incurred by our UK subsidiary were separated from other revenue to other income. The reclassification did not affect the reported operating results.

 

NOTE 17 — SUBSEQUENT EVENTS

 

Office lease

 

The Company renewed its lease for 976 square feet of administrative office space commencing on July 3, 2023, and terminating on July 2, 2024, in Dubai Studio City, UAE, for approximately $1,632 monthly.

 

Relocation of United Kingdom manufacturing division

 

Following an ever-changing global business landscape, in July 2023, the Company strategically decided to consolidate its UK division and relocate its activities to the United States in September 2023. As a result of the move, management believes that operational efficiency will be optimized, productivity will be enhanced, and our position in the global market will be strengthened. Additionally, the move will:

 

enhance our ability to meet future working capital requirements,
eliminate obsolete inventory items,
reduce the usage of our UK Colchester facility, and
simultaneously reduce miscellaneous operating costs.

 

Our commitment to continuous improvement and growth has driven our decision to relocate our manufacturing division. The relocation of our manufacturing division to the United States will cost us approximately $0.2 million in severance costs over the next six months. Our relocation process will be designed to ensure minimal disruption to our operations and employees.

 

 22 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following information should be read in conjunction with the accompanying consolidated financial statements and the associated notes thereto of this Quarterly Report, the audited consolidated financial statements and the notes thereto, and our Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as filed with the U.S. Securities and Exchange Commission on March 31, 2023.

 

Effective May 1, 2023, the Company effected a one-for-20 reverse stock split of the common stock. All per-share numbers reflect the one-for-20 reverse stock split. We have retroactively applied the reverse split throughout this quarterly report to all periods presented.

 

Cautionary Note About Forward-Looking Statements

 

This report includes forward-looking statements that, although based on assumptions that we consider reasonable, are subject to risks and uncertainties, which could cause actual events or conditions to differ materially from those currently anticipated and expressed or implied by such forward-looking statements. You should read this report and the documents we reference in this report and have filed as exhibits to this report entirely and understand that our actual future results may materially differ from what we expect. You should also review the factors and risks we describe in reports we will file or submit from time to time with the SEC after this report’s date. We qualify all of our forward-looking statements by these cautionary statements.

 

Overview of COVID-19 Effects

 

The COVID-19 pandemic has caused and may continue to cause changes in our business practices (including employee travel and work locations). We may take further actions as government agencies require efforts that we determine are in the best interests of our employees, customers, and business partners. The effectiveness of such measures cannot be guaranteed.

 

As a result of the COVID-19 pandemic and mitigation measures, global supply chains and economic conditions have been adversely impacted and may continue to be adversely impacted in the future. We may be affected by these impacts regarding development, deployment, maintenance, and demand for our products and services.

 

The extent to which the COVID-19 pandemic impacts our business, operations, cash flows, and financial condition will depend on future highly uncertain developments that cannot be predicted. The Company will continue closely monitoring COVID-19’s effect on all aspects of our business and geographies. It includes updated information concerning other virus strains and their impact.

 

Ukraine/Russian Conflict

 

The war increasingly affects global financial markets and escalates ongoing economic challenges, such as inflation and disruption of global supply chains. The degree to which entities are or will be affected depends on the nature and duration of uncertain and unpredictable events. Among these events are further military actions, additional sanctions, and reactions to the ongoing developments in international financial markets. The impact of the war on these macroeconomic conditions may necessitate many companies worldwide to consider the effects of the war on their specific accounting and financial reporting practices.

 

Neither the Company nor its employees or contractors have a physical presence in Russia, Russian-controlled territories, or Ukraine. Due to Russia’s invasion of Ukraine and sanctions imposed by the U.S. and other governments—designed to exacerbate the Russian economy—business continuity, liquidity, and asset values are being affected in Ukraine and Russia, agitating global markets. In addition to increased inflation and higher energy and transportation costs, it is difficult to estimate the impact of the ongoing invasion on the global economy; the invasion of Ukraine could negatively affect our financial results. The Company does not anticipate any risks affecting its liquidity, operating results, or financial reporting, but we monitor developments in Ukraine to determine whether they will harm our business, financial condition, or results of operations.

 

Relocation of United Kingdom manufacturing division

 

The Company will begin moving its United Kingdom manufacturing division to the United States in September 2023. The relocation to the United States is anticipated to result in approximately $1.0 million in annual savings. The relocation of our manufacturing division to the United States will cost us approximately $0.2 million in severance costs over the next six months.

 

 23 

 

 

Climate Change-Related Effects

 

Our Company, partners, and communities face both opportunities and challenges related to climate change. Physical climate parameters, regulations, public policy, technology, and product demand changes will likely influence our Company’s climate change strategy. We are responsible for responding to climate change and will continue to focus on reducing our environmental impact. We will also focus on developing innovative solutions to mitigate climate change risks. We are committed to working collaboratively with our partners to achieve a sustainable future.

 

Despite our efforts to mitigate climate change risks, we recognize that climate-related risks are inherent wherever we conduct our business. There is a possibility that any of our locations will be affected by climate change. Climate-related events can disrupt our industry and our customers, increasing attrition, losses, and extra costs. It is important to us that our company’s communities have access to clean water and reliable energy. For this reason, we are committed to developing and implementing strategies to reduce our carbon footprint and ensure sustainability. We partner with organizations and governments to promote renewable energy sources and create resilient communities.

 

The increase in temperature causes natural disasters to become more frequent and severe, disrupting the operation of our business. Wildfires, floods, droughts, hurricanes, and hurricanes are natural disasters. We can also become less productive, lose customers, and incur additional costs if we have limited access to clean water and reliable energy. We must take proactive steps to mitigate the effects of climate change. We need to develop strategies to reduce our carbon footprint and find ways to make our operations more resilient to climate-related disruptions. Additionally, we must invest in technology that can help us better prepare for and respond to extreme weather events.

 

Overview

 

The Vislink Corporation was incorporated in Delaware in 2006, and it is a global technology company dedicated to collecting, delivering, and managing high-quality, live video and related data from the action scene to the viewing screen. Vislink provides solutions for collecting live news, sports, entertainment, and news events for broadcast markets. The company offers real-time video intelligence solutions through customized transmission products to the surveillance and defense markets. We also provide professional and technical services through our technology experts. These experts have decades of practical experience and applied knowledge in the terrestrial microwave, satellite, fiber optic, and surveillance systems, delivering a broad range of solutions to our customers.

 

Live Broadcast:

 

Vislink offers a broad portfolio of products and services for the live news, sports, and entertainment industries. The solutions include video collection, transmission, management, and distribution via microwave, satellite, cellular, IP (Internet Protocol), MESH, and bonded cellular/5G networks. Furthermore, we provide solutions utilizing artificial intelligence technologies to automate news and sporting events coverage. The expertise and technology portfolio of Vislink, which has been in operation for more than 50 years, enable it to deliver integrated, seamless, end-to-end solutions. Vislink’s solutions are designed to provide high-quality content and maximize operational efficiency. The Company is committed to providing its clients with the best possible service and technology. Vislink’s solutions are tailored to meet the specific needs of each customer.

 

Several industry contributors acknowledge the value of Vislink’s live broadcast solutions. With over 200,000 systems installed worldwide, most outside wireless broadcast video content is transmitted using our equipment. It is our pleasure to work closely with the majority of broadcasters around the world. Many of the world’s most prestigious sporting and entertainment events are broadcast live using Vislink wireless cameras and ultra-compact encoders. Recent examples include international sporting contests, award shows, racing events, and cultural and music festivals. Our equipment is reliable and easy to use, making it the ideal choice for broadcast professionals. We pride ourselves on providing quality products and excellent customer service. We are dedicated to helping our customers produce the best broadcast content possible.

 

Military And Government:

 

Using our expertise in live video delivery, Vislink has developed high-quality solutions to meet the operational and industry challenges of surveillance and defense markets. The Vislink solutions are designed to facilitate interagency collaboration, utilizing an internationally recognized IP platform and a web-based video delivery interface. As a provider of comprehensive video, audio, and data communications solutions to the law enforcement community and the public safety community, Vislink can provide airborne, unmanned systems, maritime, and tactical mobile command posts. Vislink solutions are designed to provide reliable and secure communications in extreme conditions, with the ability to adapt quickly to changing environments. They also offer a range of cost-effective products and services tailored to customers’ needs.

 

 24 

 

 

Military And Government (continued):

 

These solutions may include:

 

  integrated suites of airborne downlink transmitters, receivers, and antenna systems
  data and video connectivity for airborne, marine, and ground assets
  UAV video distribution
  flexible support for COFDM and bonded cellular/5G Networks
  terrestrial point-to-point
  tactical mobile command
  IP-based, high-end encryption, full-duplex, real-time connectivity at extended operating ranges
  high-throughput air/marine/ground-to-anywhere uplink and downlink systems
  secure live streaming platforms for use in mobile and fixed assets
  personal portable products

 

Vislink public safety and surveillance solutions are deployed worldwide, including in the United States, Europe, and the Middle East, at local, regional, and federal level operations, criminal investigation, crisis management, and mobile command posts. These solutions are designed to meet the needs of field operations, command centers, and central receiving centers. Short- and long-range solutions are available in established infrastructure areas and highly remote regions, making valuable video intelligence accessible regardless of location. Solutions can be tailored to meet specific customer requirements and are backed by knowledgeable and responsive support teams. Additionally, these solutions are flexible and scalable, so they can be adapted to meet changing business needs.

 

Satellite Communications:

 

Vislink’s satellite solutions are supported by over 30 years of technical expertise. These solutions ensure robust, secure communications while offering low transmission costs for organizations that require high-quality, reliable satellite transmission. In addition to providing turnkey solutions, we offer state-of-the-art coding, compression, engine modulation, and robust, lightweight antenna systems. To ensure the best possible customer experience, Vislink Satellite Solutions focus heavily on being the smallest, lightest, and most efficient in their category. Vislink lets customers choose from a wide range of satellite designs optimized for bit rate, size, weight, and total cost. Over 2,000 satellite systems have been deployed by governments, militaries, and broadcasters worldwide. Although we continue offering satellite solutions, we no longer invest in the engineering and product development necessary to remain competitive. Although we will continue to market and sell our current satellite products, we do not anticipate introducing any further upgrades or enhancements. Instead, we focus our resources on other technologies and solutions to better serve our customers. We are confident that our new strategies will provide the best solutions and products for our customers in the future.

 

Connected Edge Solutions:

 

The Mobile Viewpoint acquisition provides Vislink with the hardware and software solutions necessary for acquiring, producing, contributing, and delivering video over private or public networks. The use of connected edge solutions facilitates the video transport concept of ubiquitous IP networks and cloud-scale computing across 5G, WiFi6, Mesh, and COFDM-enabled networks. These solutions include:

 

  Live video encoding, stream adaptation, decoding, and production solutions
  Remote production workflows
  Wireless cameras
  AI-driven automated production
  Ability to contribute video over:
    ○ Bonded cellular (3G and 4G)
    Satellite
    Fiber
    Emerging networks, including 5G and Starlink

 

 25 

 

 

Results of Operations

 

Comparison for the three and six months ended June 30, 2023, and 2022

 

Revenues

 

In the three months ended June 30, 2023, the revenue was $5.0 million compared to $6.7 million for the three months ended June 30, 2022, representing a decrease of $1.7 million or 25%. In the six months ended June 30, 2023, the revenue was $12.2 million compared to $13.6 million for the six months ended June 30, 2022, representing a decrease of $1.4 million or 10%.

 

The Company discontinued several product lines in the third and fourth quarters of 2022 due to the lack of performance expectations and appeal to our customers. The Company altered its product marketing for its customer base in the last quarter of 2022 by providing a simplified approach to accessing products and solutions. We are now focusing on the products that have been successful and will invest in their further development. We are also exploring new avenues to expand our product portfolio. Additionally, we continue evaluating the market and customer feedback to ensure we make the best decisions for our long-term success.

 

Cost of Revenue and Operating Expenses

 

Cost of Components and Personnel

 

In the three months ended June 30, 2023, the cost of components and personnel was $2.4 million compared to $ 3.2 million for the three months ended June 30, 2022, representing a decrease of $0.8 million or 25%. In the six months ended June 30, 2023, the cost of components and personnel was $5.7 million compared to $6.6 million for the six months ended June 30, 2022, representing a decrease of $0.9 million or 14%.

 

Management’s decision to discontinue several product lines in the third and fourth quarters of 2022 can be attributed to reduced components and personnel costs. This cost-cutting measure will enable the Company to focus on the more profitable product lines and increase the efficiency and productivity of its operations. The move will also help the Company remain competitive and position itself for future growth.

 

General and Administrative Expenses

 

General and administrative expenses are costs incurred during the day-to-day operation of the business, including salaries, benefits, stock-based compensation, payroll taxes, trade shows, marketing programs, promotional materials, professional services, facility upkeep, general liability insurance, travel, and other operating expenses associated with an established public entity.

 

In the three months ended June 30, 2023, the general and administrative expenses were $4.7 million compared to $4.4 million for the three months ended June 30, 2022, representing an increase of $0.3 million or 7%. In the six months ended June 30, 2023, the general and administrative expenses were $9.7 million compared to $9.3 million for the six months ended June 30, 2022, representing an increase of $0.4 million or 4%.

 

The three-month increase of $0.3 million is predominantly due to warranty costs, salaries, and benefits of $0.2 million each and multiple de minimus expenses of $0.1 million each. The decrease was primarily attributed to reductions attributable to directors’ fees, computer expenses, and travel and entertainment costs of $0.2 million each.

 

The six-month increase of $0.4 million is primarily attributable to $0.3 million in stock-based compensation, $0.2 million each for dues and subscriptions, rent and utilities, legal fees, and multiple de minimus expenses of $0.1 million each. The increase was offset by decreases of $0.2 million each for insurance and directors’ fees. In addition, there were multiple de minimus expenses of $0.1 million each.

 

Research and Development Expenses

 

Research and development expenses are primarily associated with salaries and benefits, including payroll taxes, prototypes, facilities, and travel expenses.

 

In the three months ended June 30, 2023, research and development expenses were $0.9 million compared to $1.2 million for the three months ended June 30, 2022, representing a decrease of $0.3 million or 25%. In the six months ended June 30, 2023, research and development expenses were $1.7 million compared to $2.3 million for the six months ended June 30, 2022, representing a decrease of $0.6 million or 26%.

 

The three-month decrease of $0.3 million is primarily attributable to the reduction of $ 0.2 million in salaries and benefits and $0.1 million in consulting. The six-month decline of $0.6 million is mainly attributable to $0.3 in research costs, $0.2 million in salaries and benefits, and $0.1 million in consulting.

 

 26 

 

 

Amortization and Depreciation

 

In the three months ended June 30, 2023, amortization and depreciation expenses were $0.3 million compared to $0.5 million for the three months ended June 30, 2022, representing a decrease of $0.2 million or 40%. In the six months ended June 30, 2023, amortization and depreciation expenses were $0.6 million compared to $0.9 million for the six months ended June 30, 2022, representing a decrease of $0.3 million or 33%.

 

A decrease in the net book value of intangible assets is attributed to the decreased amortization of intangible asset costs.

 

Other

 

Dividend and Interest Income

 

In the three months ended June 30, 2023, dividend and interest income was $0.4 million, compared to $0.0 million for the three months ended June 30, 2022, representing an increase of $0.4 million or 100%. In the six months ended June 30, 2023, dividend and interest income were $0.6 million compared to $0.0 million for the six months ended June 30, 2022, representing an increase of $0.6 million or 100%. The increase is due to the Company’s investment in government-backed bonds held to maturity and money market funds.

 

Net Loss

 

In the three months ended June 30, 2023, the Company had a net loss of $3.1 million compared to a net loss of $2.6 million in the three months ended June 30, 2022, or an increase in net loss of $0.6 million or 23%. The Company’s net loss for the six months ending June 30, 2023, was $5.0 million, compared to $5.4 million for the six months ending June 30, 2022, or a decrease of $0.4 million or 7%.

 

The increase of the net loss of $0.6 million for the three months ended June 30, 2023, was primarily the result of a decrease in revenue of $1.8 million, as well as an increase in general and administrative expenses of $0.3 million, which was offset by a decline in component and personnel costs of $0.8 million, a reduction in research and development expenses of $0.3 million, and an increase in interest and dividend income of $0.3 million.

 

The decrease in the net loss of $0.4 million was primarily due to a reduction of revenue of $1.4 million, an increase in general and administrative expenses of $0.4 million, offset by a decrease in component costs of $0.9 million, a reduction in research and development expenses of $0.6 million, and an increase in interest income and dividend income of $0.6 million.

 

Liquidity and Capital Resources

 

For the six months ended June 30, 2023, the Company incurred an approximate loss of $5.7 million from operations and used $3.2 million of cash for operational purposes. On June 30, 2023, the Company had $35.6 million in working capital, $304.9 million in accumulated deficits, and $11.0 million in cash.

 

During the first quarter of 2023, the Company invested approximately $10.8 million of its cash reserves in Federal bonds and $11.3 million in Federally insured money market mutual funds, primarily to increase investment income. The Company’s investments in Federal bonds and money market mutual funds are intended to provide a steady source of income and liquidity. The Company believes the investment strategy carefully balances risk and return while protecting capital.

 

The Company’s liquidity requirements may be affected by a variety of factors. These factors include inflation, foreign exchange fluctuations, market conditions, strategic acquisitions, market strategy, research and development activities, regulatory matters, and product and technology innovations. The Company believes it will have sufficient funds to continue operations for at least twelve months from the filing date of these unaudited condensed consolidated financial statements.

 

Critical Accounting Policies

 

As of the date of the filing of this quarterly report, we believe there have been no material changes to our critical accounting policies during the three months ended June 30, 2023, compared to those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on March 31, 2023. The location of additional information about these critical accounting policies is in the “Management’s Discussion & Analysis of Financial Condition and Results of Operations” section included in our Annual Report on Form 10-K for the fiscal year ending December 31, 2022.

 

 27 

 

 

Cash Flows

 

The following table sets forth the significant components of our cash flow data statements for the periods presented.

 

For the Six Months Ended

(In Thousands)

 

   June 30, 
   2023   2022 
Net cash used in operating activities  $(3,194)  $(8,238)
Net cash used in investing activities   (11,184)   (298)
Net cash used in financing activities   (213)   (458)
Effect of exchange rate changes on cash   (63)   (358)
Net decrease in cash  $(14,654)  $(9,352)

 

Operating Activities

 

Net cash used in operating activities of approximately $3.2 million during the six months ended June 30, 2023, was principally attributable to a net loss of $4.8 million, $1.3 million of stock-based compensation, $0.6 million of depreciation and amortization, an increase in $1.2 million of inventory, $0.7 million of accounts payable, $0.6 million of prepaid expenses and other current assets, offset by $0.4 million of bad debt recovery, decreases of $0.3 million of accounts receivable and operating lease liabilities each.

 

Net cash used in operating activities of approximately $8.2 million during the six months ended June 30, 2022, was principally attributable to an increase in a net loss of $5.3 million, $3.9 million in inventory, $1.0 million in stock-based compensation, a decrease in $0.6 million in deferred revenue and customer deposits, $1.1 million in prepaid expenses and other current assets, and $1.7 million of accrued expenses and interest expense.

 

Investing Activities

 

Net cash used by investing activities for the six months ended June 30, 2023, and 2022 were $11.2 million and $0.3 million, respectively, and principally related to the Company’s investment in government-backed securities and money market funds and capital expenditures for furniture and computer equipment.

 

Financing Activities

 

Net cash used in financing activities of approximately $0.2 million during the six months ended June 30, 2023, was principally attributable to principal payments made towards D & O policy premiums.

 

Net cash used in financing activities of approximately $0.5 million during the six months ended June 30, 2022, was principally attributable to principal payments made towards D & O policy premiums.

 

 28 

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

As of June 30, 2023, there have been no material changes to the information related to quantitative and qualitative disclosures about the market risk provided in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 31, 2023.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended June 30, 2023, as such term is defined in Rules 13a-15I and 15d-15I under the Exchange Act. In their assessment of the effectiveness of internal control over financial reporting as of June 30, 2023, management concluded that such control was ineffective and that there were control deficiencies that constituted material weaknesses because (i) we currently do not employ the appropriate number of accounting personnel to ensure (a) we maintain proper segregation of duties, (b) conduct a tolerable risk assessment, and (ii) we have not adequately documented a complete assessment of the effectiveness of the design and operation of our internal control over financial reporting. Considering these material weaknesses, we performed additional procedures and analyses as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles.

 

Management has engaged a third-party consultant to identify and document our internal control deficiencies and assess current controls and recommendations regarding remediation efforts to eliminate or mitigate the control deficiencies.

 

Notwithstanding the material weakness as of June 30, 2023, management, including the Certifying Officers, believes that the condensed consolidated financial statements contained in this Annual Report filing fairly present, in all material respect, our financial condition, results of operations, and cash flows for the fiscal period presented in conformity with GAAP.

 

Changes to Internal Control Over Financial Reporting

 

Although we have continued our remediation efforts in connection with identified material weaknesses, the material weakness, as discussed in our Annual Report on Form 10-K for the period ended December 31, 2022, has not been fully remediated. As we continue to remediate the material weakness in our internal controls, we have made changes during our most recently completed fiscal quarter to our internal controls, including changes to enhance the supervisory review of our accounting procedures. Notwithstanding the continuing and un-remediated material weakness, management, including the Certifying Officers, believes that the condensed consolidated financial statements contained in this Quarterly Report fairly present, in all material respects, our financial condition, results of operations, and cash flows for the fiscal periods presented in this Quarterly Report in conformity with GAAP.

 

 29 

 

 

PART II: OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

In the ordinary course of business, we may become involved in various lawsuits and legal proceedings. We cannot predict the impact or outcome of litigation, if any, and we may experience a negative outcome from time to time that may harm our business. We are currently not a party to, and our properties are not currently the subject of any material pending legal proceedings, which, individually or in the aggregate, would adversely affect our financial position or results of operations.

 

Item 1A. Risk Factors.

 

The risks described in “Risk Factors” within our 2022 Annual Report and this Quarterly Report on Form 10-Q, including the risk factor outlined in this Item 1A below, could materially and adversely affect our business, financial condition, and results of operations, and the trading price of our common stock could decline. The Risk Factors section in the 2022 Annual Report, as updated in this Quarterly Report on Form 10-Q, remains current in all material respects. These risk factors do not identify all risks that we face. Our operations could also be affected by factors not presently known to us or that we currently consider immaterial to our operations. Due to risks and uncertainties, known and unknown, our past financial results may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. Refer also to the other information outlined in this Form 10-Q, including the Forward-Looking Statements, MD&A, and Unaudited Condensed Consolidated Financial Statements sections.

 

Relocating a division from the United Kingdom (U.K.) to the United States (U.S.) can be complex and challenging. Some of the key risks involved in our relocation process are as follows:

 

1. Economic Factors:

 

Relocating a division from the U.K. to the U.S. entails significant economic risks including:

 

a) Currency Fluctuations: Changes in exchange rates between the British pound and the U.S. dollar can impact the financial stability of the relocated division. Fluctuations can affect costs, revenue, and profitability, potentially leading to financial losses.

 

b) Tax Implications: Differences in tax laws, regulations, and incentives between the U.K. and the U.S. may result in unexpected financial burdens, compliance requirements, or penalties.

 

2. Operational Factors:

 

Relocating a division involves various operational risks including:

 

a) Workforce Disruption: The relocation process may cause significant disruption to the existing workforce. Issues such as employee attrition, loss of key talent, and difficulties in hiring and training new staff can impact productivity and overall operational efficiency.

 

b) Supply Chain Disruptions: Relocating a division can disrupt established supply chains, leading to delays, increased costs, and potential customer dissatisfaction.

 

3. Legal and Regulatory Factors:

 

Relocating a division across international borders requires compliance with legal and regulatory frameworks. Key legal and regulatory risk factors include employment law matters. We will need to navigate the differences between U.K. and U.S. employment laws, including hiring, firing, and employee benefits regulations. Failure to comply with these laws can result in legal disputes, reputational damage, and financial liabilities.

 

Further, our inability to manage the relocation of our U.K. operations to the U.S. effectively may result in weaknesses in our infrastructure, give rise to operational mistakes, loss of business opportunities, loss of employees, and reduced productivity among remaining employees, any of which could have a material adverse effect on our business and financial performance.

 

 30 

 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

(a) Not applicable.

 

(b) Not applicable.

 

(c) Trading Plans

 

During the quarter that ended June 30, 2023, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (in each case, as defined in Item 408(a) of Regulation S-K).

 

Item 6. Exhibits.

 

Exhibit

Number

  Description of Exhibit
31.1*   Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*   Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Schema
101.CAL   Inline XBRL Taxonomy Calculation Linkbase
101.DEF   Inline XBRL Taxonomy Definition Linkbase
101.LAB   Inline XBRL Taxonomy Label Linkbase
101.PRE   Inline XBRL Taxonomy Presentation Linkbase
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

In accordance with SEC Release 33-8238, Exhibits 31.1, 31.2, 32.1 and 32.2 are being furnished and not filed.

 

*   Filed herewith

 

 31 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  VISLINK TECHNOLOGIES, INC.
     
Date: August 11, 2023 By: /s/ Carleton Miller
    Carleton Miller
    Chief Executive Officer
    (Duly Authorized Officer and Principal Executive Officer)
     
Date: August 11, 2023 By: /s/ Paul Norridge
    Paul Norridge
    Chief Financial Officer
    (Duly Authorized Officer and Principal Financial Officer)

 

 32 

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO 18 USC. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Carleton M. Miller, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Vislink Technologies, Inc. (the “registrant”):

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures; and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report is any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 11, 2023 /s/ Carleton M. Miller
  Carleton M. Miller
  Chief Executive Officer

 

 
EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION

OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Paul Norridge, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Vislink Technologies, Inc. (the “registrant”):

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules

13-a13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures; and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report is any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 11, 2023 /s/ Paul Norridge
  Paul Norridge
  Chief Financial Officer

 

 
EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION

OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Vislink Technologies, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2023 (the “Report”), I, Carleton M. Miller, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 11, 2023 /s/ Carleton M. Miller
  Carleton M. Miller
  Chief Executive Officer

 

A signed original of this written statement required by Section 906 or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION

OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Vislink Technologies, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2023 (the “Report”), I, Paul Norridge, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 11, 2023 /s/ Paul Norridge
  Paul Norridge
  Chief Financial Officer

 

A signed original of this written statement required by Section 906 or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

EX-101.SCH 6 visl-20230630.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statement of Changes in Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - LOSS PER SHARE link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - CASH AND CASH EQUIVALENTS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - REVENUE link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - OTHER INCOME (REBATES) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - RECLASSIFICATION OF PRIOR YEAR PRESENTATION link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - LOSS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - CASH AND CASH EQUIVALENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - REVENUE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - OTHER INCOME (REBATES) (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - SCHEDULE OF FAIR VALUE OF ITS INVESTMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - SCHEDULE OF INVESTMENTS HELD TO MATURITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - INVESTMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - SCHEDULE OF OPERATING LEASE DATA (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - SCHEDULE OF LEASE OBLIGATION ASSUMED (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - LEASES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - SCHEDULE OF EQUITY COMPENSATION PLANS (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - SCHEDULE OF MATCHING CONTRIBUTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - CONCENTRATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - SCHEDULE OF TAX REBATES (Details) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - SCHEDULE OF TAX REBATES (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 visl-20230630_cal.xml INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 visl-20230630_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 visl-20230630_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Class of Stock [Axis] Series A Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] AOCI Attributable to Parent [Member] Treasury Stock, Common [Member] Retained Earnings [Member] Financial Instrument [Axis] Federal Bonds [Member] Federal Backed Mutual Fund [Member] Antidilutive Securities [Axis] Equity Option [Member] Warrant [Member] Award Type [Axis] GBP [Member] Derivative Instrument [Axis] GBP To USD [Member] Euro [Member] Euro To GBP [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Federal Home Loan Banks [Member] Federal National Mortgage Association [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Long-Lived Tangible Asset [Axis] Proprietary Technology [Member] Patents and Licenses [Member] Trade Names And Technology [Member] Customer Relationships [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] D & O Insurance Policy Renewed [Member] Debt Instrument [Axis] Notes Payable One [Member] Notes Payable Two [Member] Geographical [Axis] Luton UK [Member] Colchester, U.K. - Waterside House [Member]. SINGAPORE Billerica, MA [Member] Hemel, UK [Member] Mount Olive, NJ [Member] Restricted Stock Units (RSUs) [Member] Common Stock Warrants [Member] Plan Name [Axis] Long Term Stock Incentive Plan Awards [Member] Time Vested Option Inducement Awards [Member] Performance Based Stock Option Inducement [Member] Time Based Restricted Stock Awards [Member] Performance Based Restricted Stock Awards [Member] Performance Based Stock Option Inducement Awards [Member] Time Based Restricted Stock Awards One [Member] Time Based Restricted Stock Awards Two [Member] Performance Based Restricted Stock Awards One [Member] Performance Based Restricted Stock Awards Two [Member] Group Personal Pension Plan, UK [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Customer Two [Member] Accounts Receivable [Member] Customer One [Member] Accounts Payable [Member] Supplier Concentration Risk [Member] Supplier [Axis] One Vendor [Member] Vendor Two [Member] Vendor One [Member] Purchase [Member] North America [Member] South America [Member] Europe [Member] Asia [Member] Rest of World [Member] Income Statement Location [Axis] Equipment Sales [Member] Installation, Integration and Repairs [Member] Warranties [Member] UNITED STATES NETHERLANDS UNITED KINGDOM UK Subsidiary [Member] Subsequent Event Type [Axis] Subsequent Event [Member] DIFX [Member] Scenario [Axis] Forecast [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current assets Cash and cash equivalents Accounts receivable, net Inventories, net Investments held to maturity Prepaid expenses and other current assets Total current assets Right of use assets, operating leases Property and equipment, net Intangible assets, net Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities Accounts payable Accrued expenses Notes payable Operating lease obligations, current Customer deposits and deferred revenue Total current liabilities Operating lease obligations, net of current portion Deferred tax liabilities Total liabilities Commitments and contingencies (See Note 12) Series A Preferred stock, $0.00001 par value per share: -0- shares authorized on June 30, 2023, and December 31, 2022, respectively; -0- and 47,419 shares issued and outstanding on June 30, 2023, and December 31, 2022, respectively. Stockholders’ equity Preferred stock, $0.00001 par value per share: 10,000,000 shares authorized on June 30, 2023, and December 31, 2022, respectively Common stock, $0.00001 par value per share, 100,000,000 shares authorized on June 30, 2023, and December 31, 2022, respectively: Common stock, 2,377,362 and 2,370,966 were issued, and 2,377,229 and 2,370,833 were outstanding on June 30, 2023, and December 31, 2022, respectively. Additional paid-in capital Accumulated other comprehensive loss Treasury stock, at cost – 133 shares as of June 30, 2023, and December 31, 2022, respectively Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Statement [Table] Statement [Line Items] Temporary equity, par value Temporary equity, shares authorized Temporary equity, shares issued Temporary equity, shares outstanding Preferred stock, par value Preferred stock, shares authorized Common stock, par value Common stock, shares authorized Common stock, shares issued Common Stock, shares outstanding Treasury stock, shares Income Statement [Abstract] Revenue, net Cost of revenue and operating expenses Cost of components and personnel Inventory valuation adjustments General and administrative expenses Research and development expenses Amortization and depreciation Total cost of revenue and operating expenses Loss from operations Other income (expense) Unrealized loss on investments held to maturity Gain on settlement of debt Other income Dividend income Interest income, net Total other income (expense) Net loss before income taxes Income taxes Deferred tax benefits Net loss Basic loss per share Diluted loss per share Weighted average number of shares outstanding: Basic Diluted Comprehensive loss: Unrealized gain (loss) on currency translation adjustment Comprehensive loss Balance Balance, shares Net loss Unrealized gain on currency translation adjustment Stock-based compensation Elimination of Series A Preferred Stock Elimination of Series A Preferred Stock, shares Issuance of common stock in connection with: Compensation awards for services previously accrued Compensation awards for services previously accrued, shares Satisfaction of accounts payable vendor balance Satisfaction of accounts payable vendor balance, shares Satisfaction of withholding tax upon conversion of restricted stock units Satisfaction of withholding tax upon conversion of restricted stock units, shares Satisfaction with the conversion of restricted stock units Satisfaction with the conversion of restricted stock units, shares Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows used in operating activities Adjustments to reconcile net loss to net cash used in operating activities Gain on settlement of debt Deferred tax benefits Unrealized loss on the fair value of investments in bonds held to maturity Accretion of bond discount Stock-based compensation Stock issuance commitments Provision for bad debt Recovery of bad debt Inventory valuation adjustments Amortization of right-of-use assets, operating assets Depreciation and amortization Changes in assets and liabilities Accounts receivable Inventories Prepaid expenses and other current assets Accounts payable Accrued expenses Operating lease obligations Customer deposits and deferred revenue Net cash used in operating activities Cash flows used in investing activities Cash used for investments held to maturity Cash used for property and equipment Net cash used in investing activities Cash flows used in financing activities Principal payments made on notes payable Net cash used in financing activities Effect of exchange rate changes on cash Net decrease in cash and cash equivalents Cash and cash equivalents, beginning of the period Cash and cash equivalents, end of the period Supplemental disclosure of cash flow information: Cash paid during the period for interest Supplemental disclosure of non-cash information: Notes payable Common stock issued in connection with: Settlement of accounts payable Compensation awards previously accrued ROU assets and operating lease obligations recognized (Note 6): Operating lease assets recognized Less: non-cash changes to operating lease assets amortization ROU assets and operating lease obligations recognized Operating lease liabilities recognized Less: non-cash changes to operating lease liabilities accretion Operating lease liabilities recognized Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Liquidity And Financial Condition LIQUIDITY AND FINANCIAL CONDITION Earnings Per Share [Abstract] LOSS PER SHARE Foreign Currency [Abstract] FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES Cash and Cash Equivalents [Abstract] CASH AND CASH EQUIVALENTS Investments, All Other Investments [Abstract] INVESTMENTS Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS Debt Disclosure [Abstract] NOTES PAYABLE Leases LEASES Equity [Abstract] STOCKHOLDERS’ EQUITY Share-Based Payment Arrangement [Abstract] STOCK-BASED COMPENSATION Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Risks and Uncertainties [Abstract] CONCENTRATIONS Revenue from Contract with Customer [Abstract] REVENUE Other Income and Expenses [Abstract] OTHER INCOME (REBATES) Reclassification Of Prior Year Presentation RECLASSIFICATION OF PRIOR YEAR PRESENTATION Subsequent Events [Abstract] SUBSEQUENT EVENTS Nature of Operations Basis of Presentation Principles of Consolidation Segment Reporting Use of Estimates Allowance for credit losses Recently Issued Accounting Principles SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME SCHEDULE OF CASH AND CASH EQUIVALENTS SCHEDULE OF FAIR VALUE OF ITS INVESTMENTS SCHEDULE OF INVESTMENTS HELD TO MATURITY SCHEDULE OF INTANGIBLE ASSETS SCHEDULE OF CAPITALIZED INTANGIBLE COSTS SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS SCHEDULE OF NOTES PAYABLE SCHEDULE OF OPERATING LEASE DATA SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES SCHEDULE OF LEASE OBLIGATION ASSUMED SCHEDULE OF WARRANT OUTSTANDING SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE SCHEDULE OF EQUITY COMPENSATION PLANS SCHEDULE OF MATCHING CONTRIBUTIONS SCHEDULE OF DISAGGREGATION OF REVENUE SCHEDULE OF TAX REBATES Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table] Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] Operating income loss Net cash provided by used in operating activities Working capital Accumulated deficit Cash Held to maturity Investments, fair value disclosure Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share: Total Net foreign exchange transactions: Losses Unrealized (gains) losses on currency translation adjustment Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Foreign currency exchange rate, translation Average foreign currency exchange rate remeasurement Cash on hand Federally insured money market mutual funds Total cash and cash equivalents Platform Operator, Crypto-Asset [Table] Platform Operator, Crypto-Asset [Line Items] Fair value of investments Amortized Cost Unrealized Gains Unrealized Losses Fair Value Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Debt instrument face amount Debt instrument face amount Debt instrument maturity date Debt instrument interest rate Debt instrument discount Debt instrument Debt instrument accrued interest Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Beginning balance cost Beginning balance, accumulated amortization Beginning balance net Intangible assets, Amortization Intangible assets, net Amortization Ending balance cost Ending balance, accumulated Amortization Ending balance net Intangible assets Amortization of intangible assets 2024 2025 2026 2027 2028 Thereafter Finite-Lived Intangible Assets, Net, Total Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Finite-lived intangible asset, useful life Finite-lived intangible assets, remaining amortization period Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Debt instrument, face amount Debt instrument down payment Debt instrument, interest rate, stated percentage Debt instrument, periodic payment, interest Interest expense Notes payable Schedule Of Operating Lease Data Operating lease cost Short-term lease cost Total lease cost Cash flows from operating leases Weighted-average remaining lease term-operating leases Weighted-average discount rate-operating leases Schedule Of Future Minimum Rental Payments For Operating Leases 2024 2025 2026 2027 2028 Thereafter Total lease payments Less: imputed interest Present value of lease liabilities Less: Current lease liabilities Non-current lease liabilities Area of land Lease-End Date Approximate Future Payments Right of use of assets Right of use assets, accumulated depreciation Operating lease liabilities Current operating lease liabilities Non-current operating lease liabilities Weighted-average remaining term Lease maturity description Weighted-average discount rate Area of land description Lease expiration Payments for rent Number of Warrants, beginning balance Weighted Average Exercise Price, beginning balance Number of Warrants, Warrants granted, exercised, canceled, or expired Weighted Average Exercise Price, Warrants granted, exercised, canceled, or expired Number of Warrants, ending outstanding Weighted Average Exercise Price, ending outstanding Schedule of Stock by Class [Table] Class of Stock [Line Items] Preferred stock par value Preferred stock, shares issed Preferred stock, shares outstanding Common stock per share value Reverse split Shares attributable to withholding tax Restricted stock options, granted Stock compensation costs Number of warrants cancelled/expired Weighted average exercise price ending exercisable Weighted average remaining contractual life Stock-based compensation expense Quantity, outstanding beginning balance Weighted Average, outstanding beginning balance Quantity, outstanding beginning balance Weighted Average, outstanding beginning balance Quantity, outstanding beginning balance Weighted Average, outstanding beginning balance Quantity, outstanding beginning balance Weighted Average, outstanding beginning balance Quantity, outstanding beginning balance Weighted Average, outstanding beginning balance Remaining compensation expense Services previously accrued Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Intrinsic value per share Share based compensation shares authorized under stock other than option plans exercise price Quantity, outstanding beginning balance [custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms] Description of equity awards vesting percentage and maturity term Company matching contributions Concentration Risk [Table] Concentration Risk [Line Items] Concentration risk, percentage Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Long-Lived Assets Tax rebate Offsetting Assets [Table] Offsetting Assets [Line Items] Increase (decrease) in tax rebates Gain loss from initial recognition of exchange rate Subsequent Event [Table] Subsequent Event [Line Items] Severance costs over next six months Inventory valuation adjustments. Stock issued during period value elimination of series A preferred stock. Stock issued during period shares elimination of series A preferred stock. Issuance of common stock in connection with abstract. Stock issued during period value compensation awards for services previously accrued. Stock issued during period shares compensation awards for services previously accrued. Satisfaction of accounts payable vendor balance. Satisfaction of withholding tax upon conversion of restricted stock units. Satisfaction with conversion of restricted stock units. Satisfaction of accounts payable vendor balance shares. Satisfaction of withholding tax upon conversion of restricted stock units shares. Satisfaction of withholding tax upon conversion. Unrealized loss on fair value of investment in bonds held to maturity. Accretion of bond discount. Recovery of bad debt. Cash used for investment in securities held to maturity. Common stock issued in connection with abstract. Compensation awards previously accrued. Settlement of amounts due accounts payable. Non cash disclosures of rou assets and operating lease obligation abstract. Operating lease assets recognized. Operating lease liabilities recognized. Noncash changes to operating lease liabilities accretion. Operating lease liabilities recognized. Operating lease asset amortization. ROU assets and operating lease obligations recognized. Stock issuance commitments. Nature of Operations [Policy Text Block] Allowance for Credit Losses [Policy Text Block] Liquidity and financial condition [Text block] Federal Bonds [Member] Federal Backed Mutual Fund [Member] Working capital. Accumulated comprehensive income unrealized loss on currency translation adjustment. GBP [Member] GBP To USD [Member] Euro [Member] Euro To GBP [Member] Federally insured money market mutual funds. Proprietary Technology [Member] Patents and Licenses [Member] Trade Names And Technology [Member] Beginning balance cost accumulated amortization. Ending Balance Cost Accumulated Amortization. D & O Insurance Policy Renewed [Member] Notes Payable Two [Member] Debt instrument down payment. Notes Payable One [Member] Operating lease accumulated amortization. Area of land description. Luton UK [Member] Schedule of lease obligations assumed [Table Text Block]. Colchester, U.K. - Waterside House [Member]. Billerica, MA [Member]. Hemel, UK [Member]. Mount Olive, NJ [Member] Lease expiration date description. Common Stock Warrants [Member] Weighted Average Exercise Price. Weighted Average Exercise Price, cancelled/expired. Weighted Average Exercise Price. Group Personal Pension Plan, UK [Member] Rest of World [Member] Equipment Sales [Member] Installation, Integration and Repairs [Member] Warranties [Member] Reclassification of Prior Year Presentation [Text Block] DIFX [Member] Long Term Stock Incentive Plan Awards [Member] Time Vested Option Inducement Awards [Member] Time Based Restricted Stock Awards [Member] Schedule Of Tax Rebates [Table Text Block] Performance Based Restricted Stock Awards [Member] Performance Based Stock Option Inducement [Member] Remaining stock compensation expenses. Amortization period. Share based compensation arrangement by share based payment award equity instruments other than options outstanding and exercisable weighted average remaining contractual terms. Intrinsic value per share. Time Based Restricted Stock Awards One [Member] Time Based Restricted Stock Awards Two [Member] Performance Based Restricted Stock Awards One [Member] Performance Based Restricted Stock Awards Two [Member] Customer Two [Member] Customer One [Member] Vendor one [Member] Vendor two [Member] Purchase [Member] One Vendor [Member] Federal National Mortgage Association [Member] Description of equity awards vesting percentage and maturity term. Share based compensation shares authorized under stock other than option plans exercise price. Performance Based Stock Option Inducement Awards [Member] Increase (decrease) in tax rebates. UK Subsidiary [Member] Federal Home Loan Banks [Member] Assets, Current Assets Liabilities, Current Liabilities Treasury Stock, Value Equity, Attributable to Parent Liabilities and Equity Costs and Expenses Operating Income (Loss) Nonoperating Income (Expense) Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding AccretionOfBondDiscount Share-Based Payment Arrangement, Noncash Expense RecoveryOfBadDebt Inventory, LIFO Reserve, Effect on Income, Net Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Contract with Customer, Liability Net Cash Provided by (Used in) Operating Activities CashUsedForInvestmentInSecuritiesHeldToMaturity Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Medium-term Notes Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Notes Issued OperatingLeaseAssetAmortization Operating lease liabilities recognized [Default Label] Debt Instrument, Fair Value Disclosure Intangible Assets, Gross (Excluding Goodwill) Finite-Lived Intangible Assets, Accumulated Amortization BeginningBalanceCostAccumulatedAmortization Amortization EndingBalanceCostAccumulatedAmortization Notes Payable Lessee, Operating Lease, Liability, to be Paid, Year One Lessee, Operating Lease, Liability, to be Paid, Year Two Lessee, Operating Lease, Liability, to be Paid, Year Three Lessee, Operating Lease, Liability, to be Paid, Year Four Lessee, Operating Lease, Liability, to be Paid, Year Five Lessee, Operating Lease, Liability, to be Paid, after Year Five Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price EX-101.PRE 10 visl-20230630_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover - shares
6 Months Ended
Jun. 30, 2023
Aug. 11, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2023  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 001-35988  
Entity Registrant Name Vislink Technologies, Inc.  
Entity Central Index Key 0001565228  
Entity Tax Identification Number 20-5856795  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 350 Clark Drive  
Entity Address, Address Line Two Suite 125  
Entity Address, City or Town Mt. Olive  
Entity Address, State or Province NJ  
Entity Address, Postal Zip Code 07828  
City Area Code (908)  
Local Phone Number 852-3700  
Title of 12(b) Security Common stock par value $0.00001 per share  
Trading Symbol VISL  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   2,377,362
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 10,973,000 $ 25,627,000
Accounts receivable, net 5,747,000 6,007,000
Inventories, net 13,177,000 12,021,000
Investments held to maturity 10,837,000
Prepaid expenses and other current assets 2,376,000 1,232,000
Total current assets 43,110,000 44,887,000
Right of use assets, operating leases 940,000 1,075,000
Property and equipment, net 1,744,000 1,434,000
Intangible assets, net 3,910,000 4,400,000
Total assets 49,704,000 51,796,000
Current liabilities    
Accounts payable 3,333,000 2,626,000
Accrued expenses 1,436,000 1,568,000
Notes payable 394,000 84,000
Operating lease obligations, current 406,000 455,000
Customer deposits and deferred revenue 1,921,000 1,540,000
Total current liabilities 7,490,000 6,273,000
Operating lease obligations, net of current portion 934,000 1,107,000
Deferred tax liabilities 655,000 764,000
Total liabilities 9,079,000 8,144,000
Commitments and contingencies (See Note 12)
Series A Preferred stock, $0.00001 par value per share: -0- shares authorized on June 30, 2023, and December 31, 2022, respectively; -0- and 47,419 shares issued and outstanding on June 30, 2023, and December 31, 2022, respectively.
Stockholders’ equity    
Preferred stock, $0.00001 par value per share: 10,000,000 shares authorized on June 30, 2023, and December 31, 2022, respectively
Common stock, $0.00001 par value per share, 100,000,000 shares authorized on June 30, 2023, and December 31, 2022, respectively: Common stock, 2,377,362 and 2,370,966 were issued, and 2,377,229 and 2,370,833 were outstanding on June 30, 2023, and December 31, 2022, respectively.
Additional paid-in capital 346,822,000 345,365,000
Accumulated other comprehensive loss (1,037,000) (1,337,000)
Treasury stock, at cost – 133 shares as of June 30, 2023, and December 31, 2022, respectively (277,000) (277,000)
Accumulated deficit (304,883,000) (300,099,000)
Total stockholders’ equity 40,625,000 43,652,000
Total liabilities and stockholders’ equity $ 49,704,000 $ 51,796,000
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Preferred stock, par value $ 0.00001 $ 0.00001
Preferred stock, shares authorized 10,000,000 10,000,000
Common stock, par value $ 0.00001 $ 0.00001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 2,377,362 2,370,966
Common Stock, shares outstanding 2,377,229 2,370,833
Treasury stock, shares 133 133
Series A Preferred Stock [Member]    
Temporary equity, par value $ 0.00001 $ 0.00001
Temporary equity, shares authorized 0 0
Temporary equity, shares issued 0 47,419
Temporary equity, shares outstanding 0 47,419
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenue, net $ 5,043,000 $ 6,766,000 $ 12,231,000 $ 13,626,000
Cost of revenue and operating expenses        
Cost of components and personnel 2,361,000 3,186,000 5,675,000 6,609,000
Inventory valuation adjustments 175,000 101,000 304,000 197,000
General and administrative expenses 4,679,000 4,439,000 9,707,000 9,349,000
Research and development expenses 908,000 1,151,000 1,675,000 2,269,000
Amortization and depreciation 304,000 465,000 602,000 922,000
Total cost of revenue and operating expenses 8,427,000 9,342,000 17,963,000 19,346,000
Loss from operations (3,384,000) (2,576,000) (5,732,000) (5,720,000)
Other income (expense)        
Unrealized loss on investments held to maturity (35,000) (63,000)
Gain on settlement of debt 9,000 9,000
Other income (11,000) (10,000) 330,000 316,000
Dividend income 128,000 219,000
Interest income, net 220,000 (5,000) 353,000 (5,000)
Total other income (expense) 302,000 (6,000) 839,000 320,000
Net loss before income taxes (3,082,000) (2,582,000) (4,893,000) (5,400,000)
Income taxes        
Deferred tax benefits 54,000 56,000 109,000 107,000
Net loss $ (3,028,000) $ (2,526,000) $ (4,784,000) $ (5,293,000)
Basic loss per share $ (1.27) $ (1.10) $ (2.02) $ (2.30)
Diluted loss per share $ (1.27) $ (1.10) $ (2.02) $ (2.30)
Weighted average number of shares outstanding:        
Basic 2,377 2,305 2,374 2,298
Diluted 2,377 2,305 2,374 2,298
Comprehensive loss:        
Unrealized gain (loss) on currency translation adjustment $ 145,000 $ (1,407,000) $ 300,000 $ (1,139,000)
Comprehensive loss $ (2,883,000) $ (3,933,000) $ (4,484,000) $ (6,432,000)
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2021 $ 343,746 $ (297) $ (277) $ (286,539) $ 56,633
Balance, shares at Dec. 31, 2021 2,287,669          
Net loss (5,293) (5,293)
Unrealized gain on currency translation adjustment (1,139) (1,139)
Stock-based compensation 955 955
Issuance of common stock in connection with:              
Satisfaction of accounts payable vendor balance 31 31
Satisfaction of accounts payable vendor balance, shares   1,935          
Satisfaction of withholding tax upon conversion of restricted stock units
Satisfaction of withholding tax upon conversion of restricted stock units, shares   17,889          
Satisfaction with the conversion of restricted stock units
Satisfaction with the conversion of restricted stock units, shares   57,952          
Balance at Jun. 30, 2022 344,732 (1,436) (277) (291,832) 51,187
Balance, shares at Jun. 30, 2022 2,365,445          
Balance at Mar. 31, 2022 344,493 (565) (277) (289,306) 54,345
Balance, shares at Mar. 31, 2022 2,287,669          
Net loss (2,526) (2,526)
Unrealized gain on currency translation adjustment (871) (871)
Stock-based compensation 208 208
Issuance of common stock in connection with:              
Satisfaction of accounts payable vendor balance 31 31
Satisfaction of accounts payable vendor balance, shares   1,935          
Satisfaction of withholding tax upon conversion of restricted stock units
Satisfaction of withholding tax upon conversion of restricted stock units, shares   17,889          
Satisfaction with the conversion of restricted stock units
Satisfaction with the conversion of restricted stock units, shares   57,952          
Balance at Jun. 30, 2022 344,732 (1,436) (277) (291,832) 51,187
Balance, shares at Jun. 30, 2022 2,365,445          
Balance at Dec. 31, 2022 345,365 (1,337) (277) (300,099) 43,652
Balance, shares at Dec. 31, 2022 47,419 2,367,362          
Net loss (4,784) (4,784)
Unrealized gain on currency translation adjustment 300 300
Stock-based compensation 1,257 1,257
Elimination of Series A Preferred Stock
Elimination of Series A Preferred Stock, shares (47,419)            
Issuance of common stock in connection with:              
Compensation awards for services previously accrued 200 200
Compensation awards for services previously accrued, shares   10,000          
Balance at Jun. 30, 2023 346,822 (1,037) (277) (304,883) 40,625
Balance, shares at Jun. 30, 2023 2,377,362          
Balance at Mar. 31, 2023 [1] 346,486 (1,182) (277) (301,855) 43,172
Balance, shares at Mar. 31, 2023 [1] 2,377,362          
Net loss (3,028) (3,028)
Unrealized gain on currency translation adjustment 145 145
Stock-based compensation 336 336
Balance at Jun. 30, 2023 $ 346,822 $ (1,037) $ (277) $ (304,883) $ 40,625
Balance, shares at Jun. 30, 2023 2,377,362          
[1] In connection with the reverse stock split implemented by the Company on May 1, 2023, the company’s stock transfer agent calculated a de minimus adjustment to the opening quantity of shares issued.
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows used in operating activities    
Net loss $ (4,784) $ (5,293)
Adjustments to reconcile net loss to net cash used in operating activities    
Gain on settlement of debt (9)
Deferred tax benefits (109) (107)
Unrealized loss on the fair value of investments in bonds held to maturity 63
Accretion of bond discount (137)
Stock-based compensation 1,257 955
Stock issuance commitments 200
Provision for bad debt 38 15
Recovery of bad debt (6) (38)
Inventory valuation adjustments 304 197
Amortization of right-of-use assets, operating assets 135 104
Depreciation and amortization 602 922
Changes in assets and liabilities    
Accounts receivable 323 111
Inventories (1,196) (3,934)
Prepaid expenses and other current assets (619) 1,118
Accounts payable 708 202
Accrued expenses 68 (1,749)
Operating lease obligations (222) (286)
Customer deposits and deferred revenue 381 (646)
Net cash used in operating activities (3,194) (8,238)
Cash flows used in investing activities    
Cash used for investments held to maturity (10,763)
Cash used for property and equipment (421) (298)
Net cash used in investing activities (11,184) (298)
Cash flows used in financing activities    
Principal payments made on notes payable (213) (458)
Net cash used in financing activities (213) (458)
Effect of exchange rate changes on cash (63) (358)
Net decrease in cash and cash equivalents (14,654) (9,352)
Cash and cash equivalents, beginning of the period 25,627 36,231
Cash and cash equivalents, end of the period 10,973 26,879
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest 6 6
Supplemental disclosure of non-cash information:    
Notes payable 523 943
Common stock issued in connection with:    
Settlement of accounts payable 31
Compensation awards previously accrued 200
ROU assets and operating lease obligations recognized (Note 6):    
Operating lease assets recognized
Less: non-cash changes to operating lease assets amortization (135) (104)
ROU assets and operating lease obligations recognized (135) (104)
Operating lease liabilities recognized
Less: non-cash changes to operating lease liabilities accretion (222) (286)
Operating lease liabilities recognized $ (222) $ (286)
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Operations

 

Incorporated in Delaware in 2006, Vislink Technologies, Inc. (“Vislink”) is an innovative technology company that collects, delivers and manages real-time video from the action scene to the viewing screen. The Company designs, develops, and deploys innovative products and turnkey solutions that deliver reliable connectivity across real-time production, military, and government sectors worldwide in the most demanding environments. Vislink is a leader in designing and deploying wireless video solutions, providing customers with reliable and secure video and data transmission. The company is committed to delivering the latest technology and the highest quality products to meet its customers’ needs. Vislink provides solutions for collecting live news, sports, and entertainment events for the broadcast markets. Our Mobile Viewpoint product line offers live streaming solutions that use bonded cellular, 5G, and AI-driven technologies to automate the production of news and sports content. In addition to creating real-time video intelligence solutions, Vislink assists first responders, law enforcement agencies at all levels of government, and military organizations with increased situational awareness. Besides providing professional and technical services, Vislink employs a team of technology experts with decades of experience and applied knowledge of terrestrial microwaves, satellites, fiber optics, surveillance systems, and wireless communications systems to offer customers a wide range of services.

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated interim financial statements and these notes should be viewed in conjunction with Vislink Technologies, Inc.’s 2022 Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on March 31, 2023, which contains the audited consolidated financial statements and notes thereto as of December 31, 2022. As of December 31, 2022, a condensed consolidated balance sheet was prepared based on audited annual financial statements but did not include all of the footnote disclosures from the annual financial statements. In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of routine recurring adjustments, necessary for a fair statement of its financial position as of June 30, 2023, as well as results of operations for the three months and six months ended June 30, 2023, and 2022, as well as cash flow for the six months ended June 30, 2023, and 2022. For the six months ended June 30, 2023, the results of operations are not necessarily indicative of the results for the entire year, any other interim period, or any future period. Effective May 1, 2023, the Company effected a one-for-20 reverse stock split of the common stock. All per-share numbers reflect the one-for-20 reverse stock split. We have retroactively applied the reverse split throughout this quarterly report to all periods presented. The accounting policies of Vislink have not materially changed since December 31, 2022. Note 3 of Vislink’s 2022 annual report on Form 10-K provides detailed information about these policies.

 

Principles of Consolidation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. The Company has eliminated all intercompany accounts and transactions upon consolidating our subsidiaries.

 

Segment Reporting

 

The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the United States, United Kingdom, and the Netherlands.

 

Use of Estimates

 

The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities at the date of the unaudited condensed consolidated financial statements. These estimates also affect the reported revenues and expenses during the reporting periods. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. Actual results could differ from estimates, and any such differences may be material to our unaudited condensed consolidated financial statements.

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Allowance for credit losses

 

Change in accounting principles

 

In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.

 

The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.

 

Recently Issued Accounting Principles

 

Recent Accounting Pronouncements

 

Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

 

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.2
LIQUIDITY AND FINANCIAL CONDITION
6 Months Ended
Jun. 30, 2023
Liquidity And Financial Condition  
LIQUIDITY AND FINANCIAL CONDITION

NOTE 2 — LIQUIDITY AND FINANCIAL CONDITION

 

For the six months ended June 30, 2023, the Company incurred an approximate loss of $5.7 million from operations and used $3.2 million of cash for operational purposes. On June 30, 2023, the Company had $35.6 million in working capital, $304.9 million in accumulated deficits, and $11.0 million in cash.

 

During the first quarter of 2023, the Company invested approximately $10.8 million of its cash reserves in Federal bonds and $11.3 million in Federally insured money market mutual funds, primarily to increase investment income.

 

The Company’s liquidity requirements may be affected by a variety of factors. These factors include inflation, foreign exchange fluctuations, market conditions, strategic acquisitions, market strategy, research and development activities, regulatory matters, and product and technology innovations. The Company believes it will have sufficient funds to continue operations for at least twelve months from the filing date of these unaudited condensed consolidated financial statements.

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.2
LOSS PER SHARE
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
LOSS PER SHARE

NOTE 3 — LOSS PER SHARE

 

The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):

 

   2023   2022 
   Six months Ended 
   June 30 
   2023   2022 
Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:          
Stock options   85    29 
Warrants   456    459 
Total   541    488 

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.2
FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES
6 Months Ended
Jun. 30, 2023
Foreign Currency [Abstract]  
FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES

NOTE 4 — FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES

 

The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive income approximately as follows:

 

   2023   2022   2023   2022 
   Three months ended   Six months ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Net foreign exchange transactions:                    
(Gains) Losses  $41,000   $(21,000)  $(3,000)  $(5,000)
Accumulated comprehensive income:                    
Unrealized (gains) losses on currency translation adjustment  $10,000   $(871,000)  $(145,000)  $(1,139,000)

 

The exchange rates adopted for foreign exchange transactions are quoted on OANDA, a Canadian-based foreign exchange company. This website offers currency conversion, online retail foreign exchange trading, foreign currency transfers, and currency information through its website. Based on the following exchange rates, the Company converted amounts between British Pounds and US Dollars and Euros into British Pounds for the respective periods:

 

  As of June 30, 2023 – £1.266150 to $1.00; €1.088440 to $1.00
     
  The average exchange rate for the six months ended June 30, 2023 – £1.233240 to $1.00; €1.080655 to $1.00
     
  As of June 30, 2022 – £ 1.080655 to $1.00; €1.044949 to $1.00
     
  The average exchange rate for the six months ended June 30, 2022 – £1.298904 to $1.00; €1.091890 to $1.00
     

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.2
CASH AND CASH EQUIVALENTS
6 Months Ended
Jun. 30, 2023
Cash and Cash Equivalents [Abstract]  
CASH AND CASH EQUIVALENTS

NOTE 5 — CASH AND CASH EQUIVALENTS

 

The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of unrestricted funds invested in a money market mutual fund. The following table illustrates the Company’s cash and cash equivalents:

 

   June 30,   December 31, 
   2023   2022 
         
Cash on hand   $1,542,000   $25,627,000 
Federally insured money market mutual funds    9,431,000     
Total cash and cash equivalents   $10,973,000   $25,627,000 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.2
INVESTMENTS
6 Months Ended
Jun. 30, 2023
Investments, All Other Investments [Abstract]  
INVESTMENTS

NOTE 6 — INVESTMENTS

 

The Company used cash to purchase the following debt instruments:

 

  On January 23, 2023, the Company purchased a bond, “HSBC USA INC CP,” with a face value of $5,065,789, a par value of $5,000,000, maturing October 24, 2023, a 5.1948% interest rate, at a discount of $253,289 totaling $4,812,500. The value on June 30, 2023, was $4,910,000.
     
  On February 1, 2023, the Company purchased a bond, “Federal Home Loan Banks,” with a face value of $4,999,750 and accrued interest of $25,729, a par value of $5,000,000, maturing December 22, 2023, at an interest rate of 4.750%, totaling $5,025,479. The value on June 30, 2023, was $4,981,000.
     
  On February 28, 2023, the Company purchased a bond, “Federal National Mortgage Association,” with a face and par value of $950,000, maturing February 28, 2024, at an interest rate of 5.07%, totaling $950,000. The value on June 30, 2023, was $946,000.

 

The Company identified these transactions as investments in debt security and will apply the guidance under ASC Topic 320, “Investments in debt securities,” and for interest income guidance under ASC Topic 310-20, “Receivables.” As of June 30, 2023, the abovementioned investments have a stated maturity of one year or less. Management intends to treat these investments as held to maturity.

 

The Company has determined the fair value of its investments held to maturity based on Level 1 input as of June 30, 2023:

 

   Level 1   Level 2   Level 3   Total 
                 
Federal Bonds  $   $10,837,000   $   $10,837,000 
                     
   $   $10,837,000   $   $10,837,000 

 

The Company’s investments held to maturity are as follows as of June 30, 2023:

 

   Amortized Cost   Unrealized Gains   Unrealized Losses   Fair Value 
                 
Federal Bonds  $10,900,000       $63,000   $10,837,000 
                     
   $10,900,000   $   $63,000   $10,837,000 

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.2
INTANGIBLE ASSETS
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS

NOTE 7 — INTANGIBLE ASSETS

 

The following table illustrates finite intangible assets as of June 30, 2023:

 

   Proprietary Technology   Patents and Licenses   Trade Names & Technology   Customer Relationships     
                                     
       Accumulated       Accumulated       Accumulated       Accumulated     
   Cost   Amortization   Cost   Amortization   Cost   Amortization   Cost   Amortization   Net 
Balance, December 31, 2022  $2,132,000   $(815,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,189,000)  $5,095,000   $(3,074,000)  $4,400,000 
                                              
Amortization       (294,000)               (69,000)       (127,000)   (490,000)
Balance, June 30, 2023  $2,132,000   $(1,109,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,258,000)  $5,095,000   $(3,201,000)  $3,910,000 

 

The Company continuously monitors intangible assets for potential impairments based on operating results, events, and circumstances. As of June 30, 2023, management identified no triggering events.

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 7 — INTANGIBLE ASSETS (continued)

 

The Company’s groups of intangible assets consist primarily of:

 

Proprietary Technology:

Generally, the Company amortizes proprietary technology over 3 to 5 years. Wireless multiplex transmitters and artificial intelligence are the proprietary technologies that MVP uses internally to produce and sell products and services to customers.

 

Patents and Licenses:

Patents and licenses filed by the Company are amortized for 18.5 to 20 years. The amortization of the costs associated with provisional patents and pending applications begins after successful review and filing.

 

Trade Name, Technology, and Customer Relationships:

Other intangible assets are amortized for 3 to 15 years. Prior IMT, Vislink, and MVP acquisitions contributed to developing these intangible assets, including trade names, technology, and customer lists.

 

The Company has recognized net capitalized intangible costs as follows:

 

   June 30,   December 31, 
   2023   2022 
Proprietary Technology  $1,025,000   $1,319,000 
Trade Names and Technology   991,000    1,060,000 
Customer Relationships   1,894,000    2,021,000 
   $3,910,000   $4,400,000 

 

The Company has recognized the amortization of intangible assets as follows:

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Proprietary Technology  $148,000   $148,000   $294,000   $293,000 
Patents and Licenses       167,000        331,000 
Trade Names and Technology   34,000    34,000    69,000    69,000 
Customer Relationships   64,000    64,000    127,000    127,000 
   $246,000   $413,000   $490,000   $820,000 

 

The weighted average remaining life of the amortization of the Company’s intangible assets is approximately 5.2 years as of June 30, 2023. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:

 

Period ending June 30,    
2024  $636,000 
2025   635,000 
2026   595,000 
2027   533,000 
2028   349,000 
Thereafter   1,162,000 
Finite-Lived Intangible Assets, Net, Total  $3,910,000 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.2
NOTES PAYABLE
6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
NOTES PAYABLE

NOTE 8 — NOTES PAYABLE

 

The table below represents the Company’s notes payable as of June 30, 2023, and December 31, 2022:

 

   Principal 
   June 30,
2023
   December 31,
2022
 
The Company renewed its D&O insurance policy on April 5, 2022, reducing the premium to approximately $1,037,000, less a down payment of $194,000, with the remaining balance financed. The loan’s terms are for nine months at a 2.09% annual interest rate and a monthly principal and interest payment of approximately $84,000. Accordingly, the Company recorded interest expenses of $-0- and $150 for the three and six months ended June 30, 2023, and $-0- and $2,000 for the three and six months ended June 30, 2022, respectively. As of June 30, 2023, the note has been fully repaid.   $   $84,000 
           
The Company renewed its D & O insurance policy on April 5, 2023, reducing the premium to approximately $811,000, less a down payment of $288,000, financing the remaining balance of approximately $523,000. The loan’s terms are for nine months at a 6.14% annual interest rate and a monthly principal and interest payment of approximately $67,000. Accordingly, the Company recorded interest expenses of $5,000 for the three and six months ended June 30, 2023, and $-0- for the three and six months ended June 30, 2022.    394,000      
   $394,000   $84,000 

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.2
LEASES
6 Months Ended
Jun. 30, 2023
Leases  
LEASES

NOTE 9 — LEASES

 

In addition to leasing office space, deployment sites, and storage warehouses, the Company also leases warehouse space internationally and domestically. Operating leases have various terms and provisions as of June 30, 2023, with lease terms remaining between one and four years. In certain individual leases, rent escalation clauses and lease concessions require additional rental payments in the later years of the lease term. These types of contracts are recognized on a straight-line basis over the minimum lease term.

 

The Company recorded $0.9 million in Right-Of-Use (“ROU”) assets on June 30, 2023, net of $1.3 million in accumulated amortization. Moreover, the Company recorded an operating lease liability of approximately $1.3 million, of which $0.4 million was current and $0.9 million was non-current. The weighted average remaining term of lease contracts on June 30, 2023, was 3.1 years, with maturity dates ranging between July 2023 and May 2027, in addition to a weighted-average discount rate of 9.5%.

 

There were no material adjustments to straight-line rental expenses for those periods. Most of the costs recognized for each period were reflected in cash used in operating activities. This expense primarily consisted of payments for office and warehouse base rent. In addition, the Company has the right to renew individual leases at various renewal terms, although the Company is not obligated to do so. Short-term lease costs, taxes, and variable service charges were immaterial.

 

A one-year lease for 600 square feet of administrative office space in Luton, UK, was signed on June 1, 2023, and will run through May 31, 2024, at approximately $2,100 per month.

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 9 — LEASES (continued)

 

The following table illustrates operating lease data for the three months ending June 30, 2023, and 2022:

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Lease cost:                    
Operating lease cost  $103,000   $114,000   $206,000   $233,000 
Short-term lease cost   10,000    10,000    20,000    159,000 
Total lease cost  $113,000   $124,000   $226,000   $392,000 
Cash paid for lease liabilities:                    
Cash flows from operating leases            $325,000   $253,000 
Weighted-average remaining lease term—operating leases             3.1 years    3.8 years 
Weighted-average discount rate—operating leases             9.5%   9.4%

 

Maturities of operating lease liabilities were as follows as of June 30, 2023:

 

     
   Amount 
2024  $507,000 
2025   468,000 
2026   341,000 
2027   186,000 
2028    
Thereafter    
Total lease payments   1,502,000 
Less: imputed interest   162,000 
Present value of lease liabilities   1,340,000 
Less: Current lease liabilities   406,000 
Non-current lease liabilities  $934,000 

 

The table below lists the location and lease expiration date from 2023 through 2027:

 

Location  Square Footage   Lease-End
Date
  Approximate
Future Payments
 
Colchester, UK   16,000   Dec 2025   $554,000 
Singapore   950   July 2023   $3,000 
Billerica, MA   2,000   Dec 2026   $43,000 
Hemel, UK   12,870   Oct 2023   $367,000 
Mount Olive, NJ   7,979   Jan 2027   $535,000 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS’ EQUITY
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 10 — STOCKHOLDERS’ EQUITY

 

Preferred stock

 

On March 22, 2023, the Board of Directors of the Corporation approved a resolution to eliminate the Corporation’s Certificate of Designation, Preferences, and Rights (the “Certificate of Elimination”) of the Series A Preferred Stock, par value $0.00001 per share (the “Series A Preferred Stock”), that was filed with the Secretary of State of the State of Delaware on November 9, 2022.

 

Upon the effective filing of this Certificate of Elimination, the shares previously designated under the certificate of designation as Series A Preferred Stock shall resume the status of authorized but unissued shares of preferred stock of the Corporation. As of March 31, 2023, 47,500 shares are authorized, and no Series A Preferred Stock was issued or outstanding.

 

Common stock

 

Nasdaq compliance and reverse stock split

 

On May 20, 2022, we received notice from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of its noncompliance with Bid Price Rule by failing to maintain a minimum bid price for its common Stock on the Nasdaq Capital Market of at least $1.00 per share for 30 consecutive business days. The Company received a grace period of 180 days, or until November 16, 2022, to regain compliance with the minimum bid price requirement.

 

On November 10, 2022, the Company submitted a request to Nasdaq for an additional 180-day grace period to regain compliance with the minimum bid price requirement. On November 17, 2022, the Company received a letter from Nasdaq advising that the Company had been granted an additional 180-day grace period extension until May 15, 2023, to regain compliance with the minimum bid price requirement and all other applicable requirements for initial listing on the Nasdaq Capital Market except for the minimum bid price requirement. On May 15, 2023, the Company received a letter from the Nasdaq informing it of its return to compliance with the Bid Price Rule. Therefore, the Common Stock continues to be traded on the Nasdaq Capital Market. If the Company fails to comply with the continued listing requirements of Nasdaq, such as its corporate governance requirements or the Bid Price Rule, Nasdaq may delist the Common Stock.

 

On January 11, 2023, the Company held a special meeting of stockholders (the “Special Meeting”) whereby stockholders approved a proposal to authorize the Board of Directors of the Company (the “Board”), in its discretion but before the one-year anniversary of the date of the Special Meeting, to implement an amendment to the Company’s certificate of incorporation to effect a reverse stock split (the “Reverse Stock Split”) of all of the outstanding shares of Common Stock, of the Company, at a ratio in the range of 1-for-2 to 1-for-50.

 

On May 1, 2023, the Company effected a 1-for-20 reverse stock split. Upon effectiveness of the reverse stock split, every twenty shares of an outstanding common stock decreased to one share of common stock. We have retroactively applied the reverse split throughout this quarterly report to all periods presented.

 

Other common stock activity

 

During the six months that ended June 30, 2023, the Company:

 

  has issued 10,000 shares of common stock to specific board members as part of a commitment agreement valued at $200,000. The common stock’s value was determined on the agreement’s original date.
     
  recognized approximately $1,257,000 of stock-based compensation costs associated with outstanding stock options in general and administrative expenses offsetting additional capital investments.

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 10 — STOCKHOLDERS’ EQUITY (continued)

 

Common stock warrants

 

In the six months ending June 30, 2023, 2,667 warrants expired. These outstanding warrants did not have an intrinsic value as of June 30, 2023. On June 30, 2023, the weighted average exercise price of warrants outstanding is $66.00, with a weighted average remaining contractual life of 2.61 years.

 

The following table sets forth common stock purchase warrants outstanding as of June 30, 2023:

 

  

Number of Warrants

(in shares)

  

Weighted

Average

Exercise

Price

 
         
Outstanding, December 31, 2022   458,747   $72.00 
Warrants granted, exercised, canceled, or expired   (2,667)    
Outstanding and exercisable, June 30, 2023   456,080   $66.00 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION

NOTE 11 — STOCK-BASED COMPENSATION

 

Long-term stock incentive plan awards:

 

The Company’s stock option plans provide options to purchase shares of common stock to officers, directors, other key employees, and consultants. The purchase price may be paid in cash or “net settled” in the Company’s common stock shares. In a net settlement of an option, the Company does not require payment of the exercise price from the holder but reduces the number of shares of common stock issued upon the exercise of the stock option by the smallest amount of whole shares that have an aggregate fair market value equal to or over the aggregate exercise price for the option shares covered by the option exercised. Options generally vest over three years from the grant date and expire ten years from the grant date.

 

Inducement Awards:

 

Time-vested options

The Company grants time-vested stock options to various employees in connection with their employment agreements. The equity awards are ten-year, non-statutory time-vested option inducement awards under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans (all subject to continued employment).

 

Performance-based stock options

The Company grants performance-based stock options to various employees in connection with their employment agreements. The equity awards are ten-year, non-statutory performance-based stock option inducement awards under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans that will vest in three equal tranches upon achievement of applicable performance conditions for each tranche (all subject to continued employment).

 

Restricted Stock Units (“RSUs”):

 

Time-based awards

The Company grants employees time-based restricted stock units (“RSUs”) subject to continued employment. The equity awards have an initial vesting between 25% and 33% on their one-year anniversary dates and will vest between 24 and 36 equal monthly periods thereafter.

 

Performance-based awards

The Company grants employees performance-based restricted stock unit awards subject to performance vesting conditions and continued employment. The equity awards will vest in three equal tranches upon reaching performance conditions for each tranche.

 

As shown in the following table, stock-based compensation expense is included in general and administrative expenses under the following plans:

 

                 
   Three months ended   Six months ended 
   June 30,   June 30, 
Equity-based plans:  2023   2022   2023   2022 
Long-term stock incentive plan awards  $   $   $   $1,000 
Time-vested option inducement awards   37,000    28,000    107,000    56,000 
Performance-based stock option inducement award   -    -        - 
Time-based restricted stock awards
   299,000    180,000    1,150,000    898,000 
Performance-based restricted stock awards                
Stock-based compensation expense  $336,000   $208,000   $1,257,000   $955,000 

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 11 — STOCK-BASED COMPENSATION (continued) 

 

The following table illustrates supplementary data under various equity compensation plans:

 

    Six months ended     Six months ended  
    June 30,     June 30,  
    2023     2022     2023     2022  
    Quantity     Weighted Average     Quantity     Weighted Average     Quantity     Weighted Average     Quantity     Weighted Average  
    Long-term stock incentive plan awards     Time-vested option inducement awards  
Balance-January 1st, outstanding     2,250     $ 1,756       2,496     $ 1,795.80       24,721     $ 13.00       24,721     $ 20.20  
Granted, canceled, expired                                                
Forfeited     (58 )     (1,166.00 )     (171 )     (1,931.60 )                        
Balance-June 30th, outstanding     2,192     $ 1,771.40       2,325     $ 1,754.00       24,721     $ 10.00       24,721     $ 17.80  
Balance-June 30th, exercisable     2,192     $ 1,771.40       2,463     $ 1,802.00       24,721     $ 18.00       14,936     $ 29.60  
Remaining compensation expense     $       $       $212,000       $442,000  
Remaining amortization period     0.0 years       0.0 years       0.6 years       1.6 years  
Weighted average remaining contractual life – options outstanding and exercisable     4.0 years and 4.0 years       5.1 years and 5.0 years       6.6 years and 6.6 years       7.6 years and 7.6 years  
Intrinsic value per share     $       $       $       $  
Range of exercise prices     $139.20 to $1,944.00       $139.20 to $23,472.00       $19.20 to $34.20       $19.20 to $34.20  
                                                                 
      Performance-based stock option inducement awards       Time-based restricted stock awards  
Balance-January 1st, outstanding     12,500     $ 33.00       12,500     $ 33.00       140,736     $ 23.00       39,933     $ 63.40  
Granted, canceled, expired                             41,250       9.00       107,053       20.80  
Forfeited                             (19,415 )     (21.40            
Balance-June 30th, outstanding     12,500      $ 33.00       12,500      $ 33.00       162,571      $ 12.60       146,986       26.20  
Balance-June 30th, exercisable         $           $       63,098     $ 40.20       12,472     $ 100.80  
Remaining compensation expense     $414,000       $414,000       $2,049,000       $3,857,000  
Remaining amortization period     1.6 years       2.6 years       1.7 years       3.0 years  
Weighted average remaining contractual life – options outstanding and exercisable     6.6 years and 0.0 years       7.6 years and 7.6 years       2.1 years and 1.8 years       3.0 years and 4.0 years  
Intrinsic value per share     $       $       $       $  
Range of exercise prices     $34.20       $34.20       $8.00 to $72.00       $19.60 to $72.00  
                               
                                      Performance-based restricted stock awards  
Balance-January 1st, outstanding                                     71,303     $ 58.00       63,369     $ 58.80  
Granted, canceled, expired                                                 71,303       21.00  
Forfeited                                     (19,649 )     (21.00 )            
Balance-June 30th, outstanding                                     51,654     $ 22.00       134,762     $ 38.80  
Balance-June 30th, exercisable                                         $       63,369     $ 82.40  
Remaining compensation expense                                     $1,085,000       $1,498,000  
Remaining amortization period                                     2.5 years       7.7 years  
Weighted average remaining contractual life – options outstanding and exercisable                                     2.5 years and 0.0 years       4.3 years and 3.8 years  
Intrinsic value per share                                     $       $  
Range of exercise prices                                     $21.00 to $72.00       $21.00 to $72.00  

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.2
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 12 — COMMITMENTS AND CONTINGENCIES

 

Pension:

 

The Company may make a matching contribution to its employees’ 401(k) plan. Furthermore, Vislink operates a Group Personal Plan through its UK subsidiary, investing funds with Royal London. Employees of the Company in the United Kingdom are entitled to participate in the Company’s employee benefit plan, to which varying amounts are contributed according to their status. Additionally, the Company operates a stakeholder pension plan in the United Kingdom.

 

The table below represents the Company’s matching contributions as follows:

 

   Three months ended   Six months ended 
   June 30,   June 30, 
   2022   2022   2022   2022 
Company matching contributions - Group Personal Pension Plan  $35,000   $48,000   $68,000   $97,000 

 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.2
CONCENTRATIONS
6 Months Ended
Jun. 30, 2023
Risks and Uncertainties [Abstract]  
CONCENTRATIONS

NOTE 13 — CONCENTRATIONS

 

Customer concentration risk

In the three and six months ended June 30, 2023, no customers exceeded 10 percent of the Company’s consolidated sales. In the three and six months ending June 30, 2022, the Company derived revenue from two customers representing more than 10% of its total consolidated sales for approximately $788,000 (12%) and $1,467,000 (11%), respectively.

 

Two customers owed the Company approximately $925,000 and 688,000, respectively, representing 16% and 12% of its consolidated net receivables on June 30, 2023. One customer owed the Company approximately $4,204,000, representing 48% of the Company’s consolidated net accounts receivable on June 30, 2022.

 

Vendor concentration risk

 

In the three months ending June 30, 2023, two vendors exceeded 10% of the Company’s consolidated purchases with approximately $465,000 and $323,000, representing 15% and 10% of the Company’s consolidated inventory purchases, respectively. In the six months ending June 30, 2023, two vendors met the criteria beyond 10% of the Company’s consolidated purchases of approximately $595,000 and $587,000, representing 10% of the Company’s consolidated inventory purchases, respectively. During the three and six months ended June 30, 2022, no vendor made purchases exceeding 10% of the Company’s total consolidated purchases.

 

As of June 30, 2023, one vendor exceeded 10% of the Company’s consolidated accounts payable of approximately $610,000 (18%). As of June 30, 2022, no vendor represented more than 10% of the Company’s accounts payable.

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.2
REVENUE
6 Months Ended
Jun. 30, 2023
Revenue from Contract with Customer [Abstract]  
REVENUE

NOTE 14 – REVENUE

 

The Company has one operating segment, with the senior executive management team as the decision-making group. In the following table, the Company has disaggregated revenue by the Company’s primary geographical markets and revenue sources:

 

   Three months Ended   Six months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Primary geographical markets:                
North America  $1,721,000   $3,472,000   $4,888,000   $5,900,000 
South America   38,000    49,000    227,000    99,000 
Europe   1,593,000    2,105,000    3,436,000    4,294,000 
Asia   1,305,000    830,000    2,024,000    1,372,000 
Rest of World   386,000    310,000    1,656,000    1,961,000 
   $5,043,000   $6,766,000   $12,231,000   $13,626,000 
Primary revenue source:                    
Equipment sales  $4,279,000   $6,194,000   $10,673,000   $12,472,000 
Installation, integration, and repairs   263,000    330,000    749,000    573,000 
Warranties   501,000    242,000    809,000    581,000 
   $5,043,000   $6,766,000   $12,231,000   $13,626,000 
Long-Lived Assets:                    
United States            $2,174,000   $2,227,000 
Netherlands             23,000    28,000 
United Kingdom             4,397,000    5,471,000 
             $6,594,000   $7,726,000 

 

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.2
OTHER INCOME (REBATES)
6 Months Ended
Jun. 30, 2023
Other Income and Expenses [Abstract]  
OTHER INCOME (REBATES)

NOTE 15 — OTHER INCOME (REBATES)

 

The following table represents tax rebates related to the research costs incurred by our U.K. subsidiary.

 

   Three months Ended   Six months Ended 
   June 30,    June 30, 
    2023    2022    2023    2022 
Total tax rebates  $**5,000  $*(10,000)  $329,000   $284,000 

 

** An increase of $5,000 represents a strengthening in the exchange rate from British Pounds to U.S. dollars, resulting in a gain from initial recognition of $324,000 in the first quarter of fiscal 2023.
     
*   As a result of a weakening in the translation rate from British pounds to U.S. dollars, this $10,000 decrease represents a loss compared to the initially recognized $294,000 in fiscal 2022.

 

While the Company plans to continue filing rebate forms for the 2023 fiscal year, it cannot guarantee that rebates will be available at a similar level or at all in future years.

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.2
RECLASSIFICATION OF PRIOR YEAR PRESENTATION
6 Months Ended
Jun. 30, 2023
Reclassification Of Prior Year Presentation  
RECLASSIFICATION OF PRIOR YEAR PRESENTATION

NOTE 16 — RECLASSIFICATION OF PRIOR YEAR PRESENTATION

 

We reclassified other income amounts from the prior year to ensure consistency with the presentation of the current year’s condensed consolidated statement of operations. For the three and six months ended June 30, 2022, adjustments have been made to the condensed consolidated statements of operations and comprehensive loss. Tax rebates related to research costs incurred by our UK subsidiary were separated from other revenue to other income. The reclassification did not affect the reported operating results.

 

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.2
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 17 — SUBSEQUENT EVENTS

 

Office lease

 

The Company renewed its lease for 976 square feet of administrative office space commencing on July 3, 2023, and terminating on July 2, 2024, in Dubai Studio City, UAE, for approximately $1,632 monthly.

 

Relocation of United Kingdom manufacturing division

 

Following an ever-changing global business landscape, in July 2023, the Company strategically decided to consolidate its UK division and relocate its activities to the United States in September 2023. As a result of the move, management believes that operational efficiency will be optimized, productivity will be enhanced, and our position in the global market will be strengthened. Additionally, the move will:

 

enhance our ability to meet future working capital requirements,
eliminate obsolete inventory items,
reduce the usage of our UK Colchester facility, and
simultaneously reduce miscellaneous operating costs.

 

Our commitment to continuous improvement and growth has driven our decision to relocate our manufacturing division. The relocation of our manufacturing division to the United States will cost us approximately $0.2 million in severance costs over the next six months. Our relocation process will be designed to ensure minimal disruption to our operations and employees.

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.2
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of Operations

Nature of Operations

 

Incorporated in Delaware in 2006, Vislink Technologies, Inc. (“Vislink”) is an innovative technology company that collects, delivers and manages real-time video from the action scene to the viewing screen. The Company designs, develops, and deploys innovative products and turnkey solutions that deliver reliable connectivity across real-time production, military, and government sectors worldwide in the most demanding environments. Vislink is a leader in designing and deploying wireless video solutions, providing customers with reliable and secure video and data transmission. The company is committed to delivering the latest technology and the highest quality products to meet its customers’ needs. Vislink provides solutions for collecting live news, sports, and entertainment events for the broadcast markets. Our Mobile Viewpoint product line offers live streaming solutions that use bonded cellular, 5G, and AI-driven technologies to automate the production of news and sports content. In addition to creating real-time video intelligence solutions, Vislink assists first responders, law enforcement agencies at all levels of government, and military organizations with increased situational awareness. Besides providing professional and technical services, Vislink employs a team of technology experts with decades of experience and applied knowledge of terrestrial microwaves, satellites, fiber optics, surveillance systems, and wireless communications systems to offer customers a wide range of services.

 

Basis of Presentation

Basis of Presentation

 

The accompanying unaudited condensed consolidated interim financial statements and these notes should be viewed in conjunction with Vislink Technologies, Inc.’s 2022 Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on March 31, 2023, which contains the audited consolidated financial statements and notes thereto as of December 31, 2022. As of December 31, 2022, a condensed consolidated balance sheet was prepared based on audited annual financial statements but did not include all of the footnote disclosures from the annual financial statements. In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of routine recurring adjustments, necessary for a fair statement of its financial position as of June 30, 2023, as well as results of operations for the three months and six months ended June 30, 2023, and 2022, as well as cash flow for the six months ended June 30, 2023, and 2022. For the six months ended June 30, 2023, the results of operations are not necessarily indicative of the results for the entire year, any other interim period, or any future period. Effective May 1, 2023, the Company effected a one-for-20 reverse stock split of the common stock. All per-share numbers reflect the one-for-20 reverse stock split. We have retroactively applied the reverse split throughout this quarterly report to all periods presented. The accounting policies of Vislink have not materially changed since December 31, 2022. Note 3 of Vislink’s 2022 annual report on Form 10-K provides detailed information about these policies.

 

Principles of Consolidation

Principles of Consolidation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. The Company has eliminated all intercompany accounts and transactions upon consolidating our subsidiaries.

 

Segment Reporting

Segment Reporting

 

The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the United States, United Kingdom, and the Netherlands.

 

Use of Estimates

Use of Estimates

 

The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities at the date of the unaudited condensed consolidated financial statements. These estimates also affect the reported revenues and expenses during the reporting periods. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. Actual results could differ from estimates, and any such differences may be material to our unaudited condensed consolidated financial statements.

 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Allowance for credit losses

Allowance for credit losses

 

Change in accounting principles

 

In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.

 

The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.

 

Recently Issued Accounting Principles

Recently Issued Accounting Principles

 

Recent Accounting Pronouncements

 

Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.2
LOSS PER SHARE (Tables)
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE

The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):

 

   2023   2022 
   Six months Ended 
   June 30 
   2023   2022 
Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:          
Stock options   85    29 
Warrants   456    459 
Total   541    488 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.2
FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Tables)
6 Months Ended
Jun. 30, 2023
Foreign Currency [Abstract]  
SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME

The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive income approximately as follows:

 

   2023   2022   2023   2022 
   Three months ended   Six months ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Net foreign exchange transactions:                    
(Gains) Losses  $41,000   $(21,000)  $(3,000)  $(5,000)
Accumulated comprehensive income:                    
Unrealized (gains) losses on currency translation adjustment  $10,000   $(871,000)  $(145,000)  $(1,139,000)
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.2
CASH AND CASH EQUIVALENTS (Tables)
6 Months Ended
Jun. 30, 2023
Cash and Cash Equivalents [Abstract]  
SCHEDULE OF CASH AND CASH EQUIVALENTS

The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of unrestricted funds invested in a money market mutual fund. The following table illustrates the Company’s cash and cash equivalents:

 

   June 30,   December 31, 
   2023   2022 
         
Cash on hand   $1,542,000   $25,627,000 
Federally insured money market mutual funds    9,431,000     
Total cash and cash equivalents   $10,973,000   $25,627,000 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.2
INVESTMENTS (Tables)
6 Months Ended
Jun. 30, 2023
Investments, All Other Investments [Abstract]  
SCHEDULE OF FAIR VALUE OF ITS INVESTMENTS

The Company has determined the fair value of its investments held to maturity based on Level 1 input as of June 30, 2023:

 

   Level 1   Level 2   Level 3   Total 
                 
Federal Bonds  $   $10,837,000   $   $10,837,000 
                     
   $   $10,837,000   $   $10,837,000 
SCHEDULE OF INVESTMENTS HELD TO MATURITY

The Company’s investments held to maturity are as follows as of June 30, 2023:

 

   Amortized Cost   Unrealized Gains   Unrealized Losses   Fair Value 
                 
Federal Bonds  $10,900,000       $63,000   $10,837,000 
                     
   $10,900,000   $   $63,000   $10,837,000 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.2
INTANGIBLE ASSETS (Tables)
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF INTANGIBLE ASSETS

The following table illustrates finite intangible assets as of June 30, 2023:

 

   Proprietary Technology   Patents and Licenses   Trade Names & Technology   Customer Relationships     
                                     
       Accumulated       Accumulated       Accumulated       Accumulated     
   Cost   Amortization   Cost   Amortization   Cost   Amortization   Cost   Amortization   Net 
Balance, December 31, 2022  $2,132,000   $(815,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,189,000)  $5,095,000   $(3,074,000)  $4,400,000 
                                              
Amortization       (294,000)               (69,000)       (127,000)   (490,000)
Balance, June 30, 2023  $2,132,000   $(1,109,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,258,000)  $5,095,000   $(3,201,000)  $3,910,000 
SCHEDULE OF CAPITALIZED INTANGIBLE COSTS

The Company has recognized net capitalized intangible costs as follows:

 

   June 30,   December 31, 
   2023   2022 
Proprietary Technology  $1,025,000   $1,319,000 
Trade Names and Technology   991,000    1,060,000 
Customer Relationships   1,894,000    2,021,000 
   $3,910,000   $4,400,000 
SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS

The Company has recognized the amortization of intangible assets as follows:

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Proprietary Technology  $148,000   $148,000   $294,000   $293,000 
Patents and Licenses       167,000        331,000 
Trade Names and Technology   34,000    34,000    69,000    69,000 
Customer Relationships   64,000    64,000    127,000    127,000 
   $246,000   $413,000   $490,000   $820,000 
SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS

The weighted average remaining life of the amortization of the Company’s intangible assets is approximately 5.2 years as of June 30, 2023. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:

 

Period ending June 30,    
2024  $636,000 
2025   635,000 
2026   595,000 
2027   533,000 
2028   349,000 
Thereafter   1,162,000 
Finite-Lived Intangible Assets, Net, Total  $3,910,000 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.2
NOTES PAYABLE (Tables)
6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
SCHEDULE OF NOTES PAYABLE

The table below represents the Company’s notes payable as of June 30, 2023, and December 31, 2022:

 

   Principal 
   June 30,
2023
   December 31,
2022
 
The Company renewed its D&O insurance policy on April 5, 2022, reducing the premium to approximately $1,037,000, less a down payment of $194,000, with the remaining balance financed. The loan’s terms are for nine months at a 2.09% annual interest rate and a monthly principal and interest payment of approximately $84,000. Accordingly, the Company recorded interest expenses of $-0- and $150 for the three and six months ended June 30, 2023, and $-0- and $2,000 for the three and six months ended June 30, 2022, respectively. As of June 30, 2023, the note has been fully repaid.   $   $84,000 
           
The Company renewed its D & O insurance policy on April 5, 2023, reducing the premium to approximately $811,000, less a down payment of $288,000, financing the remaining balance of approximately $523,000. The loan’s terms are for nine months at a 6.14% annual interest rate and a monthly principal and interest payment of approximately $67,000. Accordingly, the Company recorded interest expenses of $5,000 for the three and six months ended June 30, 2023, and $-0- for the three and six months ended June 30, 2022.    394,000      
   $394,000   $84,000 
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.2
LEASES (Tables)
6 Months Ended
Jun. 30, 2023
Leases  
SCHEDULE OF OPERATING LEASE DATA

The following table illustrates operating lease data for the three months ending June 30, 2023, and 2022:

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Lease cost:                    
Operating lease cost  $103,000   $114,000   $206,000   $233,000 
Short-term lease cost   10,000    10,000    20,000    159,000 
Total lease cost  $113,000   $124,000   $226,000   $392,000 
Cash paid for lease liabilities:                    
Cash flows from operating leases            $325,000   $253,000 
Weighted-average remaining lease term—operating leases             3.1 years    3.8 years 
Weighted-average discount rate—operating leases             9.5%   9.4%
SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES

Maturities of operating lease liabilities were as follows as of June 30, 2023:

 

     
   Amount 
2024  $507,000 
2025   468,000 
2026   341,000 
2027   186,000 
2028    
Thereafter    
Total lease payments   1,502,000 
Less: imputed interest   162,000 
Present value of lease liabilities   1,340,000 
Less: Current lease liabilities   406,000 
Non-current lease liabilities  $934,000 
SCHEDULE OF LEASE OBLIGATION ASSUMED

The table below lists the location and lease expiration date from 2023 through 2027:

 

Location  Square Footage   Lease-End
Date
  Approximate
Future Payments
 
Colchester, UK   16,000   Dec 2025   $554,000 
Singapore   950   July 2023   $3,000 
Billerica, MA   2,000   Dec 2026   $43,000 
Hemel, UK   12,870   Oct 2023   $367,000 
Mount Olive, NJ   7,979   Jan 2027   $535,000 
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS’ EQUITY (Tables)
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
SCHEDULE OF WARRANT OUTSTANDING

The following table sets forth common stock purchase warrants outstanding as of June 30, 2023:

 

  

Number of Warrants

(in shares)

  

Weighted

Average

Exercise

Price

 
         
Outstanding, December 31, 2022   458,747   $72.00 
Warrants granted, exercised, canceled, or expired   (2,667)    
Outstanding and exercisable, June 30, 2023   456,080   $66.00 
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

As shown in the following table, stock-based compensation expense is included in general and administrative expenses under the following plans:

 

                 
   Three months ended   Six months ended 
   June 30,   June 30, 
Equity-based plans:  2023   2022   2023   2022 
Long-term stock incentive plan awards  $   $   $   $1,000 
Time-vested option inducement awards   37,000    28,000    107,000    56,000 
Performance-based stock option inducement award   -    -        - 
Time-based restricted stock awards
   299,000    180,000    1,150,000    898,000 
Performance-based restricted stock awards                
Stock-based compensation expense  $336,000   $208,000   $1,257,000   $955,000 
SCHEDULE OF EQUITY COMPENSATION PLANS

The following table illustrates supplementary data under various equity compensation plans:

 

    Six months ended     Six months ended  
    June 30,     June 30,  
    2023     2022     2023     2022  
    Quantity     Weighted Average     Quantity     Weighted Average     Quantity     Weighted Average     Quantity     Weighted Average  
    Long-term stock incentive plan awards     Time-vested option inducement awards  
Balance-January 1st, outstanding     2,250     $ 1,756       2,496     $ 1,795.80       24,721     $ 13.00       24,721     $ 20.20  
Granted, canceled, expired                                                
Forfeited     (58 )     (1,166.00 )     (171 )     (1,931.60 )                        
Balance-June 30th, outstanding     2,192     $ 1,771.40       2,325     $ 1,754.00       24,721     $ 10.00       24,721     $ 17.80  
Balance-June 30th, exercisable     2,192     $ 1,771.40       2,463     $ 1,802.00       24,721     $ 18.00       14,936     $ 29.60  
Remaining compensation expense     $       $       $212,000       $442,000  
Remaining amortization period     0.0 years       0.0 years       0.6 years       1.6 years  
Weighted average remaining contractual life – options outstanding and exercisable     4.0 years and 4.0 years       5.1 years and 5.0 years       6.6 years and 6.6 years       7.6 years and 7.6 years  
Intrinsic value per share     $       $       $       $  
Range of exercise prices     $139.20 to $1,944.00       $139.20 to $23,472.00       $19.20 to $34.20       $19.20 to $34.20  
                                                                 
      Performance-based stock option inducement awards       Time-based restricted stock awards  
Balance-January 1st, outstanding     12,500     $ 33.00       12,500     $ 33.00       140,736     $ 23.00       39,933     $ 63.40  
Granted, canceled, expired                             41,250       9.00       107,053       20.80  
Forfeited                             (19,415 )     (21.40            
Balance-June 30th, outstanding     12,500      $ 33.00       12,500      $ 33.00       162,571      $ 12.60       146,986       26.20  
Balance-June 30th, exercisable         $           $       63,098     $ 40.20       12,472     $ 100.80  
Remaining compensation expense     $414,000       $414,000       $2,049,000       $3,857,000  
Remaining amortization period     1.6 years       2.6 years       1.7 years       3.0 years  
Weighted average remaining contractual life – options outstanding and exercisable     6.6 years and 0.0 years       7.6 years and 7.6 years       2.1 years and 1.8 years       3.0 years and 4.0 years  
Intrinsic value per share     $       $       $       $  
Range of exercise prices     $34.20       $34.20       $8.00 to $72.00       $19.60 to $72.00  
                               
                                      Performance-based restricted stock awards  
Balance-January 1st, outstanding                                     71,303     $ 58.00       63,369     $ 58.80  
Granted, canceled, expired                                                 71,303       21.00  
Forfeited                                     (19,649 )     (21.00 )            
Balance-June 30th, outstanding                                     51,654     $ 22.00       134,762     $ 38.80  
Balance-June 30th, exercisable                                         $       63,369     $ 82.40  
Remaining compensation expense                                     $1,085,000       $1,498,000  
Remaining amortization period                                     2.5 years       7.7 years  
Weighted average remaining contractual life – options outstanding and exercisable                                     2.5 years and 0.0 years       4.3 years and 3.8 years  
Intrinsic value per share                                     $       $  
Range of exercise prices                                     $21.00 to $72.00       $21.00 to $72.00  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.2
COMMITMENTS AND CONTINGENCIES (Tables)
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
SCHEDULE OF MATCHING CONTRIBUTIONS

The table below represents the Company’s matching contributions as follows:

 

   Three months ended   Six months ended 
   June 30,   June 30, 
   2022   2022   2022   2022 
Company matching contributions - Group Personal Pension Plan  $35,000   $48,000   $68,000   $97,000 
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.2
REVENUE (Tables)
6 Months Ended
Jun. 30, 2023
Revenue from Contract with Customer [Abstract]  
SCHEDULE OF DISAGGREGATION OF REVENUE

The Company has one operating segment, with the senior executive management team as the decision-making group. In the following table, the Company has disaggregated revenue by the Company’s primary geographical markets and revenue sources:

 

   Three months Ended   Six months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Primary geographical markets:                
North America  $1,721,000   $3,472,000   $4,888,000   $5,900,000 
South America   38,000    49,000    227,000    99,000 
Europe   1,593,000    2,105,000    3,436,000    4,294,000 
Asia   1,305,000    830,000    2,024,000    1,372,000 
Rest of World   386,000    310,000    1,656,000    1,961,000 
   $5,043,000   $6,766,000   $12,231,000   $13,626,000 
Primary revenue source:                    
Equipment sales  $4,279,000   $6,194,000   $10,673,000   $12,472,000 
Installation, integration, and repairs   263,000    330,000    749,000    573,000 
Warranties   501,000    242,000    809,000    581,000 
   $5,043,000   $6,766,000   $12,231,000   $13,626,000 
Long-Lived Assets:                    
United States            $2,174,000   $2,227,000 
Netherlands             23,000    28,000 
United Kingdom             4,397,000    5,471,000 
             $6,594,000   $7,726,000 
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.2
OTHER INCOME (REBATES) (Tables)
6 Months Ended
Jun. 30, 2023
Other Income and Expenses [Abstract]  
SCHEDULE OF TAX REBATES

The following table represents tax rebates related to the research costs incurred by our U.K. subsidiary.

 

   Three months Ended   Six months Ended 
   June 30,    June 30, 
    2023    2022    2023    2022 
Total tax rebates  $**5,000  $*(10,000)  $329,000   $284,000 

 

** An increase of $5,000 represents a strengthening in the exchange rate from British Pounds to U.S. dollars, resulting in a gain from initial recognition of $324,000 in the first quarter of fiscal 2023.
     
*   As a result of a weakening in the translation rate from British pounds to U.S. dollars, this $10,000 decrease represents a loss compared to the initially recognized $294,000 in fiscal 2022.
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.2
LIQUIDITY AND FINANCIAL CONDITION (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Mar. 31, 2023
Dec. 31, 2022
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]            
Operating income loss $ 3,384 $ 2,576 $ 5,732 $ 5,720    
Net cash provided by used in operating activities     3,194 $ 8,238    
Working capital 35,600   35,600      
Accumulated deficit 304,883   304,883     $ 300,099
Cash 11,000   11,000      
Held to maturity 10,837   10,837      
Investments, fair value disclosure 10,837   10,837      
Federal Bonds [Member]            
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]            
Held to maturity         $ 10,800  
Investments, fair value disclosure 10,837   10,837      
Federal Backed Mutual Fund [Member]            
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]            
Held to maturity $ 10,837   $ 10,837      
Investments, fair value disclosure         $ 11,300  
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE (Details) - shares
shares in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:    
Total 541 488
Equity Option [Member]    
Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:    
Total 85 29
Warrant [Member]    
Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:    
Total 456 459
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Foreign Currency [Abstract]        
Net foreign exchange transactions: Losses $ 41 $ (21) $ (3) $ (5)
Unrealized (gains) losses on currency translation adjustment $ 10 $ (871) $ (145) $ (1,139)
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.2
FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Details Narrative)
Jun. 30, 2023
Jun. 30, 2022
GBP To USD [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 1.00 1.00
Average foreign currency exchange rate remeasurement 1.00 1.00
GBP [Member] | GBP To USD [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 1.266150 1.080655
Average foreign currency exchange rate remeasurement 1.233240 1.298904
GBP [Member] | Euro To GBP [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 1.00 1.00
Average foreign currency exchange rate remeasurement 1.00 1.00
Euro [Member] | Euro To GBP [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Foreign currency exchange rate, translation 1.088440 1.044949
Average foreign currency exchange rate remeasurement 1.080655 1.091890
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Cash and Cash Equivalents [Abstract]    
Cash on hand $ 1,542,000 $ 25,627,000
Federally insured money market mutual funds 9,431,000
Total cash and cash equivalents $ 10,973,000 $ 25,627,000
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF FAIR VALUE OF ITS INVESTMENTS (Details)
$ in Thousands
Jun. 30, 2023
USD ($)
Platform Operator, Crypto-Asset [Line Items]  
Fair value of investments $ 10,837
Federal Bonds [Member]  
Platform Operator, Crypto-Asset [Line Items]  
Fair value of investments 10,837
Fair Value, Inputs, Level 1 [Member]  
Platform Operator, Crypto-Asset [Line Items]  
Fair value of investments
Fair Value, Inputs, Level 1 [Member] | Federal Bonds [Member]  
Platform Operator, Crypto-Asset [Line Items]  
Fair value of investments
Fair Value, Inputs, Level 2 [Member]  
Platform Operator, Crypto-Asset [Line Items]  
Fair value of investments 10,837
Fair Value, Inputs, Level 2 [Member] | Federal Bonds [Member]  
Platform Operator, Crypto-Asset [Line Items]  
Fair value of investments 10,837
Fair Value, Inputs, Level 3 [Member]  
Platform Operator, Crypto-Asset [Line Items]  
Fair value of investments
Fair Value, Inputs, Level 3 [Member] | Federal Bonds [Member]  
Platform Operator, Crypto-Asset [Line Items]  
Fair value of investments
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF INVESTMENTS HELD TO MATURITY (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2023
USD ($)
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]  
Amortized Cost $ 10,900
Unrealized Gains
Unrealized Losses 63
Fair Value 10,837
Federal Backed Mutual Fund [Member]  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]  
Amortized Cost 10,900
Unrealized Gains
Unrealized Losses 63,000
Fair Value $ 10,837
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.2
INVESTMENTS (Details Narrative) - USD ($)
Feb. 28, 2023
Feb. 01, 2023
Jan. 23, 2023
Jun. 30, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Debt instrument face amount $ 950,000 $ 4,999,750 $ 5,065,789  
Debt instrument face amount   $ 5,000,000 $ 5,000,000  
Debt instrument maturity date Feb. 28, 2024 Dec. 22, 2023 Oct. 24, 2023  
Debt instrument interest rate 5.07% 4.75% 5.1948%  
Debt instrument discount     $ 253,289  
Debt instrument $ 950,000 $ 5,025,479 $ 4,812,500 $ 4,910,000
Debt instrument accrued interest   $ 25,729    
Federal Home Loan Banks [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Debt instrument       4,981,000
Federal National Mortgage Association [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Debt instrument       $ 946,000
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Property, Plant and Equipment [Line Items]        
Beginning balance net     $ 4,400,000  
Intangible assets, net Amortization $ (246,000) $ (413,000) (490,000) $ (820,000)
Ending balance net 3,910,000   3,910,000  
Proprietary Technology [Member]        
Property, Plant and Equipment [Line Items]        
Beginning balance cost     2,132,000  
Beginning balance, accumulated amortization     (815,000)  
Intangible assets, Amortization      
Intangible assets, net Amortization (148,000) (148,000) (294,000) (293,000)
Ending balance cost 2,132,000   2,132,000  
Ending balance, accumulated Amortization (1,109,000)   (1,109,000)  
Patents and Licenses [Member]        
Property, Plant and Equipment [Line Items]        
Beginning balance cost     12,378,000  
Beginning balance, accumulated amortization     (12,378,000)  
Intangible assets, Amortization      
Intangible assets, net Amortization (167,000) (331,000)
Ending balance cost 12,378,000   12,378,000  
Ending balance, accumulated Amortization (12,378,000)   (12,378,000)  
Trade Names And Technology [Member]        
Property, Plant and Equipment [Line Items]        
Beginning balance cost     2,251,000  
Beginning balance, accumulated amortization     (1,189,000)  
Intangible assets, Amortization      
Intangible assets, net Amortization (34,000) (34,000) (69,000) (69,000)
Ending balance cost 2,251,000   2,251,000  
Ending balance, accumulated Amortization (1,258,000)   (1,258,000)  
Customer Relationships [Member]        
Property, Plant and Equipment [Line Items]        
Beginning balance cost     5,095,000  
Beginning balance, accumulated amortization     (3,074,000)  
Intangible assets, Amortization      
Intangible assets, net Amortization (64,000) $ (64,000) (127,000) $ (127,000)
Ending balance cost 5,095,000   5,095,000  
Ending balance, accumulated Amortization $ (3,201,000)   $ (3,201,000)  
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Intangible assets $ 3,910,000 $ 4,400,000
Proprietary Technology [Member]    
Property, Plant and Equipment [Line Items]    
Intangible assets 1,025,000 1,319,000
Trade Names And Technology [Member]    
Property, Plant and Equipment [Line Items]    
Intangible assets 991,000 1,060,000
Customer Relationships [Member]    
Property, Plant and Equipment [Line Items]    
Intangible assets $ 1,894,000 $ 2,021,000
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Property, Plant and Equipment [Line Items]        
Amortization of intangible assets $ 246,000 $ 413,000 $ 490,000 $ 820,000
Proprietary Technology [Member]        
Property, Plant and Equipment [Line Items]        
Amortization of intangible assets 148,000 148,000 294,000 293,000
Patents and Licenses [Member]        
Property, Plant and Equipment [Line Items]        
Amortization of intangible assets 167,000 331,000
Trade Names And Technology [Member]        
Property, Plant and Equipment [Line Items]        
Amortization of intangible assets 34,000 34,000 69,000 69,000
Customer Relationships [Member]        
Property, Plant and Equipment [Line Items]        
Amortization of intangible assets $ 64,000 $ 64,000 $ 127,000 $ 127,000
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
2024 $ 636,000  
2025 635,000  
2026 595,000  
2027 533,000  
2028 349,000  
Thereafter 1,162,000  
Finite-Lived Intangible Assets, Net, Total $ 3,910,000 $ 4,400,000
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.2
INTANGIBLE ASSETS (Details Narrative)
Jun. 30, 2023
Finite-Lived Intangible Assets [Line Items]  
Finite-lived intangible assets, remaining amortization period 5 years 2 months 12 days
Proprietary Technology [Member] | Minimum [Member]  
Finite-Lived Intangible Assets [Line Items]  
Finite-lived intangible asset, useful life 3 years
Proprietary Technology [Member] | Maximum [Member]  
Finite-Lived Intangible Assets [Line Items]  
Finite-lived intangible asset, useful life 5 years
Patents and Licenses [Member] | Minimum [Member]  
Finite-Lived Intangible Assets [Line Items]  
Finite-lived intangible asset, useful life 18 years 6 months
Patents and Licenses [Member] | Maximum [Member]  
Finite-Lived Intangible Assets [Line Items]  
Finite-lived intangible asset, useful life 20 years
Trade Names And Technology [Member] | Minimum [Member]  
Finite-Lived Intangible Assets [Line Items]  
Finite-lived intangible asset, useful life 3 years
Trade Names And Technology [Member] | Maximum [Member]  
Finite-Lived Intangible Assets [Line Items]  
Finite-lived intangible asset, useful life 15 years
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical) - USD ($)
3 Months Ended 6 Months Ended
Apr. 05, 2023
Apr. 05, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Feb. 28, 2023
Feb. 01, 2023
Jan. 23, 2023
Short-Term Debt [Line Items]                  
Debt instrument, face amount             $ 950,000 $ 4,999,750 $ 5,065,789
Debt instrument, interest rate, stated percentage             5.07% 4.75% 5.1948%
D & O Insurance Policy Renewed [Member] | Notes Payable One [Member]                  
Short-Term Debt [Line Items]                  
Debt instrument, face amount   $ 1,037,000              
Debt instrument down payment   $ 194,000              
Debt instrument, interest rate, stated percentage   2.09%              
Debt instrument, periodic payment, interest   $ 84,000              
Interest expense     $ 0 $ 0 $ 150 $ 2,000      
D & O Insurance Policy Renewed [Member] | Notes Payable Two [Member]                  
Short-Term Debt [Line Items]                  
Debt instrument, face amount $ 811,000                
Debt instrument down payment $ 288,000                
Debt instrument, interest rate, stated percentage 6.14%                
Debt instrument, periodic payment, interest $ 67,000                
Interest expense     $ 5,000 $ 0 $ 5,000 $ 0      
Notes payable $ 523,000                
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF NOTES PAYABLE (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Short-Term Debt [Line Items]    
Notes payable $ 394,000 $ 84,000
Notes Payable One [Member]    
Short-Term Debt [Line Items]    
Notes payable $ 84,000
Notes Payable Two [Member]    
Short-Term Debt [Line Items]    
Notes payable $ 394,000  
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF OPERATING LEASE DATA (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Leases        
Operating lease cost $ 103,000 $ 114,000 $ 206,000 $ 233,000
Short-term lease cost 10,000 10,000 20,000 159,000
Total lease cost $ 113,000 $ 124,000 226,000 392,000
Cash flows from operating leases     $ 325,000 $ 253,000
Weighted-average remaining lease term-operating leases 3 years 1 month 6 days 3 years 9 months 18 days 3 years 1 month 6 days 3 years 9 months 18 days
Weighted-average discount rate-operating leases 9.50% 9.40% 9.50% 9.40%
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Leases    
2024 $ 507  
2025 468  
2026 341  
2027 186  
2028  
Thereafter  
Total lease payments 1,502  
Less: imputed interest 162  
Present value of lease liabilities 1,340  
Less: Current lease liabilities 406 $ 455
Non-current lease liabilities $ 934 $ 1,107
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF LEASE OBLIGATION ASSUMED (Details)
6 Months Ended
Jun. 30, 2023
USD ($)
ft²
Approximate Future Payments $ 1,502,000
Colchester, U.K. - Waterside House [Member].  
Area of land | ft² 16,000
Lease-End Date 2025
Approximate Future Payments $ 554,000
SINGAPORE  
Area of land | ft² 950
Lease-End Date 2023
Approximate Future Payments $ 3,000
Billerica, MA [Member]  
Area of land | ft² 2,000
Lease-End Date 2026
Approximate Future Payments $ 43,000
Hemel, UK [Member]  
Area of land | ft² 12,870
Lease-End Date 2023
Approximate Future Payments $ 367,000
Mount Olive, NJ [Member]  
Area of land | ft² 7,979
Lease-End Date 2027
Approximate Future Payments $ 535,000
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.23.2
LEASES (Details Narrative)
6 Months Ended
Jun. 30, 2023
USD ($)
ft²
Dec. 31, 2022
USD ($)
Jun. 30, 2022
Right of use of assets $ 940,000 $ 1,075,000  
Right of use assets, accumulated depreciation 1,300,000    
Operating lease liabilities 1,340,000    
Current operating lease liabilities 406,000 455,000  
Non-current operating lease liabilities $ 934,000 $ 1,107,000  
Weighted-average remaining term 3 years 1 month 6 days   3 years 9 months 18 days
Lease maturity description July 2023 and May 2027    
Weighted-average discount rate 9.50%   9.40%
Luton UK [Member]      
Area of land description A one-year lease for 600 square feet of administrative office space in Luton, UK, was signed on June 1, 2023, and will run through May 31, 2024, at approximately $2,100 per month.    
Area of land | ft² 600    
Lease expiration May 31, 2024    
Payments for rent $ 2,100    
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF WARRANT OUTSTANDING (Details)
6 Months Ended
Jun. 30, 2023
$ / shares
shares
Equity [Abstract]  
Number of Warrants, beginning balance | shares 458,747
Weighted Average Exercise Price, beginning balance | $ / shares $ 72.00
Number of Warrants, Warrants granted, exercised, canceled, or expired | shares (2,667)
Weighted Average Exercise Price, Warrants granted, exercised, canceled, or expired | $ / shares
Number of Warrants, ending outstanding | shares 456,080
Weighted Average Exercise Price, ending outstanding | $ / shares $ 66.00
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
May 01, 2023
Jan. 11, 2023
Jan. 10, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Mar. 31, 2023
Mar. 22, 2023
Dec. 31, 2022
May 20, 2022
Class of Stock [Line Items]                      
Preferred stock par value       $ 0.00001   $ 0.00001       $ 0.00001  
Preferred stock, shares authorized       10,000,000   10,000,000       10,000,000  
Common stock per share value       $ 0.00001   $ 0.00001       $ 0.00001 $ 1.00
Reverse split 1-for-20 1-for-50 1-for-2                
Stock compensation costs       $ 336,000 $ 208,000 $ 1,257,000 $ 955,000        
Number of warrants cancelled/expired           2,667          
Common Stock Warrants [Member]                      
Class of Stock [Line Items]                      
Number of warrants cancelled/expired           2,667          
Weighted average exercise price ending exercisable       $ 66.00   $ 66.00          
Weighted average remaining contractual life           2 years 7 months 9 days          
Restricted Stock Units (RSUs) [Member]                      
Class of Stock [Line Items]                      
Shares attributable to withholding tax           10,000          
Restricted Stock Units (RSUs) [Member] | Common Stock [Member]                      
Class of Stock [Line Items]                      
Restricted stock options, granted           $ 200,000,000          
Series A Preferred Stock [Member]                      
Class of Stock [Line Items]                      
Preferred stock par value                 $ 0.00001    
Preferred stock, shares authorized               47,500      
Preferred stock, shares issed               0      
Preferred stock, shares outstanding               0      
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation expense $ 336,000 $ 208,000 $ 1,257,000 $ 955,000
Long Term Stock Incentive Plan Awards [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation expense 1,000,000
Time Vested Option Inducement Awards [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation expense 37,000,000 28,000,000 107,000,000 56,000,000
Performance Based Stock Option Inducement [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation expense
Time Based Restricted Stock Awards [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation expense 299,000,000 180,000,000 1,150,000,000 898,000,000
Performance Based Restricted Stock Awards [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock-based compensation expense
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF EQUITY COMPENSATION PLANS (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Long Term Stock Incentive Plan Awards [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Quantity, outstanding beginning balance 2,250 2,496
Weighted Average, outstanding beginning balance $ 1,756 $ 1,795.80
Quantity, outstanding beginning balance
Weighted Average, outstanding beginning balance
Quantity, outstanding beginning balance (58) (171)
Weighted Average, outstanding beginning balance $ (1,166.00) $ (1,931.60)
Quantity, outstanding beginning balance 2,192 2,325
Weighted Average, outstanding beginning balance $ 1,771.40 $ 1,754.00
Quantity, outstanding beginning balance 2,192 2,463
Weighted Average, outstanding beginning balance $ 1,771.40 $ 1,802.00
Remaining compensation expense
Services previously accrued 0 years 0 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 4 years 5 years 1 month 6 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 4 years 5 years
Intrinsic value per share
Quantity, outstanding beginning balance
Long Term Stock Incentive Plan Awards [Member] | Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share based compensation shares authorized under stock other than option plans exercise price $ 139.20 $ 139.20
Long Term Stock Incentive Plan Awards [Member] | Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share based compensation shares authorized under stock other than option plans exercise price $ 1,944.00 $ 23,472.00
Time Vested Option Inducement Awards [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Quantity, outstanding beginning balance 24,721 24,721
Weighted Average, outstanding beginning balance $ 13.00 $ 20.20
Quantity, outstanding beginning balance
Weighted Average, outstanding beginning balance
Quantity, outstanding beginning balance
Weighted Average, outstanding beginning balance
Quantity, outstanding beginning balance 24,721 24,721
Weighted Average, outstanding beginning balance $ 10.00 $ 17.80
Quantity, outstanding beginning balance 24,721 14,936
Weighted Average, outstanding beginning balance $ 18.00 $ 29.60
Remaining compensation expense $ 212,000 $ 442,000
Services previously accrued 7 months 6 days 1 year 7 months 6 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 6 years 7 months 6 days 7 years 7 months 6 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 6 years 7 months 6 days 7 years 7 months 6 days
Intrinsic value per share
Quantity, outstanding beginning balance
Time Vested Option Inducement Awards [Member] | Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share based compensation shares authorized under stock other than option plans exercise price $ 19.20 $ 19.20
Time Vested Option Inducement Awards [Member] | Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share based compensation shares authorized under stock other than option plans exercise price $ 34.20 $ 34.20
Performance Based Stock Option Inducement Awards [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Quantity, outstanding beginning balance 12,500 12,500
Weighted Average, outstanding beginning balance $ 33.00 $ 33.00
Quantity, outstanding beginning balance
Weighted Average, outstanding beginning balance
Quantity, outstanding beginning balance
Weighted Average, outstanding beginning balance
Quantity, outstanding beginning balance 12,500 12,500
Weighted Average, outstanding beginning balance $ 33.00 $ 33.00
Quantity, outstanding beginning balance
Weighted Average, outstanding beginning balance
Remaining compensation expense $ 414,000 $ 414,000
Services previously accrued 1 year 7 months 6 days 2 years 7 months 6 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 6 years 7 months 6 days 7 years 7 months 6 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 0 years 7 years 7 months 6 days
Intrinsic value per share
Share based compensation shares authorized under stock other than option plans exercise price $ 34.20 $ 34.20
Quantity, outstanding beginning balance
Time Based Restricted Stock Awards [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Quantity, outstanding beginning balance 140,736 39,933
Weighted Average, outstanding beginning balance $ 23.00 $ 63.40
Quantity, outstanding beginning balance (41,250) (107,053)
Weighted Average, outstanding beginning balance $ 9.00 $ 20.80
Quantity, outstanding beginning balance (19,415)
Weighted Average, outstanding beginning balance $ (21.40)
Quantity, outstanding beginning balance 162,571 146,986
Weighted Average, outstanding beginning balance $ 12.60 $ 26.20
Quantity, outstanding beginning balance 63,098 12,472
Weighted Average, outstanding beginning balance $ 40.20 $ 100.80
Remaining compensation expense $ 2,049,000 $ 3,857,000
Services previously accrued 1 year 8 months 12 days 3 years
Intrinsic value per share
Quantity, outstanding beginning balance 41,250 107,053
Time Based Restricted Stock Awards [Member] | Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share based compensation shares authorized under stock other than option plans exercise price $ 8.00 $ 19.60
Time Based Restricted Stock Awards [Member] | Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share based compensation shares authorized under stock other than option plans exercise price $ 72.00 $ 72.00
Time Based Restricted Stock Awards One [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 2 years 1 month 6 days 3 years
Time Based Restricted Stock Awards Two [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 1 year 9 months 18 days 4 years
Performance Based Restricted Stock Awards [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Quantity, outstanding beginning balance 71,303 63,369
Weighted Average, outstanding beginning balance $ 58.00 $ 58.80
Quantity, outstanding beginning balance (71,303)
Weighted Average, outstanding beginning balance $ 21.00
Quantity, outstanding beginning balance (19,649)
Weighted Average, outstanding beginning balance $ (21.00)
Quantity, outstanding beginning balance 51,654 134,762
Weighted Average, outstanding beginning balance $ 22.00 $ 38.80
Quantity, outstanding beginning balance 63,369
Weighted Average, outstanding beginning balance $ 82.40
Remaining compensation expense $ 1,085,000 $ 1,498,000
Services previously accrued 2 years 6 months 7 years 8 months 12 days
Intrinsic value per share
Quantity, outstanding beginning balance 71,303
Performance Based Restricted Stock Awards [Member] | Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share based compensation shares authorized under stock other than option plans exercise price $ 21.00 $ 21.00
Performance Based Restricted Stock Awards [Member] | Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share based compensation shares authorized under stock other than option plans exercise price $ 72.00 $ 72.00
Performance Based Restricted Stock Awards One [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms] 2 years 6 months 4 years 3 months 18 days
Performance Based Restricted Stock Awards Two [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms] 0 years 3 years 9 months 18 days
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION (Details Narrative)
6 Months Ended
Jun. 30, 2023
Restricted Stock Units (RSUs) [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Description of equity awards vesting percentage and maturity term The equity awards have an initial vesting between 25% and 33% on their one-year anniversary dates and will vest between 24 and 36 equal monthly periods thereafter.
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF MATCHING CONTRIBUTIONS (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Group Personal Pension Plan, UK [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Company matching contributions $ 35,000 $ 48,000 $ 68,000 $ 97,000
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.23.2
CONCENTRATIONS (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Concentration Risk [Line Items]          
Revenue, net $ 5,043,000 $ 6,766,000 $ 12,231,000 $ 13,626,000  
Accounts payable 3,333,000   3,333,000   $ 2,626,000
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer Two [Member]          
Concentration Risk [Line Items]          
Revenue, net   $ 788,000   $ 1,467,000  
Concentration risk, percentage   12.00%   11.00%  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer Two [Member]          
Concentration Risk [Line Items]          
Revenue, net     $ 688,000    
Concentration risk, percentage     12.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer One [Member]          
Concentration Risk [Line Items]          
Revenue, net     $ 925,000 $ 4,204,000  
Concentration risk, percentage     16.00% 48.00%  
Accounts Payable [Member] | Supplier Concentration Risk [Member] | One Vendor [Member]          
Concentration Risk [Line Items]          
Accounts payable 465,000   $ 465,000    
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor Two [Member]          
Concentration Risk [Line Items]          
Concentration risk, percentage     10.00%    
Accounts payable $ 323,000   $ 323,000    
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor One [Member]          
Concentration Risk [Line Items]          
Concentration risk, percentage 15.00%   18.00%    
Accounts payable $ 610,000   $ 610,000    
Purchase [Member] | Supplier Concentration Risk [Member] | Vendor Two [Member]          
Concentration Risk [Line Items]          
Revenue, net     587,000    
Purchase [Member] | Supplier Concentration Risk [Member] | Vendor One [Member]          
Concentration Risk [Line Items]          
Revenue, net     $ 595,000    
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF DISAGGREGATION OF REVENUE (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of Revenue [Line Items]        
Revenue, net $ 5,043,000 $ 6,766,000 $ 12,231,000 $ 13,626,000
Long-Lived Assets 6,594,000 7,726,000 6,594,000 7,726,000
Equipment Sales [Member]        
Disaggregation of Revenue [Line Items]        
Revenue, net 4,279,000 6,194,000 10,673,000 12,472,000
Installation, Integration and Repairs [Member]        
Disaggregation of Revenue [Line Items]        
Revenue, net 263,000 330,000 749,000 573,000
Warranties [Member]        
Disaggregation of Revenue [Line Items]        
Revenue, net 501,000 242,000 809,000 581,000
North America [Member]        
Disaggregation of Revenue [Line Items]        
Revenue, net 1,721,000 3,472,000 4,888,000 5,900,000
South America [Member]        
Disaggregation of Revenue [Line Items]        
Revenue, net 38,000 49,000 227,000 99,000
Europe [Member]        
Disaggregation of Revenue [Line Items]        
Revenue, net 1,593,000 2,105,000 3,436,000 4,294,000
Asia [Member]        
Disaggregation of Revenue [Line Items]        
Revenue, net 1,305,000 830,000 2,024,000 1,372,000
Rest of World [Member]        
Disaggregation of Revenue [Line Items]        
Revenue, net 386,000 310,000 1,656,000 1,961,000
UNITED STATES        
Disaggregation of Revenue [Line Items]        
Long-Lived Assets 2,174,000 2,227,000 2,174,000 2,227,000
NETHERLANDS        
Disaggregation of Revenue [Line Items]        
Long-Lived Assets 23,000 28,000 23,000 28,000
UNITED KINGDOM        
Disaggregation of Revenue [Line Items]        
Long-Lived Assets $ 4,397,000 $ 5,471,000 $ 4,397,000 $ 5,471,000
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF TAX REBATES (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
UK Subsidiary [Member]        
Tax rebate $ 5,000 [1] $ (10,000) [2] $ 329,000 $ 284,000
[1] An increase of $5,000 represents a strengthening in the exchange rate from British Pounds to U.S. dollars, resulting in a gain from initial recognition of $324,000 in the first quarter of fiscal 2023.
[2] As a result of a weakening in the translation rate from British pounds to U.S. dollars, this $10,000 decrease represents a loss compared to the initially recognized $294,000 in fiscal 2022.
XML 75 R65.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF TAX REBATES (Parenthetical) (Details) - GBP To USD [Member] - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Offsetting Assets [Line Items]    
Increase (decrease) in tax rebates $ 5,000 $ (10,000)
Gain loss from initial recognition of exchange rate $ 324,000 $ 294,000
XML 76 R66.htm IDEA: XBRL DOCUMENT v3.23.2
SUBSEQUENT EVENTS (Details Narrative)
$ in Thousands
1 Months Ended
Jul. 03, 2023
USD ($)
ft²
Sep. 30, 2023
USD ($)
Forecast [Member]    
Subsequent Event [Line Items]    
Severance costs over next six months   $ 200
Subsequent Event [Member] | DIFX [Member]    
Subsequent Event [Line Items]    
Area of land | ft² 976  
Payments for rent $ 1,632  
XML 77 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001565228 2023-01-01 2023-06-30 0001565228 2023-08-11 0001565228 2023-06-30 0001565228 2022-12-31 0001565228 us-gaap:SeriesAPreferredStockMember 2023-06-30 0001565228 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001565228 2023-04-01 2023-06-30 0001565228 2022-04-01 2022-06-30 0001565228 2022-01-01 2022-06-30 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001565228 us-gaap:CommonStockMember 2023-03-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001565228 us-gaap:TreasuryStockCommonMember 2023-03-31 0001565228 us-gaap:RetainedEarningsMember 2023-03-31 0001565228 2023-03-31 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001565228 us-gaap:CommonStockMember 2022-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001565228 us-gaap:TreasuryStockCommonMember 2022-12-31 0001565228 us-gaap:RetainedEarningsMember 2022-12-31 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001565228 us-gaap:CommonStockMember 2022-03-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001565228 us-gaap:TreasuryStockCommonMember 2022-03-31 0001565228 us-gaap:RetainedEarningsMember 2022-03-31 0001565228 2022-03-31 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001565228 us-gaap:CommonStockMember 2021-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001565228 us-gaap:TreasuryStockCommonMember 2021-12-31 0001565228 us-gaap:RetainedEarningsMember 2021-12-31 0001565228 2021-12-31 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001565228 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001565228 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001565228 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0001565228 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-06-30 0001565228 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001565228 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001565228 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-06-30 0001565228 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001565228 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001565228 us-gaap:TreasuryStockCommonMember 2022-04-01 2022-06-30 0001565228 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-06-30 0001565228 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001565228 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-06-30 0001565228 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001565228 us-gaap:CommonStockMember 2023-06-30 0001565228 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001565228 us-gaap:TreasuryStockCommonMember 2023-06-30 0001565228 us-gaap:RetainedEarningsMember 2023-06-30 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001565228 us-gaap:CommonStockMember 2022-06-30 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001565228 us-gaap:TreasuryStockCommonMember 2022-06-30 0001565228 us-gaap:RetainedEarningsMember 2022-06-30 0001565228 2022-06-30 0001565228 VISL:FederalBondsMember 2023-03-31 0001565228 VISL:FederalBackedMutualFundMember 2023-03-31 0001565228 us-gaap:StockOptionMember 2023-01-01 2023-06-30 0001565228 us-gaap:StockOptionMember 2022-01-01 2022-06-30 0001565228 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001565228 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001565228 VISL:GBPMember VISL:GBPToUSDMember 2023-06-30 0001565228 VISL:GBPToUSDMember 2023-06-30 0001565228 VISL:EuroMember VISL:EuroToGBPMember 2023-06-30 0001565228 VISL:GBPMember VISL:EuroToGBPMember 2023-06-30 0001565228 VISL:GBPMember VISL:GBPToUSDMember 2022-06-30 0001565228 VISL:GBPToUSDMember 2022-06-30 0001565228 VISL:EuroMember VISL:EuroToGBPMember 2022-06-30 0001565228 VISL:GBPMember VISL:EuroToGBPMember 2022-06-30 0001565228 2023-01-23 0001565228 2023-01-22 2023-01-23 0001565228 2023-02-01 0001565228 2023-02-01 2023-02-01 0001565228 VISL:FederalHomeLoanBanksMember 2023-06-30 0001565228 2023-02-28 0001565228 2023-02-27 2023-02-28 0001565228 VISL:FederalNationalMortgageAssociationMember 2023-06-30 0001565228 us-gaap:FairValueInputsLevel1Member VISL:FederalBondsMember 2023-06-30 0001565228 us-gaap:FairValueInputsLevel2Member VISL:FederalBondsMember 2023-06-30 0001565228 us-gaap:FairValueInputsLevel3Member VISL:FederalBondsMember 2023-06-30 0001565228 VISL:FederalBondsMember 2023-06-30 0001565228 us-gaap:FairValueInputsLevel1Member 2023-06-30 0001565228 us-gaap:FairValueInputsLevel2Member 2023-06-30 0001565228 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001565228 VISL:FederalBackedMutualFundMember 2023-06-30 0001565228 VISL:FederalBackedMutualFundMember 2023-01-01 2023-06-30 0001565228 VISL:ProprietaryTechnologyMember 2022-12-31 0001565228 VISL:PatentsAndLicensesMember 2022-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2022-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2022-12-31 0001565228 VISL:ProprietaryTechnologyMember 2023-01-01 2023-06-30 0001565228 VISL:PatentsAndLicensesMember 2023-01-01 2023-06-30 0001565228 VISL:TradeNamesAndTechnologyMember 2023-01-01 2023-06-30 0001565228 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-06-30 0001565228 VISL:ProprietaryTechnologyMember 2023-06-30 0001565228 VISL:PatentsAndLicensesMember 2023-06-30 0001565228 VISL:TradeNamesAndTechnologyMember 2023-06-30 0001565228 us-gaap:CustomerRelationshipsMember 2023-06-30 0001565228 srt:MinimumMember VISL:ProprietaryTechnologyMember 2023-06-30 0001565228 srt:MaximumMember VISL:ProprietaryTechnologyMember 2023-06-30 0001565228 srt:MinimumMember VISL:PatentsAndLicensesMember 2023-06-30 0001565228 srt:MaximumMember VISL:PatentsAndLicensesMember 2023-06-30 0001565228 srt:MinimumMember VISL:TradeNamesAndTechnologyMember 2023-06-30 0001565228 srt:MaximumMember VISL:TradeNamesAndTechnologyMember 2023-06-30 0001565228 VISL:ProprietaryTechnologyMember 2023-04-01 2023-06-30 0001565228 VISL:ProprietaryTechnologyMember 2022-04-01 2022-06-30 0001565228 VISL:ProprietaryTechnologyMember 2022-01-01 2022-06-30 0001565228 VISL:PatentsAndLicensesMember 2023-04-01 2023-06-30 0001565228 VISL:PatentsAndLicensesMember 2022-04-01 2022-06-30 0001565228 VISL:PatentsAndLicensesMember 2022-01-01 2022-06-30 0001565228 VISL:TradeNamesAndTechnologyMember 2023-04-01 2023-06-30 0001565228 VISL:TradeNamesAndTechnologyMember 2022-04-01 2022-06-30 0001565228 VISL:TradeNamesAndTechnologyMember 2022-01-01 2022-06-30 0001565228 us-gaap:CustomerRelationshipsMember 2023-04-01 2023-06-30 0001565228 us-gaap:CustomerRelationshipsMember 2022-04-01 2022-06-30 0001565228 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-06-30 0001565228 VISL:NotesPayableOneMember VISL:DAndOInsurancePolicyRenewedMember 2022-04-05 0001565228 VISL:NotesPayableOneMember VISL:DAndOInsurancePolicyRenewedMember 2022-04-04 2022-04-05 0001565228 VISL:NotesPayableOneMember VISL:DAndOInsurancePolicyRenewedMember 2023-04-01 2023-06-30 0001565228 VISL:NotesPayableOneMember VISL:DAndOInsurancePolicyRenewedMember 2023-01-01 2023-06-30 0001565228 VISL:NotesPayableOneMember VISL:DAndOInsurancePolicyRenewedMember 2022-04-01 2022-06-30 0001565228 VISL:NotesPayableOneMember VISL:DAndOInsurancePolicyRenewedMember 2022-01-01 2022-06-30 0001565228 VISL:NotesPayableTwoMember VISL:DAndOInsurancePolicyRenewedMember 2023-04-05 0001565228 VISL:NotesPayableTwoMember VISL:DAndOInsurancePolicyRenewedMember 2023-04-04 2023-04-05 0001565228 VISL:NotesPayableTwoMember VISL:DAndOInsurancePolicyRenewedMember 2023-04-01 2023-06-30 0001565228 VISL:NotesPayableTwoMember VISL:DAndOInsurancePolicyRenewedMember 2023-01-01 2023-06-30 0001565228 VISL:NotesPayableTwoMember VISL:DAndOInsurancePolicyRenewedMember 2022-04-01 2022-06-30 0001565228 VISL:NotesPayableTwoMember VISL:DAndOInsurancePolicyRenewedMember 2022-01-01 2022-06-30 0001565228 VISL:NotesPayableOneMember 2023-06-30 0001565228 VISL:NotesPayableOneMember 2022-12-31 0001565228 VISL:NotesPayableTwoMember 2023-06-30 0001565228 VISL:LutonUKMember 2023-01-01 2023-06-30 0001565228 VISL:LutonUKMember 2023-06-30 0001565228 VISL:ColchesterUKWatersideHouseMember 2023-06-30 0001565228 VISL:ColchesterUKWatersideHouseMember 2023-01-01 2023-06-30 0001565228 country:SG 2023-06-30 0001565228 country:SG 2023-01-01 2023-06-30 0001565228 VISL:BillericaMaMember 2023-06-30 0001565228 VISL:BillericaMaMember 2023-01-01 2023-06-30 0001565228 VISL:HemelUKMember 2023-06-30 0001565228 VISL:HemelUKMember 2023-01-01 2023-06-30 0001565228 VISL:MountOliveNJMember 2023-06-30 0001565228 VISL:MountOliveNJMember 2023-01-01 2023-06-30 0001565228 us-gaap:SeriesAPreferredStockMember 2023-03-22 0001565228 us-gaap:SeriesAPreferredStockMember 2023-03-31 0001565228 2022-05-20 0001565228 2023-01-10 2023-01-10 0001565228 2023-01-11 2023-01-11 0001565228 2023-05-01 2023-05-01 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001565228 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001565228 VISL:CommonStockWarrantsMember 2023-01-01 2023-06-30 0001565228 VISL:CommonStockWarrantsMember 2023-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2023-04-01 2023-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2022-04-01 2022-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2023-04-01 2023-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2022-04-01 2022-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2023-04-01 2023-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2022-04-01 2022-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2023-01-01 2023-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2022-01-01 2022-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2023-04-01 2023-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2022-04-01 2022-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2023-04-01 2023-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2022-04-01 2022-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2022-12-31 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2021-12-31 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2022-12-31 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2021-12-31 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2023-06-30 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2022-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2023-06-30 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2022-06-30 0001565228 srt:MinimumMember VISL:LongTermStockIncentivePlanAwardsMember 2023-01-01 2023-06-30 0001565228 srt:MaximumMember VISL:LongTermStockIncentivePlanAwardsMember 2023-01-01 2023-06-30 0001565228 srt:MinimumMember VISL:LongTermStockIncentivePlanAwardsMember 2022-01-01 2022-06-30 0001565228 srt:MaximumMember VISL:LongTermStockIncentivePlanAwardsMember 2022-01-01 2022-06-30 0001565228 srt:MinimumMember VISL:TimeVestedOptionInducementAwardsMember 2023-01-01 2023-06-30 0001565228 srt:MaximumMember VISL:TimeVestedOptionInducementAwardsMember 2023-01-01 2023-06-30 0001565228 srt:MinimumMember VISL:TimeVestedOptionInducementAwardsMember 2022-01-01 2022-06-30 0001565228 srt:MaximumMember VISL:TimeVestedOptionInducementAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementAwardsMember 2022-12-31 0001565228 VISL:PerformanceBasedStockOptionInducementAwardsMember 2021-12-31 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2022-12-31 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2021-12-31 0001565228 VISL:PerformanceBasedStockOptionInducementAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementAwardsMember 2023-06-30 0001565228 VISL:PerformanceBasedStockOptionInducementAwardsMember 2022-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2023-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2022-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsOneMember 2023-01-01 2023-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsTwoMember 2023-01-01 2023-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsOneMember 2022-01-01 2022-06-30 0001565228 VISL:TimeBasedRestrictedStockAwardsTwoMember 2022-01-01 2022-06-30 0001565228 srt:MinimumMember VISL:TimeBasedRestrictedStockAwardsMember 2023-01-01 2023-06-30 0001565228 srt:MaximumMember VISL:TimeBasedRestrictedStockAwardsMember 2023-01-01 2023-06-30 0001565228 srt:MinimumMember VISL:TimeBasedRestrictedStockAwardsMember 2022-01-01 2022-06-30 0001565228 srt:MaximumMember VISL:TimeBasedRestrictedStockAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2022-12-31 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2021-12-31 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2023-01-01 2023-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2023-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2022-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsOneMember 2023-01-01 2023-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsTwoMember 2023-01-01 2023-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsOneMember 2022-01-01 2022-06-30 0001565228 VISL:PerformanceBasedRestrictedStockAwardsTwoMember 2022-01-01 2022-06-30 0001565228 srt:MinimumMember VISL:PerformanceBasedRestrictedStockAwardsMember 2023-01-01 2023-06-30 0001565228 srt:MaximumMember VISL:PerformanceBasedRestrictedStockAwardsMember 2023-01-01 2023-06-30 0001565228 srt:MinimumMember VISL:PerformanceBasedRestrictedStockAwardsMember 2022-01-01 2022-06-30 0001565228 srt:MaximumMember VISL:PerformanceBasedRestrictedStockAwardsMember 2022-01-01 2022-06-30 0001565228 VISL:GroupPersonalPensionPlanUKMember 2023-04-01 2023-06-30 0001565228 VISL:GroupPersonalPensionPlanUKMember 2022-04-01 2022-06-30 0001565228 VISL:GroupPersonalPensionPlanUKMember 2023-01-01 2023-06-30 0001565228 VISL:GroupPersonalPensionPlanUKMember 2022-01-01 2022-06-30 0001565228 VISL:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001565228 VISL:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001565228 VISL:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001565228 VISL:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001565228 VISL:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:OneVendorMember 2023-06-30 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:VendorTwoMember 2023-06-30 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:VendorOneMember 2023-04-01 2023-06-30 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:VendorTwoMember 2023-01-01 2023-06-30 0001565228 VISL:PurchaseMember us-gaap:SupplierConcentrationRiskMember VISL:VendorOneMember 2023-01-01 2023-06-30 0001565228 VISL:PurchaseMember us-gaap:SupplierConcentrationRiskMember VISL:VendorTwoMember 2023-01-01 2023-06-30 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:VendorOneMember 2023-06-30 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:VendorOneMember 2023-01-01 2023-06-30 0001565228 srt:NorthAmericaMember 2023-04-01 2023-06-30 0001565228 srt:NorthAmericaMember 2022-04-01 2022-06-30 0001565228 srt:NorthAmericaMember 2023-01-01 2023-06-30 0001565228 srt:NorthAmericaMember 2022-01-01 2022-06-30 0001565228 srt:SouthAmericaMember 2023-04-01 2023-06-30 0001565228 srt:SouthAmericaMember 2022-04-01 2022-06-30 0001565228 srt:SouthAmericaMember 2023-01-01 2023-06-30 0001565228 srt:SouthAmericaMember 2022-01-01 2022-06-30 0001565228 srt:EuropeMember 2023-04-01 2023-06-30 0001565228 srt:EuropeMember 2022-04-01 2022-06-30 0001565228 srt:EuropeMember 2023-01-01 2023-06-30 0001565228 srt:EuropeMember 2022-01-01 2022-06-30 0001565228 srt:AsiaMember 2023-04-01 2023-06-30 0001565228 srt:AsiaMember 2022-04-01 2022-06-30 0001565228 srt:AsiaMember 2023-01-01 2023-06-30 0001565228 srt:AsiaMember 2022-01-01 2022-06-30 0001565228 VISL:RestOfWorldMember 2023-04-01 2023-06-30 0001565228 VISL:RestOfWorldMember 2022-04-01 2022-06-30 0001565228 VISL:RestOfWorldMember 2023-01-01 2023-06-30 0001565228 VISL:RestOfWorldMember 2022-01-01 2022-06-30 0001565228 VISL:EquipmentSalesMember 2023-04-01 2023-06-30 0001565228 VISL:EquipmentSalesMember 2022-04-01 2022-06-30 0001565228 VISL:EquipmentSalesMember 2023-01-01 2023-06-30 0001565228 VISL:EquipmentSalesMember 2022-01-01 2022-06-30 0001565228 VISL:InstallationIntegrationAndRepairsMember 2023-04-01 2023-06-30 0001565228 VISL:InstallationIntegrationAndRepairsMember 2022-04-01 2022-06-30 0001565228 VISL:InstallationIntegrationAndRepairsMember 2023-01-01 2023-06-30 0001565228 VISL:InstallationIntegrationAndRepairsMember 2022-01-01 2022-06-30 0001565228 VISL:WarrantiesMember 2023-04-01 2023-06-30 0001565228 VISL:WarrantiesMember 2022-04-01 2022-06-30 0001565228 VISL:WarrantiesMember 2023-01-01 2023-06-30 0001565228 VISL:WarrantiesMember 2022-01-01 2022-06-30 0001565228 country:US 2023-06-30 0001565228 country:US 2022-06-30 0001565228 country:NL 2023-06-30 0001565228 country:NL 2022-06-30 0001565228 country:GB 2023-06-30 0001565228 country:GB 2022-06-30 0001565228 VISL:UKSubsidiaryMember 2023-04-01 2023-06-30 0001565228 VISL:UKSubsidiaryMember 2022-04-01 2022-06-30 0001565228 VISL:UKSubsidiaryMember 2023-01-01 2023-06-30 0001565228 VISL:UKSubsidiaryMember 2022-01-01 2022-06-30 0001565228 VISL:GBPToUSDMember 2023-01-01 2023-03-31 0001565228 VISL:GBPToUSDMember 2022-01-01 2022-12-31 0001565228 VISL:DIFXMember us-gaap:SubsequentEventMember 2023-07-03 0001565228 VISL:DIFXMember us-gaap:SubsequentEventMember 2023-07-03 2023-07-03 0001565228 srt:ScenarioForecastMember 2023-09-01 2023-09-30 iso4217:USD shares iso4217:USD shares iso4217:GBP utr:sqft iso4217:AED iso4217:EUR pure 0001565228 false Q2 --12-31 -10000000 10-Q true 2023-06-30 2023 false 001-35988 Vislink Technologies, Inc. DE 20-5856795 350 Clark Drive Suite 125 Mt. Olive NJ 07828 (908) 852-3700 Common stock par value $0.00001 per share VISL NASDAQ Yes Yes Non-accelerated Filer true false false 2377362 10973000 25627000 5747000 6007000 13177000 12021000 10837000 2376000 1232000 43110000 44887000 940000 1075000 1744000 1434000 3910000 4400000 49704000 51796000 3333000 2626000 1436000 1568000 394000 84000 406000 455000 1921000 1540000 7490000 6273000 934000 1107000 655000 764000 9079000 8144000 0.00001 0.00001 0 0 0 0 47419 47419 0.00001 0.00001 10000000 10000000 0.00001 0.00001 100000000 100000000 2377362 2370966 2377229 2370833 346822000 345365000 -1037000 -1337000 133 133 277000 277000 -304883000 -300099000 40625000 43652000 49704000 51796000 5043000 6766000 12231000 13626000 2361000 3186000 5675000 6609000 175000 101000 304000 197000 4679000 4439000 9707000 9349000 908000 1151000 1675000 2269000 304000 465000 602000 922000 8427000 9342000 17963000 19346000 -3384000 -2576000 -5732000 -5720000 -35000 -63000 9000 9000 -11000 -10000 330000 316000 128000 219000 220000 -5000 353000 -5000 302000 -6000 839000 320000 -3082000 -2582000 -4893000 -5400000 -54000 -56000 -109000 -107000 -3028000 -2526000 -4784000 -5293000 -1.27 -1.27 -1.10 -1.10 -2.02 -2.02 -2.30 -2.30 -1.27 -1.10 -2.02 -2.30 2377 2377 2305 2305 2374 2374 2298 2298 2377 2305 2374 2298 -3028000 -2526000 -4784000 -5293000 -145000 1407000 -300000 1139000 -2883000 -3933000 -4484000 -6432000 2377362 346486000 -1182000 -277000 -301855000 43172000 -3028000 -3028000 145000 145000 336000 336000 2377362 346822000 -1037000 -277000 -304883000 40625000 47419 2367362 345365000 -1337000 -277000 -300099000 43652000 -4784000 -4784000 300000 300000 -47419 10000 200000 200000 1257000 1257000 2377362 346822000 -1037000 -277000 -304883000 40625000 2287669 344493000 -565000 -277000 -289306000 54345000 -2526000 -2526000 -871000 -871000 1935 31000 31000 17889 57952 208000 208000 2365445 344732000 -1436000 -277000 -291832000 51187000 2287669 343746000 -297000 -277000 -286539000 56633000 2287669 343746000 -297000 -277000 -286539000 56633000 -5293000 -5293000 -1139000 -1139000 1935 31000 31000 17889 57952 955000 955000 2365445 344732000 -1436000 -277000 -291832000 51187000 2365445 344732000 -1436000 -277000 -291832000 51187000 -4784000 -5293000 9000 -109000 -107000 63000 137000 1257000 955000 200000 38000 15000 6000 38000 304000 197000 135000 104000 602000 922000 -323000 -111000 1196000 3934000 619000 -1118000 708000 202000 68000 -1749000 -222000 -286000 381000 -646000 -3194000 -8238000 10763000 421000 298000 -11184000 -298000 213000 458000 -213000 -458000 -63000 -358000 -14654000 -9352000 25627000 36231000 10973000 26879000 6000 6000 523000 943000 31000 200000 135000 104000 -135000 -104000 -222000 -286000 -222000 -286000 <p id="xdx_800_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_zWLDz7p8VYni" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 — <span id="xdx_824_zoXcEWIkAOS2">ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_ecustom--NatureOfOperationsPolicyTextBlock_zWlRRTqk4Nz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zQNoFbydg26l">Nature of Operations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated in Delaware in 2006, Vislink Technologies, Inc. (“Vislink”) is an innovative technology company that collects, delivers and manages real-time video from the action scene to the viewing screen. The Company designs, develops, and deploys innovative products and turnkey solutions that deliver reliable connectivity across real-time production, military, and government sectors worldwide in the most demanding environments. Vislink is a leader in designing and deploying wireless video solutions, providing customers with reliable and secure video and data transmission. The company is committed to delivering the latest technology and the highest quality products to meet its customers’ needs. Vislink provides solutions for collecting live news, sports, and entertainment events for the broadcast markets. Our Mobile Viewpoint product line offers live streaming solutions that use bonded cellular, 5G, and AI-driven technologies to automate the production of news and sports content. In addition to creating real-time video intelligence solutions, Vislink assists first responders, law enforcement agencies at all levels of government, and military organizations with increased situational awareness. Besides providing professional and technical services, Vislink employs a team of technology experts with decades of experience and applied knowledge of terrestrial microwaves, satellites, fiber optics, surveillance systems, and wireless communications systems to offer customers a wide range of services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zlKfg8Fvou0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zjLDQRsW47fb">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated interim financial statements and these notes should be viewed in conjunction with Vislink Technologies, Inc.’s 2022 Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on March 31, 2023, which contains the audited consolidated financial statements and notes thereto as of December 31, 2022. As of December 31, 2022, a condensed consolidated balance sheet was prepared based on audited annual financial statements but did not include all of the footnote disclosures from the annual financial statements. In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of routine recurring adjustments, necessary for a fair statement of its financial position as of June 30, 2023, as well as results of operations for the three months and six months ended June 30, 2023, and 2022, as well as cash flow for the six months ended June 30, 2023, and 2022. For the six months ended June 30, 2023, the results of operations are not necessarily indicative of the results for the entire year, any other interim period, or any future period. Effective May 1, 2023, the Company effected a one-for-20 reverse stock split of the common stock. All per-share numbers reflect the one-for-20 reverse stock split. We have retroactively applied the reverse split throughout this quarterly report to all periods presented. The accounting policies of Vislink have not materially changed since December 31, 2022. Note 3 of Vislink’s 2022 annual report on Form 10-K provides detailed information about these policies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zyaSGS3HOYd9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zpfLIA9o93rf">Principles of Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. The Company has eliminated all intercompany accounts and transactions upon consolidating our subsidiaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84C_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zJWdRW13XdE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zRw90yUm3hzf">Segment Reporting</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the United States, United Kingdom, and the Netherlands.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_zGCYs8mP8Oi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zmLSFhKvIL5b">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities at the date of the unaudited condensed consolidated financial statements. These estimates also affect the reported revenues and expenses during the reporting periods. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. Actual results could differ from estimates, and any such differences may be material to our unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_842_ecustom--AllowanceForCreditLossesPolicyTextBlock_zucLmTziaLif" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zzCaJpyr2jX6">Allowance for credit losses</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Change in accounting principles</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zOx2pbfKmg6h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_znmS0gnB1fSd">Recently Issued Accounting Principles</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Recent Accounting Pronouncements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.</span></p> <p id="xdx_857_zwFD3PGywHza" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_ecustom--NatureOfOperationsPolicyTextBlock_zWlRRTqk4Nz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zQNoFbydg26l">Nature of Operations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated in Delaware in 2006, Vislink Technologies, Inc. (“Vislink”) is an innovative technology company that collects, delivers and manages real-time video from the action scene to the viewing screen. The Company designs, develops, and deploys innovative products and turnkey solutions that deliver reliable connectivity across real-time production, military, and government sectors worldwide in the most demanding environments. Vislink is a leader in designing and deploying wireless video solutions, providing customers with reliable and secure video and data transmission. The company is committed to delivering the latest technology and the highest quality products to meet its customers’ needs. Vislink provides solutions for collecting live news, sports, and entertainment events for the broadcast markets. Our Mobile Viewpoint product line offers live streaming solutions that use bonded cellular, 5G, and AI-driven technologies to automate the production of news and sports content. In addition to creating real-time video intelligence solutions, Vislink assists first responders, law enforcement agencies at all levels of government, and military organizations with increased situational awareness. Besides providing professional and technical services, Vislink employs a team of technology experts with decades of experience and applied knowledge of terrestrial microwaves, satellites, fiber optics, surveillance systems, and wireless communications systems to offer customers a wide range of services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zlKfg8Fvou0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zjLDQRsW47fb">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated interim financial statements and these notes should be viewed in conjunction with Vislink Technologies, Inc.’s 2022 Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on March 31, 2023, which contains the audited consolidated financial statements and notes thereto as of December 31, 2022. As of December 31, 2022, a condensed consolidated balance sheet was prepared based on audited annual financial statements but did not include all of the footnote disclosures from the annual financial statements. In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of routine recurring adjustments, necessary for a fair statement of its financial position as of June 30, 2023, as well as results of operations for the three months and six months ended June 30, 2023, and 2022, as well as cash flow for the six months ended June 30, 2023, and 2022. For the six months ended June 30, 2023, the results of operations are not necessarily indicative of the results for the entire year, any other interim period, or any future period. Effective May 1, 2023, the Company effected a one-for-20 reverse stock split of the common stock. All per-share numbers reflect the one-for-20 reverse stock split. We have retroactively applied the reverse split throughout this quarterly report to all periods presented. The accounting policies of Vislink have not materially changed since December 31, 2022. Note 3 of Vislink’s 2022 annual report on Form 10-K provides detailed information about these policies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zyaSGS3HOYd9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zpfLIA9o93rf">Principles of Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. The Company has eliminated all intercompany accounts and transactions upon consolidating our subsidiaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84C_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zJWdRW13XdE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zRw90yUm3hzf">Segment Reporting</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the United States, United Kingdom, and the Netherlands.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_zGCYs8mP8Oi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zmLSFhKvIL5b">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities at the date of the unaudited condensed consolidated financial statements. These estimates also affect the reported revenues and expenses during the reporting periods. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. Actual results could differ from estimates, and any such differences may be material to our unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_842_ecustom--AllowanceForCreditLossesPolicyTextBlock_zucLmTziaLif" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zzCaJpyr2jX6">Allowance for credit losses</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Change in accounting principles</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zOx2pbfKmg6h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_znmS0gnB1fSd">Recently Issued Accounting Principles</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Recent Accounting Pronouncements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.</span></p> <p id="xdx_80D_ecustom--LiquidityAndFinancialConditionTextBlock_z9PTh5T3Ceuh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 — <span id="xdx_82F_zcNUuzMUiuq7">LIQUIDITY AND FINANCIAL CONDITION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the six months ended June 30, 2023, the Company incurred an approximate loss of $<span id="xdx_905_eus-gaap--OperatingIncomeLoss_iN_pn5n6_di_c20230101__20230630_zRaKr7Vp0oU3" title="Operating income loss">5.7</span> million from operations and used $<span id="xdx_90A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20230101__20230630_zP77Bjzs6HGi" title="Net cash provided by used in operating activities">3.2</span> million of cash for operational purposes. On June 30, 2023, the Company had $<span id="xdx_901_ecustom--WorkingCapital_iI_pn5n6_c20230630_z2ZbUk8yFfAj" title="Working capital">35.6</span> million in working capital, $<span id="xdx_90A_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20230630_zDTqkaHm0pId" title="Accumulated deficit">304.9</span> million in accumulated deficits, and $<span id="xdx_908_eus-gaap--Cash_iI_pn5n6_c20230630_zmXRprHUZkV2" title="Cash">11.0</span> million in cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first quarter of 2023, the Company invested approximately $<span id="xdx_90A_eus-gaap--HeldToMaturitySecuritiesFairValue_iI_pn5n6_c20230331__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_zj0Ly719F15d" title="Held to maturity">10.8</span> million of its cash reserves in Federal bonds and $<span id="xdx_900_eus-gaap--InvestmentsFairValueDisclosure_iI_pn5n6_c20230331__us-gaap--FinancialInstrumentAxis__custom--FederalBackedMutualFundMember_zHbgLP7uxNv" title="Investments, fair value disclosure">11.3</span> million in Federally insured money market mutual funds, primarily to increase investment income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s liquidity requirements may be affected by a variety of factors. These factors include inflation, foreign exchange fluctuations, market conditions, strategic acquisitions, market strategy, research and development activities, regulatory matters, and product and technology innovations. The Company believes it will have sufficient funds to continue operations for at least twelve months from the filing date of these unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> -5700000 -3200000 35600000 -304900000 11000000.0 10800000 11300000 <p id="xdx_808_eus-gaap--EarningsPerShareTextBlock_z6wEYNzWdsV" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — <span id="xdx_820_z0tDgT5PhUyb">LOSS PER SHARE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z12ZczpBQWi8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_z0pmz68XoZY7" style="display: none">SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20230630_ztkQsZCogLhd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20220630_z4eacU6JO6ul" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--EarningsPerShareDilutedOtherDisclosuresAbstract_iB_zUhE9Two9Pra" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zf5qlOpfMRji" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: justify; padding-left: 10pt">Stock options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">85</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">29</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zMkt0F0SCPB2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">456</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">459</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zuUUdjUbf0me" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.25in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">541</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">488</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zKLUkKd2K8Gf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z12ZczpBQWi8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_z0pmz68XoZY7" style="display: none">SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20230630_ztkQsZCogLhd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20220630_z4eacU6JO6ul" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--EarningsPerShareDilutedOtherDisclosuresAbstract_iB_zUhE9Two9Pra" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zf5qlOpfMRji" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: justify; padding-left: 10pt">Stock options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">85</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">29</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zMkt0F0SCPB2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">456</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">459</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zuUUdjUbf0me" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.25in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">541</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">488</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 85000 29000 456000 459000 541000 488000 <p id="xdx_801_eus-gaap--ForeignCurrencyDisclosureTextBlock_z6yGpxm1vi4h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 — <span id="xdx_822_z0zR5hVSAZe4">FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zG5QA9cFqYIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive income approximately as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zU15Z3w51i45" style="display: none">SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20230401__20230630_z06QxyIJx8Lh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220401__20220630_zc54f0o6Sr7j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230101__20230630_z1BUK7fHgjQ7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20220630_zjvvLgpwMMmf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three months ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net foreign exchange transactions:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pn3d_zNRRtPDwDCKi" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; text-align: left; padding-bottom: 2.5pt; padding-left: 0.1in">(Gains) Losses</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">41,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">(21,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">(3,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">(5,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pn3d_zMb696Pwykyb" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.1in">Net foreign exchange transactions: Losses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">41,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(21,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(5,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accumulated comprehensive income:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--AccumulatedComprehensiveIncomeUnrealizedLossOnCurrencyTranslationAdjustment_pn3d_zHFgcET6PsG" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.1in">Unrealized (gains) losses on currency translation adjustment</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(871,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(145,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,139,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AD_z8hViDvU1vki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The exchange rates adopted for foreign exchange transactions are quoted on OANDA, a Canadian-based foreign exchange company. This website offers currency conversion, online retail foreign exchange trading, foreign currency transfers, and currency information through its website. Based on the following exchange rates, the Company converted amounts between British Pounds and US Dollars and Euros into British Pounds for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023 – £<span id="xdx_90B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230630__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_z7dDsLyWJMgk" title="Foreign currency exchange rate, translation">1.266150</span> to $<span id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230630__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zumSMB19rhlg" title="Foreign currency exchange rate, translation">1.00</span>; €<span id="xdx_902_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230630__us-gaap--AwardTypeAxis__custom--EuroMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zit9WeCKg7U8" title="Foreign exchange rates">1.088440</span> to $<span id="xdx_902_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20230630__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zCu0WKQNLJnl" title="Foreign currency exchange rate, translation">1.00</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The average exchange rate for the six months ended June 30, 2023 – £<span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20230630__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_z2dEcGAXtMla" title="Average foreign currency exchange rate remeasurement">1.233240</span> to $<span id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20230630__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_z2UqOapUnggg" title="Foreign currency exchange rate, remeasurement">1.00</span>; €<span id="xdx_90F_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20230630__us-gaap--AwardTypeAxis__custom--EuroMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zNKgD16sqmR7" title="Average foreign currency exchange rate remeasurement">1.080655</span> to $<span id="xdx_900_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20230630__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zTQp90r6rik3" title="Foreign currency exchange rate, remeasurement">1.00</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2022 – £ <span id="xdx_90A_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220630__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zw1L7sgtOTD" title="Foreign currency exchange rate, translation">1.080655</span> to $<span id="xdx_908_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_ztbOGt2pCsY9" title="Foreign currency exchange rate, translation">1.00</span>; €<span id="xdx_903_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220630__us-gaap--AwardTypeAxis__custom--EuroMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zyg14YkhJ1E1" title="Foreign currency exchange rate, translation">1.044949</span> to $<span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20220630__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zTzXH4Mpqua5" title="Foreign currency exchange rate, translation">1.00</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The average exchange rate for the six months ended June 30, 2022 – £<span id="xdx_90B_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20220630__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zhyy7TZPlRBk" title="Average foreign currency exchange rate remeasurement">1.298904</span> to $<span id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_z6f6sDR56hah" title="Average foreign currency exchange rate remeasurement">1.00</span>; €<span id="xdx_90C_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20220630__us-gaap--AwardTypeAxis__custom--EuroMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zCjb1xR1Nfal" title="Average foreign currency exchange rate remeasurement">1.091890</span> to $<span id="xdx_90D_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20220630__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zSEgpXxARfG2" title="Average foreign currency exchange rate remeasurement">1.00</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89B_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zG5QA9cFqYIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive income approximately as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zU15Z3w51i45" style="display: none">SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20230401__20230630_z06QxyIJx8Lh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220401__20220630_zc54f0o6Sr7j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230101__20230630_z1BUK7fHgjQ7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20220630_zjvvLgpwMMmf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three months ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net foreign exchange transactions:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pn3d_zNRRtPDwDCKi" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; text-align: left; padding-bottom: 2.5pt; padding-left: 0.1in">(Gains) Losses</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">41,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">(21,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">(3,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">(5,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pn3d_zMb696Pwykyb" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.1in">Net foreign exchange transactions: Losses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">41,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(21,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(5,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accumulated comprehensive income:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--AccumulatedComprehensiveIncomeUnrealizedLossOnCurrencyTranslationAdjustment_pn3d_zHFgcET6PsG" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.1in">Unrealized (gains) losses on currency translation adjustment</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(871,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(145,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,139,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 41000 -21000 -3000 -5000 41000 -21000 -3000 -5000 10000 -871000 -145000 -1139000 1.266150 1.00 1.088440 1.00 1.233240 1.00 1.080655 1.00 1.080655 1.00 1.044949 1.00 1.298904 1.00 1.091890 1.00 <p id="xdx_803_eus-gaap--CashAndCashEquivalentsDisclosureTextBlock_zZA6c2nPpkk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 — <span id="xdx_82F_z8tNW8031O8i">CASH AND CASH EQUIVALENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zzNZhQqs1dje" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of unrestricted funds invested in a money market mutual fund. The following table illustrates the Company’s cash and cash equivalents:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zE24HcE9bEzi" style="display: none">SCHEDULE OF CASH AND CASH EQUIVALENTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_490_20230630_zLNwdF92KPY" style="text-align: center; font-weight: bold">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_494_20221231_zjtQC19aOiac" style="text-align: center; font-weight: bold">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_408_eus-gaap--CashEquivalentsAtCarryingValue_iI_pid_maCACEAzGPk_zil87nROE8Ve" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Cash on hand </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,542,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">25,627,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--FederallyInsuredMoneyMarketMutualFunds_iI_pid_maCACEAzGPk_zIKYWLxt4mLj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Federally insured money market mutual funds </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,431,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0914">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iTI_pid_mtCACEAzGPk_zaWk9FcV5ZE4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt; text-align: left">Total cash and cash equivalents </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,973,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">25,627,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zwMqLYaPuXM" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_891_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zzNZhQqs1dje" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of unrestricted funds invested in a money market mutual fund. The following table illustrates the Company’s cash and cash equivalents:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zE24HcE9bEzi" style="display: none">SCHEDULE OF CASH AND CASH EQUIVALENTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_490_20230630_zLNwdF92KPY" style="text-align: center; font-weight: bold">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_494_20221231_zjtQC19aOiac" style="text-align: center; font-weight: bold">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_408_eus-gaap--CashEquivalentsAtCarryingValue_iI_pid_maCACEAzGPk_zil87nROE8Ve" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Cash on hand </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,542,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">25,627,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--FederallyInsuredMoneyMarketMutualFunds_iI_pid_maCACEAzGPk_zIKYWLxt4mLj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Federally insured money market mutual funds </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,431,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0914">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iTI_pid_mtCACEAzGPk_zaWk9FcV5ZE4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt; text-align: left">Total cash and cash equivalents </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,973,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">25,627,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1542000 25627000 9431000 10973000 25627000 <p id="xdx_80C_eus-gaap--InvestmentTextBlock_zn8s8i548VJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 — <span id="xdx_82C_zxW6O4DSEGn9">INVESTMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company used cash to purchase the following debt instruments:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 23, 2023, the Company purchased a bond, “HSBC USA INC CP,” with a face value of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20230123_z7GqBUHhdJre" title="Debt instrument face amount">5,065,789</span>, a par value of $<span id="xdx_906_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20230123_zMqK2NCD6dn1" title="Debt instrument face amount">5,000,000</span>, maturing <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20230122__20230123_zUxo7UMRNkk6" title="Debt instrument maturity date">October 24, 2023</span>, a <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230123_zTp1MFlcMO91" title="Debt instrument interest rate">5.1948</span>% interest rate, at a discount of $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pp0p0_c20230123_zSXD9nP06FJ" title="Debt instrument discount">253,289</span> totaling $<span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20230123_zm1IQVnRscF5" title="Debt instrument">4,812,500</span>. The value on June 30, 2023, was $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20230630_zrUcs6KD65Zc" title="Debt instrument">4,910,000</span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 1, 2023, the Company purchased a bond, “Federal Home Loan Banks,” with a face value of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20230201_zz9swj3sILPa" title="Debt instrument face amount">4,999,750</span> and accrued interest of $<span id="xdx_90A_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pp0p0_c20230201__20230201_zccU9749fT4f" title="Debt instrument accrued interest">25,729</span>, a par value of $<span id="xdx_90F_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20230201_zpsGFYT5CL6g" title="Debt instrument face amount">5,000,000</span>, maturing <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_c20230201__20230201_zVNh0JVJP9v3" title="Debt instrument maturity date">December 22, 2023</span>, at an interest rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230201_z40NYKppjvJd" title="Debt instrument interest rate">4.750</span>%, totaling $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20230201_zNqGIeGVYMY4" title="Debt instrument">5,025,479</span>. The value on June 30, 2023, was $<span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20230630__us-gaap--TypeOfArrangementAxis__custom--FederalHomeLoanBanksMember_zF03F37Me2Jh" title="Debt instrument">4,981,000</span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 28, 2023, the Company purchased a bond, “Federal National Mortgage Association,” with a face and par value of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20230228_zfN9id9FnNii" title="Debt instrument face amount">950,000</span>, maturing <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_c20230227__20230228_zkZkLbpXN0T5" title="Debt instrument maturity date">February 28, 2024</span>, at an interest rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230228_zGZaoMjAm7K6" title="Debt instrument interest rate">5.07</span>%, totaling $<span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20230228_zNQRQrNn2qdj" title="Debt instrument">950,000</span>. The value on June 30, 2023, was $<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20230630__us-gaap--TypeOfArrangementAxis__custom--FederalNationalMortgageAssociationMember_zq4vGPQVUsfd" title="Debt instrument">946,000</span>.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company identified these transactions as investments in debt security and will apply the guidance under ASC Topic 320, “Investments in debt securities,” and for interest income guidance under ASC Topic 310-20, “Receivables.” As of June 30, 2023, the abovementioned investments have a stated maturity of one year or less. Management intends to treat these investments as held to maturity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89B_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zHaRHzRzVcS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has determined the fair value of its investments held to maturity based on Level 1 input as of June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zbJxuNPirXOj" style="display: none">SCHEDULE OF FAIR VALUE OF ITS INVESTMENTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify; padding-bottom: 1.5pt">Federal Bonds</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--InvestmentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_zQlr6bGYYRph" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0960">—</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3d_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_zENIIqEFSWuf" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">10,837,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_z15OqXcYKN86" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0962">—</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3d_c20230630__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_z7N6wD4cgjI8" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">10,837,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_znxZw8cIiPC7" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of investments"><span style="-sec-ix-hidden: xdx2ixbrl0965">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3d_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zZIqaa3H7cok" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of investments">10,837,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHq6alaM5e5i" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of investments"><span style="-sec-ix-hidden: xdx2ixbrl0969">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3d_c20230630_zWZeqn5CsGwc" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of investments">10,837,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_z0RbeQsKAYE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--HeldToMaturitySecuritiesTextBlock_zZ0ekTKcRMua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s investments held to maturity are as follows as of June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_z6sxTY5HUwZi" style="display: none">SCHEDULE OF INVESTMENTS HELD TO MATURITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Amortized Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unrealized Gains</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unrealized Losses</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify; padding-bottom: 1.5pt">Federal Bonds</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_iI_pn3d_c20230630__us-gaap--FinancialInstrumentAxis__custom--FederalBackedMutualFundMember_zLWetJn1WKx6" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">10,900,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20230101__20230630__us-gaap--FinancialInstrumentAxis__custom--FederalBackedMutualFundMember_zTQnlPgl68n7" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0975">—</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DebtSecuritiesRealizedGainLoss_c20230101__20230630__us-gaap--FinancialInstrumentAxis__custom--FederalBackedMutualFundMember_zTGpWc8SQGSa" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">63,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--HeldToMaturitySecuritiesFairValue_iI_pn3d_c20230630__us-gaap--FinancialInstrumentAxis__custom--FederalBackedMutualFundMember_zjwd3y8yJGW1" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">10,837,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_iI_pn3d_c20230630_zqCls8kE7FKa" style="border-bottom: Black 2.5pt double; text-align: right" title="Amortized Cost">10,900,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20230101__20230630_zKOe0gZYMeuk" style="border-bottom: Black 2.5pt double; text-align: right" title="Unrealized Gains"><span style="-sec-ix-hidden: xdx2ixbrl0981">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DebtSecuritiesRealizedGainLoss_pn3d_c20230101__20230630_zCwcinwm2tvh" style="border-bottom: Black 2.5pt double; text-align: right" title="Unrealized Losses">63,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--HeldToMaturitySecuritiesFairValue_iI_pn3d_c20230630_zwFbUv3J2Bn1" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair Value">10,837,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zvStokDoZjN" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 5065789 5000000 2023-10-24 0.051948 253289 4812500 4910000 4999750 25729 5000000 2023-12-22 0.04750 5025479 4981000 950000 2024-02-28 0.0507 950000 946000 <p id="xdx_89B_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zHaRHzRzVcS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has determined the fair value of its investments held to maturity based on Level 1 input as of June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zbJxuNPirXOj" style="display: none">SCHEDULE OF FAIR VALUE OF ITS INVESTMENTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify; padding-bottom: 1.5pt">Federal Bonds</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--InvestmentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_zQlr6bGYYRph" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0960">—</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3d_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_zENIIqEFSWuf" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">10,837,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_z15OqXcYKN86" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0962">—</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3d_c20230630__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_z7N6wD4cgjI8" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">10,837,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_znxZw8cIiPC7" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of investments"><span style="-sec-ix-hidden: xdx2ixbrl0965">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3d_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zZIqaa3H7cok" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of investments">10,837,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20230630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHq6alaM5e5i" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of investments"><span style="-sec-ix-hidden: xdx2ixbrl0969">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentsFairValueDisclosure_iI_pn3d_c20230630_zWZeqn5CsGwc" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of investments">10,837,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 10837000 10837000 10837000 10837000 <p id="xdx_896_eus-gaap--HeldToMaturitySecuritiesTextBlock_zZ0ekTKcRMua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s investments held to maturity are as follows as of June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_z6sxTY5HUwZi" style="display: none">SCHEDULE OF INVESTMENTS HELD TO MATURITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Amortized Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unrealized Gains</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unrealized Losses</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify; padding-bottom: 1.5pt">Federal Bonds</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_iI_pn3d_c20230630__us-gaap--FinancialInstrumentAxis__custom--FederalBackedMutualFundMember_zLWetJn1WKx6" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">10,900,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20230101__20230630__us-gaap--FinancialInstrumentAxis__custom--FederalBackedMutualFundMember_zTQnlPgl68n7" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0975">—</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DebtSecuritiesRealizedGainLoss_c20230101__20230630__us-gaap--FinancialInstrumentAxis__custom--FederalBackedMutualFundMember_zTGpWc8SQGSa" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">63,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--HeldToMaturitySecuritiesFairValue_iI_pn3d_c20230630__us-gaap--FinancialInstrumentAxis__custom--FederalBackedMutualFundMember_zjwd3y8yJGW1" style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">10,837,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_iI_pn3d_c20230630_zqCls8kE7FKa" style="border-bottom: Black 2.5pt double; text-align: right" title="Amortized Cost">10,900,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20230101__20230630_zKOe0gZYMeuk" style="border-bottom: Black 2.5pt double; text-align: right" title="Unrealized Gains"><span style="-sec-ix-hidden: xdx2ixbrl0981">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DebtSecuritiesRealizedGainLoss_pn3d_c20230101__20230630_zCwcinwm2tvh" style="border-bottom: Black 2.5pt double; text-align: right" title="Unrealized Losses">63,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--HeldToMaturitySecuritiesFairValue_iI_pn3d_c20230630_zwFbUv3J2Bn1" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair Value">10,837,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 10900000 63000000 10837000 10900000 63000 10837000 <p id="xdx_80B_eus-gaap--IntangibleAssetsDisclosureTextBlock_zBaZAfEHvLzj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 — <span id="xdx_829_zYsYTBwbbNjd">INTANGIBLE ASSETS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_ztPohnxHEKB2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates finite intangible assets as of June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B9_zuYoVhVofEv2" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Proprietary Technology</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Patents and Licenses</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Trade Names &amp; Technology</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Customer Relationships</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 37%">Balance, December 31, 2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zvKpfgZ7QO72" style="width: 4%; text-align: right" title="Beginning balance cost">2,132,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_z6czAk6keU47" style="width: 4%; text-align: right" title="Beginning balance, accumulated amortization">(815,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_z7rbi4AQVtp9" style="width: 4%; text-align: right" title="Beginning balance cost">12,378,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zPOY25yfNii9" style="width: 4%; text-align: right" title="Beginning balance, accumulated amortization">(12,378,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z4Zc5m8l2hob" style="width: 4%; text-align: right" title="Beginning balance cost">2,251,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zG0kyAQ8Z9U4" style="width: 4%; text-align: right" title="Beginning balance, accumulated amortization">(1,189,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zg8Ne1T6sdGc" style="width: 4%; text-align: right" title="Beginning balance cost">5,095,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zOBspTkcK7Dj" style="width: 4%; text-align: right" title="Beginning balance, accumulated amortization">(3,074,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--BeginningBalanceCostAccumulatedAmortization_iS_pp0p0_c20230101__20230630_zYPaIYgNxE5f" style="width: 4%; text-align: right" title="Beginning balance net">4,400,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AdjustmentForAmortization_iN_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zy3iM0UOYHq7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1009">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zDhIYATfFkZ7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets accumulated Amortization">(294,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zAoZOg5L9cKd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1013">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zsIDxlZec387" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets accumulated Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1015">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zO5f4mls9ri2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1017">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zpFdIQEaU5a2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets accumulated Amortization">(69,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_z4cgrTwvWZ37" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1021">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zodFY3jKkvx2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets accumulated Amortization">(127,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20230630_zNE2u8SiHwDj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, net Amortization">(490,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance, June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zGgNylj6PLyc" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance cost">2,132,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zgkhTaHFPBNb" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, accumulated Amortization">(1,109,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zTZB0FSMgiCi" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance cost">12,378,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zofMwSLTLx4d" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, accumulated Amortization">(12,378,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z0x2cbBmHRMi" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance cost">2,251,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zBDYc98GeX99" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance cost">(1,258,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zWFk57nbg1n7" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance cost">5,095,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_z0gL63vwUQJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, accumulated Amortization">(3,201,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--EndingBalanceCostAccumulatedAmortization_iE_pp0p0_c20230101__20230630_zdOVJ7eiUqik" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance net">3,910,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zHLqd2wkSi4h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company continuously monitors intangible assets for potential impairments based on operating results, events, and circumstances. As of June 30, 2023, management identified no triggering events.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 — INTANGIBLE ASSETS (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s groups of intangible assets consist primarily of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Proprietary Technology:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, the Company amortizes proprietary technology over <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember__srt--RangeAxis__srt--MinimumMember_zjPL1lVfwLg" title="Finite-lived intangible asset, useful life">3</span> to <span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember__srt--RangeAxis__srt--MaximumMember_zV7jMXOSxx12" title="Finite-lived intangible asset, useful life">5</span> years. Wireless multiplex transmitters and artificial intelligence are the proprietary technologies that MVP uses internally to produce and sell products and services to customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Patents and Licenses:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents and licenses filed by the Company are amortized for <span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember__srt--RangeAxis__srt--MinimumMember_zgjxHvO0J2Pe" title="Finite-lived intangible asset, useful life">18.5</span> to <span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember__srt--RangeAxis__srt--MaximumMember_zZzpcwJ4JIGi" title="Finite-lived intangible asset, useful life">20</span> years. The amortization of the costs associated with provisional patents and pending applications begins after successful review and filing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Trade Name, Technology, and Customer Relationships:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other intangible assets are amortized for <span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember__srt--RangeAxis__srt--MinimumMember_zllNwsM69AJj" title="Finite-lived intangible asset, useful life">3</span> to <span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember__srt--RangeAxis__srt--MaximumMember_z6aNvvG6Vy2a" title="Finite-lived intangible asset, useful life">15</span> years. Prior IMT, Vislink, and MVP acquisitions contributed to developing these intangible assets, including trade names, technology, and customer lists.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zJMAyyCy15ke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized net capitalized intangible costs as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_zC91XfrXjAQ6" style="display: none">SCHEDULE OF CAPITALIZED INTANGIBLE COSTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Proprietary Technology</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zdASp7OudXdb" style="width: 16%; text-align: right" title="Intangible assets">1,025,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zzgQw6cFXP68" style="width: 16%; text-align: right" title="Intangible assets">1,319,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trade Names and Technology</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zOHJxfiFWoui" style="text-align: right" title="Intangible assets">991,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zONO87dIqoE2" style="text-align: right" title="Intangible assets">1,060,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Customer Relationships</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zRGDSvuHr7vl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets">1,894,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zuCC9czKrnF5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets">2,021,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230630_zqvBgRmXw4Y" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets">3,910,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231_zGPcSecuEkqi" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets">4,400,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zarkqhHjZQRb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_z9fQ1RceBOm8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized the amortization of intangible assets as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_zKTb9w0pAote" style="display: none">SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="text-align: center; font-weight: bold">Three Months Ended</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="6" style="text-align: center; font-weight: bold">Six Months Ended</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">June 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">June 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Proprietary Technology</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230401__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zoByDanlcTQ9" style="width: 11%; text-align: right" title="Amortization of intangible assets">148,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220401__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zNXj6uZhYell" style="width: 11%; text-align: right" title="Amortization of intangible assets">148,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zAQGYmHMDJR5" style="width: 11%; text-align: right" title="Amortization of intangible assets">294,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zBBwDYbpokJ8" style="width: 11%; text-align: right" title="Amortization of intangible assets">293,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Patents and Licenses</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230401__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zYhtImBTyVf8" style="text-align: right" title="Amortization of intangible assets"><span style="-sec-ix-hidden: xdx2ixbrl1085">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220401__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zcZuW3HNLBAb" style="text-align: right" title="Amortization of intangible assets">167,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_z0p0TwKJLUhk" style="text-align: right" title="Amortization of intangible assets"><span style="-sec-ix-hidden: xdx2ixbrl1089">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zMGnhLkn6Z9b" style="text-align: right" title="Amortization of intangible assets">331,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Trade Names and Technology</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230401__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z2TOVsKG7AL9" style="text-align: right" title="Amortization of intangible assets">34,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220401__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z0RgMivcgiW7" style="text-align: right" title="Amortization of intangible assets">34,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z9VBWstAm5mg" style="text-align: right" title="Amortization of intangible assets">69,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zClBeasObcRc" style="text-align: right" title="Amortization of intangible assets">69,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Customer Relationships</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230401__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zZUYeARTDeki" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization of intangible assets">64,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220401__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zmT54ThlruX" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization of intangible assets">64,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_z9c9D0N2dYsl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization of intangible assets">127,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zZu0RaUqtNZ9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization of intangible assets">127,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230401__20230630_zQC4roaCVRNg" style="border-bottom: Black 2.5pt double; text-align: right" title="Amortization of intangible assets">246,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220401__20220630_zpes2SBldadl" style="border-bottom: Black 2.5pt double; text-align: right" title="Amortization of intangible assets">413,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20230630_zessCsxdpvL5" style="border-bottom: Black 2.5pt double; text-align: right" title="Amortization of intangible assets">490,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20220630_zAhNLjrNxysd" style="border-bottom: Black 2.5pt double; text-align: right" title="Amortization of intangible assets">820,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zSJVohafCZE7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zp5cy7Sntyvc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average remaining life of the amortization of the Company’s intangible assets is approximately <span class="xdx_phnt_RGlzY2xvc3VyZSAtIElOVEFOR0lCTEUgQVNTRVRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230630_zBLpuKeDdkj6" title="Finite-lived intangible assets, remaining amortization period">5.2</span> years as of June 30, 2023. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zIdBxQJcLbj" style="display: none">SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Period ending June 30,</td><td> </td> <td colspan="2" id="xdx_494_20230630_zv9Ot3WCpzz5"> </td><td> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_maFLIANzD8P_zwtGOn0Lovj7" style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left; padding-left: 10pt">2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">636,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_maFLIANzD8P_zEravJPORE56" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">635,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_maFLIANzD8P_zPDlXCga5pai" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">595,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_maFLIANzD8P_zWqZjRmrCVYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">533,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_maFLIANzD8P_zDeCFqdRP7Mh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">349,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_maFLIANzD8P_zIcvshhxF9Ya" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 20pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,162,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzD8P_z6FnctLEfO2f" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-Lived Intangible Assets, Net, Total</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,910,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zRDjbk5MF4Gj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_ztPohnxHEKB2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates finite intangible assets as of June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B9_zuYoVhVofEv2" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Proprietary Technology</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Patents and Licenses</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Trade Names &amp; Technology</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Customer Relationships</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 37%">Balance, December 31, 2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zvKpfgZ7QO72" style="width: 4%; text-align: right" title="Beginning balance cost">2,132,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_z6czAk6keU47" style="width: 4%; text-align: right" title="Beginning balance, accumulated amortization">(815,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_z7rbi4AQVtp9" style="width: 4%; text-align: right" title="Beginning balance cost">12,378,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zPOY25yfNii9" style="width: 4%; text-align: right" title="Beginning balance, accumulated amortization">(12,378,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z4Zc5m8l2hob" style="width: 4%; text-align: right" title="Beginning balance cost">2,251,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zG0kyAQ8Z9U4" style="width: 4%; text-align: right" title="Beginning balance, accumulated amortization">(1,189,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zg8Ne1T6sdGc" style="width: 4%; text-align: right" title="Beginning balance cost">5,095,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zOBspTkcK7Dj" style="width: 4%; text-align: right" title="Beginning balance, accumulated amortization">(3,074,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--BeginningBalanceCostAccumulatedAmortization_iS_pp0p0_c20230101__20230630_zYPaIYgNxE5f" style="width: 4%; text-align: right" title="Beginning balance net">4,400,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AdjustmentForAmortization_iN_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zy3iM0UOYHq7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1009">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zDhIYATfFkZ7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets accumulated Amortization">(294,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zAoZOg5L9cKd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1013">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zsIDxlZec387" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets accumulated Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1015">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zO5f4mls9ri2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1017">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zpFdIQEaU5a2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets accumulated Amortization">(69,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_z4cgrTwvWZ37" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1021">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zodFY3jKkvx2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets accumulated Amortization">(127,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20230630_zNE2u8SiHwDj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets, net Amortization">(490,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance, June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zGgNylj6PLyc" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance cost">2,132,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zgkhTaHFPBNb" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, accumulated Amortization">(1,109,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zTZB0FSMgiCi" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance cost">12,378,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zofMwSLTLx4d" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, accumulated Amortization">(12,378,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z0x2cbBmHRMi" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance cost">2,251,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zBDYc98GeX99" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance cost">(1,258,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zWFk57nbg1n7" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance cost">5,095,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_z0gL63vwUQJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, accumulated Amortization">(3,201,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--EndingBalanceCostAccumulatedAmortization_iE_pp0p0_c20230101__20230630_zdOVJ7eiUqik" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance net">3,910,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2132000 -815000 12378000 -12378000 2251000 -1189000 5095000 -3074000 4400000 294000 69000 127000 490000 2132000 -1109000 12378000 -12378000 2251000 -1258000 5095000 -3201000 3910000 P3Y P5Y P18Y6M P20Y P3Y P15Y <p id="xdx_89C_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zJMAyyCy15ke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized net capitalized intangible costs as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_zC91XfrXjAQ6" style="display: none">SCHEDULE OF CAPITALIZED INTANGIBLE COSTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Proprietary Technology</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zdASp7OudXdb" style="width: 16%; text-align: right" title="Intangible assets">1,025,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zzgQw6cFXP68" style="width: 16%; text-align: right" title="Intangible assets">1,319,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trade Names and Technology</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zOHJxfiFWoui" style="text-align: right" title="Intangible assets">991,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zONO87dIqoE2" style="text-align: right" title="Intangible assets">1,060,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Customer Relationships</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zRGDSvuHr7vl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets">1,894,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zuCC9czKrnF5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Intangible assets">2,021,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230630_zqvBgRmXw4Y" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets">3,910,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231_zGPcSecuEkqi" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets">4,400,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1025000 1319000 991000 1060000 1894000 2021000 3910000 4400000 <p id="xdx_891_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_z9fQ1RceBOm8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized the amortization of intangible assets as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_zKTb9w0pAote" style="display: none">SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="text-align: center; font-weight: bold">Three Months Ended</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="6" style="text-align: center; font-weight: bold">Six Months Ended</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">June 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">June 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Proprietary Technology</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230401__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zoByDanlcTQ9" style="width: 11%; text-align: right" title="Amortization of intangible assets">148,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220401__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zNXj6uZhYell" style="width: 11%; text-align: right" title="Amortization of intangible assets">148,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zAQGYmHMDJR5" style="width: 11%; text-align: right" title="Amortization of intangible assets">294,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zBBwDYbpokJ8" style="width: 11%; text-align: right" title="Amortization of intangible assets">293,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Patents and Licenses</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230401__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zYhtImBTyVf8" style="text-align: right" title="Amortization of intangible assets"><span style="-sec-ix-hidden: xdx2ixbrl1085">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220401__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zcZuW3HNLBAb" style="text-align: right" title="Amortization of intangible assets">167,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_z0p0TwKJLUhk" style="text-align: right" title="Amortization of intangible assets"><span style="-sec-ix-hidden: xdx2ixbrl1089">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zMGnhLkn6Z9b" style="text-align: right" title="Amortization of intangible assets">331,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Trade Names and Technology</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230401__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z2TOVsKG7AL9" style="text-align: right" title="Amortization of intangible assets">34,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220401__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z0RgMivcgiW7" style="text-align: right" title="Amortization of intangible assets">34,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z9VBWstAm5mg" style="text-align: right" title="Amortization of intangible assets">69,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zClBeasObcRc" style="text-align: right" title="Amortization of intangible assets">69,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Customer Relationships</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230401__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zZUYeARTDeki" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization of intangible assets">64,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220401__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zmT54ThlruX" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization of intangible assets">64,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_z9c9D0N2dYsl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization of intangible assets">127,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zZu0RaUqtNZ9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amortization of intangible assets">127,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230401__20230630_zQC4roaCVRNg" style="border-bottom: Black 2.5pt double; text-align: right" title="Amortization of intangible assets">246,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220401__20220630_zpes2SBldadl" style="border-bottom: Black 2.5pt double; text-align: right" title="Amortization of intangible assets">413,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20230630_zessCsxdpvL5" style="border-bottom: Black 2.5pt double; text-align: right" title="Amortization of intangible assets">490,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20220630_zAhNLjrNxysd" style="border-bottom: Black 2.5pt double; text-align: right" title="Amortization of intangible assets">820,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 148000 148000 294000 293000 167000 331000 34000 34000 69000 69000 64000 64000 127000 127000 246000 413000 490000 820000 <p id="xdx_894_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zp5cy7Sntyvc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average remaining life of the amortization of the Company’s intangible assets is approximately <span class="xdx_phnt_RGlzY2xvc3VyZSAtIElOVEFOR0lCTEUgQVNTRVRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20230630_zBLpuKeDdkj6" title="Finite-lived intangible assets, remaining amortization period">5.2</span> years as of June 30, 2023. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zIdBxQJcLbj" style="display: none">SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Period ending June 30,</td><td> </td> <td colspan="2" id="xdx_494_20230630_zv9Ot3WCpzz5"> </td><td> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_maFLIANzD8P_zwtGOn0Lovj7" style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left; padding-left: 10pt">2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">636,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_maFLIANzD8P_zEravJPORE56" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">635,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_maFLIANzD8P_zPDlXCga5pai" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">595,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_maFLIANzD8P_zWqZjRmrCVYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">533,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_maFLIANzD8P_zDeCFqdRP7Mh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">349,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_maFLIANzD8P_zIcvshhxF9Ya" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 20pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,162,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzD8P_z6FnctLEfO2f" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-Lived Intangible Assets, Net, Total</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,910,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> P5Y2M12D 636000 635000 595000 533000 349000 1162000 3910000 <p id="xdx_80D_eus-gaap--DebtDisclosureTextBlock_z8GaETXzIoLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 — <span id="xdx_821_znH5JqPCbrxg">NOTES PAYABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfDebtTableTextBlock_zuvdCuEqKLke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below represents the Company’s notes payable as of June 30, 2023, and December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zy6yT9pccnza" style="display: none">SCHEDULE OF NOTES PAYABLE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Principal</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">June 30,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify">The Company renewed its D&amp;O insurance policy on April 5, 2022, reducing the premium to approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zqARuQX3v7Xa" title="Debt instrument, face amount">1,037,000</span>, less a down payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_908_ecustom--DebtInstrumentDownPayment_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_z7SAHV291Nal" title="Debt instrument down payment">194,000</span>, with the remaining balance financed. The loan’s terms are for nine months at a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zbJDMvAsr4O" title="Debt instrument, interest rate, stated percentage">2.09</span>% annual interest rate and a monthly principal and interest payment of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90C_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20220404__20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zneDNO9K79p7" title="Debt instrument, periodic payment, interest">84,000</span>. Accordingly, the Company recorded interest expenses of $-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_904_eus-gaap--InterestExpense_pp0p0_c20230401__20230630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zAgTIW8iMbrd" title="Interest expense">0</span>- and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_902_eus-gaap--InterestExpense_pp0p0_c20230101__20230630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_z4gucw02bl3k" title="Interest expense">150</span> for the three and six months ended June 30, 2023, and $-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_901_eus-gaap--InterestExpense_pp0p0_c20220401__20220630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zTlLEZxv727a" title="Interest expense">0</span>- and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90D_eus-gaap--InterestExpense_pp0p0_c20220101__20220630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zGKzT3BMRScb" title="Interest expense">2,000</span> for the three and six months ended June 30, 2022, respectively. As of June 30, 2023, the note has been fully repaid. </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20230630__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zIVq4SC640n8" style="width: 14%; text-align: right" title="Notes payable"><span style="-sec-ix-hidden: xdx2ixbrl1155">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zbj8X048pR09" style="width: 14%; text-align: right" title="Notes payable">84,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Remaining debt principal payment"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Remaining debt principal payment"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify">The Company renewed its D &amp; O insurance policy on April 5, 2023, reducing the premium to approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zuc1npnIkkb4" title="Debt instrument, face amount">811,000</span>, less a down payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_901_ecustom--DebtInstrumentDownPayment_iI_pp0p0_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zGLkOf7mGnD5" title="Debt instrument down payment">288,000</span>, financing the remaining balance of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90A_eus-gaap--NotesPayable_iI_pp0p0_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zu8tFwBlFe01" title="Notes payable">523,000</span>. The loan’s terms are for nine months at a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zImxxoNAejRa" title="Debt instrument, interest rate, stated percentage">6.14</span>% annual interest rate and a monthly principal and interest payment of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20230404__20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_z2Gns6WU26Dl" title="Debt instrument, periodic payment, interest">67,000</span>. Accordingly, the Company recorded interest expenses of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_906_eus-gaap--InterestExpense_pp0p0_c20230401__20230630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zObvXzNHFKT" title="Interest expense"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_907_eus-gaap--InterestExpense_pp0p0_c20230101__20230630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zU3btLPv5d9j" title="Interest expense">5,000</span></span> for the three and six months ended June 30, 2023, and $-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90D_eus-gaap--InterestExpense_pp0p0_c20220401__20220630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zUyJYfYR4Qff" title="Interest expense"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_906_eus-gaap--InterestExpense_pp0p0_c20220101__20220630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zHyXJTlI4SQi" title="Interest expense">0</span></span>- for the three and six months ended June 30, 2022. </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20230630__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zWs9fW6fz8H3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Notes payable">394,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20230630_zDe0Whyi7NQ5" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable">394,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20221231_zf4TPHc6xC48" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable">84,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zpyH2ZR2Trmc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfDebtTableTextBlock_zuvdCuEqKLke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below represents the Company’s notes payable as of June 30, 2023, and December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zy6yT9pccnza" style="display: none">SCHEDULE OF NOTES PAYABLE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Principal</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">June 30,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify">The Company renewed its D&amp;O insurance policy on April 5, 2022, reducing the premium to approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zqARuQX3v7Xa" title="Debt instrument, face amount">1,037,000</span>, less a down payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_908_ecustom--DebtInstrumentDownPayment_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_z7SAHV291Nal" title="Debt instrument down payment">194,000</span>, with the remaining balance financed. The loan’s terms are for nine months at a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zbJDMvAsr4O" title="Debt instrument, interest rate, stated percentage">2.09</span>% annual interest rate and a monthly principal and interest payment of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90C_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20220404__20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zneDNO9K79p7" title="Debt instrument, periodic payment, interest">84,000</span>. Accordingly, the Company recorded interest expenses of $-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_904_eus-gaap--InterestExpense_pp0p0_c20230401__20230630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zAgTIW8iMbrd" title="Interest expense">0</span>- and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_902_eus-gaap--InterestExpense_pp0p0_c20230101__20230630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_z4gucw02bl3k" title="Interest expense">150</span> for the three and six months ended June 30, 2023, and $-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_901_eus-gaap--InterestExpense_pp0p0_c20220401__20220630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zTlLEZxv727a" title="Interest expense">0</span>- and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90D_eus-gaap--InterestExpense_pp0p0_c20220101__20220630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zGKzT3BMRScb" title="Interest expense">2,000</span> for the three and six months ended June 30, 2022, respectively. As of June 30, 2023, the note has been fully repaid. </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20230630__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zIVq4SC640n8" style="width: 14%; text-align: right" title="Notes payable"><span style="-sec-ix-hidden: xdx2ixbrl1155">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zbj8X048pR09" style="width: 14%; text-align: right" title="Notes payable">84,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Remaining debt principal payment"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Remaining debt principal payment"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify">The Company renewed its D &amp; O insurance policy on April 5, 2023, reducing the premium to approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zuc1npnIkkb4" title="Debt instrument, face amount">811,000</span>, less a down payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_901_ecustom--DebtInstrumentDownPayment_iI_pp0p0_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zGLkOf7mGnD5" title="Debt instrument down payment">288,000</span>, financing the remaining balance of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90A_eus-gaap--NotesPayable_iI_pp0p0_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zu8tFwBlFe01" title="Notes payable">523,000</span>. The loan’s terms are for nine months at a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zImxxoNAejRa" title="Debt instrument, interest rate, stated percentage">6.14</span>% annual interest rate and a monthly principal and interest payment of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20230404__20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_z2Gns6WU26Dl" title="Debt instrument, periodic payment, interest">67,000</span>. Accordingly, the Company recorded interest expenses of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_906_eus-gaap--InterestExpense_pp0p0_c20230401__20230630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zObvXzNHFKT" title="Interest expense"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_907_eus-gaap--InterestExpense_pp0p0_c20230101__20230630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zU3btLPv5d9j" title="Interest expense">5,000</span></span> for the three and six months ended June 30, 2023, and $-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90D_eus-gaap--InterestExpense_pp0p0_c20220401__20220630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zUyJYfYR4Qff" title="Interest expense"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_906_eus-gaap--InterestExpense_pp0p0_c20220101__20220630__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zHyXJTlI4SQi" title="Interest expense">0</span></span>- for the three and six months ended June 30, 2022. </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20230630__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zWs9fW6fz8H3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Notes payable">394,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20230630_zDe0Whyi7NQ5" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable">394,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20221231_zf4TPHc6xC48" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable">84,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1037000 194000 0.0209 84000 0 150 0 2000 84000 811000 288000 523000 0.0614 67000 5000 5000 0 0 394000 394000 84000 <p id="xdx_803_eus-gaap--LesseeOperatingLeasesTextBlock_zLKzS0me1aya" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 — <span id="xdx_82C_zYDPaAaB7tcf">LEASES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to leasing office space, deployment sites, and storage warehouses, the Company also leases warehouse space internationally and domestically. Operating leases have various terms and provisions as of June 30, 2023, with lease terms remaining between one and four years. In certain individual leases, rent escalation clauses and lease concessions require additional rental payments in the later years of the lease term. These types of contracts are recognized on a straight-line basis over the minimum lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded $<span id="xdx_905_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn5n6_c20230630_zrSo70202Gh3" title="Right of use of assets">0.9</span> million in Right-Of-Use (“ROU”) assets on June 30, 2023, net of $<span id="xdx_906_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_pn5n6_c20230101__20230630_zRpwzvmUOeBe" title="Right of use assets, accumulated depreciation">1.3</span> million in accumulated amortization. Moreover, the Company recorded an operating lease liability of approximately $<span id="xdx_90B_eus-gaap--OperatingLeaseLiability_iI_pn5n6_c20230630_z8Vw58YjcKM8" title="Operating lease liabilities">1.3</span> million, of which $<span id="xdx_902_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn5n6_c20230630_zPlI0I7PZA9e" title="Current operating lease liabilities">0.4</span> million was current and $<span id="xdx_904_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn5n6_c20230630_zx7zGuJBj2z2" title="Non-current operating lease liabilities">0.9</span> million was non-current. The weighted average remaining term of lease contracts on June 30, 2023, was <span id="xdx_900_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zb4ckmjws3E1" title="Weighted-average remaining term">3.1</span> years, with maturity dates ranging between <span id="xdx_900_eus-gaap--LesseeOperatingLeaseOptionToTerminate_c20230101__20230630_zMU1ui0mi93h" title="Lease maturity description">July 2023 and May 2027</span>, in addition to a weighted-average discount rate of <span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230630_ze6v62L3TnV" title="Weighted-average discount rate">9.5%</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no material adjustments to straight-line rental expenses for those periods. Most of the costs recognized for each period were reflected in cash used in operating activities. This expense primarily consisted of payments for office and warehouse base rent. In addition, the Company has the right to renew individual leases at various renewal terms, although the Company is not obligated to do so. Short-term lease costs, taxes, and variable service charges were immaterial.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--AreaOfLandDescription_pp0p0_c20230101__20230630__srt--StatementGeographicalAxis__custom--LutonUKMember_zzLqgPdJkAPe" title="Area of land description">A one-year lease for <span id="xdx_900_eus-gaap--AreaOfLand_iI_uSquareFeet_c20230630__srt--StatementGeographicalAxis__custom--LutonUKMember_zjr3ZttqpnJd" title="Area of land">600</span> square feet of administrative office space in Luton, UK, was signed on June 1, 2023, and will run through <span id="xdx_900_eus-gaap--LeaseExpirationDate1_c20230101__20230630__srt--StatementGeographicalAxis__custom--LutonUKMember_z8BluwWbMZ9g" title="Lease expiration">May 31, 2024</span>, at approximately $<span id="xdx_903_eus-gaap--PaymentsForRent_c20230101__20230630__srt--StatementGeographicalAxis__custom--LutonUKMember_zMYvsKBWwHe6" title="Payments for rent">2,100</span> per month.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 — LEASES (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--LeaseCostTableTextBlock_zwmuqvC4P0w9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates operating lease data for the three months ending June 30, 2023, and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zgm5lv9xj205" style="display: none">SCHEDULE OF OPERATING LEASE DATA</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230401__20230630_z4R9DAIJfqqd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220401__20220630_zFjd64JAXWH" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230101__20230630_zLwT8DfqCej3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20220101__20220630_z2VQmapR9sH" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Lease cost:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseCost_pp0p0_z5L5JNijQS76" style="vertical-align: bottom; background-color: White"> <td style="width: 44%; text-align: left; padding-left: 0.1in">Operating lease cost</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">103,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">114,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">206,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">233,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_pp0p0_zjo4YfkunFS9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.1in">Short-term lease cost</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">159,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LeaseCost_pp0p0_zX9Lu1uajPSi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total lease cost</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">113,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">124,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">226,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">392,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash paid for lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingLeasePayments_pp0p0_zB8ZvKAtP2Pj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.1in">Cash flows from operating leases</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">325,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">253,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average remaining lease term—operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zHM2duheEkM8" title="Weighted-average remaining lease term-operating leases">3.1</span> years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zdow7srjIFM3" title="Weighted-average remaining lease term-operating leases">3.8</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted-average discount rate—operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230630_zLsD4mGUVa69" title="Weighted-average discount rate-operating leases">9.5</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20220630_zDyKhpMOtSJ" title="Weighted-average discount rate-operating leases">9.4</span></td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8AC_zE66ZuuDVWV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zlJlhy3mTzSc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturities of operating lease liabilities were as follows as of June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_zCx8rCcOk4Ge" style="display: none">SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20230630_zByvnmzGgq7e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3d_maLOLLPzCqh_zIVky2YTgCwb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">507,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3d_maLOLLPzCqh_z8r5U40EDEag" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">468,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3d_maLOLLPzCqh_zcukkl9UhFYh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">341,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3d_maLOLLPzCqh_zAKuMt8kBDR8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">186,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3d_maLOLLPzCqh_zuFcR13pHVm4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1249">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3d_maLOLLPzCqh_zsUueSdNQXtg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1251">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3d_mtLOLLPzCqh_zX2ZYz2eSOcb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,502,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pn3d_zbTQMI2NOUP9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Less: imputed interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">162,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiability_iI_pn3d_zCPerPqA1vY2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Present value of lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,340,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3d_zkodYfHhLUYi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Less: Current lease liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">406,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3d_zwAQlSOw60q5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Non-current lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">934,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_z0ottYmpvote" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89C_ecustom--ScheduleOfLeaseObligationsAssumedTableTextBlock_zbWcyONJx1Ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below lists the location and lease expiration date from 2023 through 2027:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span><span id="xdx_8B9_zQ3BzX7Yqq9e" style="display: none">SCHEDULE OF LEASE OBLIGATION ASSUMED</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Location</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Square Footage</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Lease-End<br/> Date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Approximate <br/> Future Payments</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 51%; text-align: left">Colchester, UK</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20230630__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_znGdxnJ7Cv7k" style="width: 14%; text-align: right" title="Area of land">16,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 5%; text-align: center">Dec</td> <td style="width: 5%; text-align: right"><span id="xdx_904_ecustom--LeaseExpirationDateDescription_c20230101__20230630__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zBT92fkHRjol" title="Lease-End Date">2025</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zTsskjCxgLM9" style="width: 14%; text-align: right" title="Approximate Future Payments">554,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20230630__srt--StatementGeographicalAxis__country--SG_zky6rK0FBPki" style="text-align: right" title="Area of land">950</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">July</td> <td style="text-align: right"><span id="xdx_900_ecustom--LeaseExpirationDateDescription_c20230101__20230630__srt--StatementGeographicalAxis__country--SG_zjW4fOPTzxP5" title="Lease-End Date">2023</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__country--SG_zLzIUwqWxnsl" style="text-align: right" title="Approximate Future Payments">3,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Billerica, MA</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20230630__srt--StatementGeographicalAxis__custom--BillericaMaMember_zvdWoxQRHDb7" style="text-align: right" title="Area of land">2,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">Dec</td> <td style="text-align: right"><span id="xdx_90E_ecustom--LeaseExpirationDateDescription_c20230101__20230630__srt--StatementGeographicalAxis__custom--BillericaMaMember_zq6I0HGjBfga" title="Lease-End Date">2026</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__custom--BillericaMaMember_zskKCBstHRD9" style="text-align: right" title="Approximate Future Payments">43,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Hemel, UK</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20230630__srt--StatementGeographicalAxis__custom--HemelUKMember_zxuIbAxaKf18" style="text-align: right" title="Area of land">12,870</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">Oct</td> <td style="text-align: right"><span id="xdx_906_ecustom--LeaseExpirationDateDescription_c20230101__20230630__srt--StatementGeographicalAxis__custom--HemelUKMember_zr5kdrhDK37h" title="Lease-End Date">2023</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__custom--HemelUKMember_zXd9rbX3mNub" style="text-align: right" title="Approximate Future Payments">367,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Mount Olive, NJ</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20230630__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zpxjDrS0GCPb" style="text-align: right" title="Area of land">7,979</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">Jan</td> <td style="text-align: right"><span id="xdx_905_ecustom--LeaseExpirationDateDescription_c20230101__20230630__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zsXil1ZjAVS6" title="Lease-End Date">2027</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__custom--MountOliveNJMember_z4sn78hxVdPl" style="text-align: right" title="Approximate Future Payments">535,000</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AD_zDV2R8vdJash" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 900000 1300000 1300000 400000 900000 P3Y1M6D July 2023 and May 2027 0.095 A one-year lease for 600 square feet of administrative office space in Luton, UK, was signed on June 1, 2023, and will run through May 31, 2024, at approximately $2,100 per month. 600 2024-05-31 2100 <p id="xdx_894_eus-gaap--LeaseCostTableTextBlock_zwmuqvC4P0w9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates operating lease data for the three months ending June 30, 2023, and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zgm5lv9xj205" style="display: none">SCHEDULE OF OPERATING LEASE DATA</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230401__20230630_z4R9DAIJfqqd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220401__20220630_zFjd64JAXWH" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230101__20230630_zLwT8DfqCej3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20220101__20220630_z2VQmapR9sH" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Lease cost:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseCost_pp0p0_z5L5JNijQS76" style="vertical-align: bottom; background-color: White"> <td style="width: 44%; text-align: left; padding-left: 0.1in">Operating lease cost</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">103,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">114,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">206,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">233,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_pp0p0_zjo4YfkunFS9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.1in">Short-term lease cost</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">159,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LeaseCost_pp0p0_zX9Lu1uajPSi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total lease cost</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">113,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">124,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">226,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">392,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash paid for lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingLeasePayments_pp0p0_zB8ZvKAtP2Pj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.1in">Cash flows from operating leases</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">325,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">253,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average remaining lease term—operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zHM2duheEkM8" title="Weighted-average remaining lease term-operating leases">3.1</span> years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zdow7srjIFM3" title="Weighted-average remaining lease term-operating leases">3.8</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted-average discount rate—operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230630_zLsD4mGUVa69" title="Weighted-average discount rate-operating leases">9.5</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20220630_zDyKhpMOtSJ" title="Weighted-average discount rate-operating leases">9.4</span></td><td style="text-align: left">%</td></tr> </table> 103000 114000 206000 233000 10000 10000 20000 159000 113000 124000 226000 392000 325000 253000 P3Y1M6D P3Y9M18D 0.095 0.094 <p id="xdx_892_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zlJlhy3mTzSc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturities of operating lease liabilities were as follows as of June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_zCx8rCcOk4Ge" style="display: none">SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20230630_zByvnmzGgq7e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3d_maLOLLPzCqh_zIVky2YTgCwb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">507,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3d_maLOLLPzCqh_z8r5U40EDEag" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">468,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3d_maLOLLPzCqh_zcukkl9UhFYh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">341,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3d_maLOLLPzCqh_zAKuMt8kBDR8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">186,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3d_maLOLLPzCqh_zuFcR13pHVm4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1249">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3d_maLOLLPzCqh_zsUueSdNQXtg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1251">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3d_mtLOLLPzCqh_zX2ZYz2eSOcb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,502,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pn3d_zbTQMI2NOUP9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Less: imputed interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">162,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiability_iI_pn3d_zCPerPqA1vY2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Present value of lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,340,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3d_zkodYfHhLUYi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Less: Current lease liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">406,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3d_zwAQlSOw60q5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Non-current lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">934,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 507000 468000 341000 186000 1502000 162000 1340000 406000 934000 <p id="xdx_89C_ecustom--ScheduleOfLeaseObligationsAssumedTableTextBlock_zbWcyONJx1Ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below lists the location and lease expiration date from 2023 through 2027:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span><span id="xdx_8B9_zQ3BzX7Yqq9e" style="display: none">SCHEDULE OF LEASE OBLIGATION ASSUMED</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Location</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Square Footage</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Lease-End<br/> Date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Approximate <br/> Future Payments</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 51%; text-align: left">Colchester, UK</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20230630__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_znGdxnJ7Cv7k" style="width: 14%; text-align: right" title="Area of land">16,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 5%; text-align: center">Dec</td> <td style="width: 5%; text-align: right"><span id="xdx_904_ecustom--LeaseExpirationDateDescription_c20230101__20230630__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zBT92fkHRjol" title="Lease-End Date">2025</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zTsskjCxgLM9" style="width: 14%; text-align: right" title="Approximate Future Payments">554,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20230630__srt--StatementGeographicalAxis__country--SG_zky6rK0FBPki" style="text-align: right" title="Area of land">950</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">July</td> <td style="text-align: right"><span id="xdx_900_ecustom--LeaseExpirationDateDescription_c20230101__20230630__srt--StatementGeographicalAxis__country--SG_zjW4fOPTzxP5" title="Lease-End Date">2023</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__country--SG_zLzIUwqWxnsl" style="text-align: right" title="Approximate Future Payments">3,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Billerica, MA</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20230630__srt--StatementGeographicalAxis__custom--BillericaMaMember_zvdWoxQRHDb7" style="text-align: right" title="Area of land">2,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">Dec</td> <td style="text-align: right"><span id="xdx_90E_ecustom--LeaseExpirationDateDescription_c20230101__20230630__srt--StatementGeographicalAxis__custom--BillericaMaMember_zq6I0HGjBfga" title="Lease-End Date">2026</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__custom--BillericaMaMember_zskKCBstHRD9" style="text-align: right" title="Approximate Future Payments">43,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Hemel, UK</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20230630__srt--StatementGeographicalAxis__custom--HemelUKMember_zxuIbAxaKf18" style="text-align: right" title="Area of land">12,870</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">Oct</td> <td style="text-align: right"><span id="xdx_906_ecustom--LeaseExpirationDateDescription_c20230101__20230630__srt--StatementGeographicalAxis__custom--HemelUKMember_zr5kdrhDK37h" title="Lease-End Date">2023</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__custom--HemelUKMember_zXd9rbX3mNub" style="text-align: right" title="Approximate Future Payments">367,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Mount Olive, NJ</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20230630__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zpxjDrS0GCPb" style="text-align: right" title="Area of land">7,979</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">Jan</td> <td style="text-align: right"><span id="xdx_905_ecustom--LeaseExpirationDateDescription_c20230101__20230630__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zsXil1ZjAVS6" title="Lease-End Date">2027</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__custom--MountOliveNJMember_z4sn78hxVdPl" style="text-align: right" title="Approximate Future Payments">535,000</td><td style="text-align: left"> </td></tr> </table> 16000 2025 554000 950 2023 3000 2000 2026 43000 12870 2023 367000 7979 2027 535000 <p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zpUuG44Cj6Qi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 — <span id="xdx_829_zSB9VKmpOHR8">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 22, 2023, the Board of Directors of the Corporation approved a resolution to eliminate the Corporation’s Certificate of Designation, Preferences, and Rights (the “Certificate of Elimination”) of the Series A Preferred Stock, par value $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20230322__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zNUlmqByvFR7" title="Preferred stock par value">0.00001</span> per share (the “Series A Preferred Stock”), that was filed with the Secretary of State of the State of Delaware on November 9, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon the effective filing of this Certificate of Elimination, the shares previously designated under the certificate of designation as Series A Preferred Stock shall resume the status of authorized but unissued shares of preferred stock of the Corporation. As of March 31, 2023, <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zw3C8mu2Rele" title="Preferred stock, shares authorized">47,500</span> shares are authorized, and <span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zgSs2cYCMFyf" title="Preferred stock, shares issed"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zH1KIa7XNpKf" title="Preferred stock, shares outstanding">no</span></span> Series A Preferred Stock was issued or outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common stock </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Nasdaq compliance and reverse stock split</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 20, 2022, we received notice from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of its noncompliance with Bid Price Rule by failing to maintain a minimum bid price for its common Stock on the Nasdaq Capital Market of at least $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220520_zuH4QpUecTK6" title="Common stock per share value">1.00</span> per share for 30 consecutive business days. The Company received a grace period of 180 days, or until November 16, 2022, to regain compliance with the minimum bid price requirement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 10, 2022, the Company submitted a request to Nasdaq for an additional 180-day grace period to regain compliance with the minimum bid price requirement. On November 17, 2022, the Company received a letter from Nasdaq advising that the Company had been granted an additional 180-day grace period extension until May 15, 2023, to regain compliance with the minimum bid price requirement and all other applicable requirements for initial listing on the Nasdaq Capital Market except for the minimum bid price requirement. On May 15, 2023, the Company received a letter from the Nasdaq informing it of its return to compliance with the Bid Price Rule. Therefore, the Common Stock continues to be traded on the Nasdaq Capital Market. If the Company fails to comply with the continued listing requirements of Nasdaq, such as its corporate governance requirements or the Bid Price Rule, Nasdaq may delist the Common Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 11, 2023, the Company held a special meeting of stockholders (the “Special Meeting”) whereby stockholders approved a proposal to authorize the Board of Directors of the Company (the “Board”), in its discretion but before the one-year anniversary of the date of the Special Meeting, to implement an amendment to the Company’s certificate of incorporation to effect a reverse stock split (the “Reverse Stock Split”) of all of the outstanding shares of Common Stock, of the Company, at a ratio in the range of <span id="xdx_902_eus-gaap--StockholdersEquityReverseStockSplit_c20230110__20230110_z2dzbi64TLX4" title="Reverse split">1-for-2</span> to <span id="xdx_905_eus-gaap--StockholdersEquityReverseStockSplit_c20230111__20230111_zbfIi9qb2jU2" title="Reverse split">1-for-50</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 1, 2023, the Company effected a <span id="xdx_906_eus-gaap--StockholdersEquityReverseStockSplit_c20230501__20230501_znX9kgWHdQc2" title="Reverse split">1-for-20</span> reverse stock split. Upon effectiveness of the reverse stock split, every twenty shares of an outstanding common stock decreased to one share of common stock. We have retroactively applied the reverse split throughout this quarterly report to all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other common stock activity</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months that ended June 30, 2023, the Company:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">has issued <span id="xdx_902_eus-gaap--SharesPaidForTaxWithholdingForShareBasedCompensation_pid_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zM6YYLItxcz2" title="Shares attributable to withholding tax">10,000</span> shares of common stock to specific board members as part of a commitment agreement valued at $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsvpMgH5LnR8" title="Restricted stock options, granted">200,000</span>. The common stock’s value was determined on the agreement’s original date.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognized approximately $<span id="xdx_904_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20230101__20230630_zqNX4ISjnHs9" title="Stock compensation costs">1,257,000</span> of stock-based compensation costs associated with outstanding stock options in general and administrative expenses offsetting additional capital investments.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 — STOCKHOLDERS’ EQUITY (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common stock warrants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the six months ending June 30, 2023, <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zEGp6zkn1n69" title="Number of warrants cancelled/expired">2,667</span> warrants expired. These outstanding warrants did not have an intrinsic value as of June 30, 2023. On June 30, 2023, the weighted average exercise price of warrants outstanding is $<span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableOutstandingWeightedAverageExercisePrice_iI_pid_c20230630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zrRiWbUvUwKa" title="Weighted average exercise price ending exercisable">66.00</span>, with a weighted average remaining contractual life of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zAxrkkH3mYoa" title="Weighted average remaining contractual life">2.61</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zn3H4tA74qGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth common stock purchase warrants outstanding as of June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zRIHExApm0hk" style="display: none">SCHEDULE OF WARRANT OUTSTANDING</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Warrants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in shares)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Outstanding, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20230630_zKytEZO8caz4" style="width: 16%; text-align: right" title="Number of Warrants, beginning balance">458,747</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630_zcrKr17NdQ57" style="width: 16%; text-align: right" title="Weighted Average Exercise Price, beginning balance">72.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Warrants granted, exercised, canceled, or expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20230101__20230630_zvNmQGO95ujj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Warrants, Warrants granted, exercised, canceled, or expired">(2,667</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630_zuMX5W0X6V4b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants granted, exercised, canceled, or expired"><span style="-sec-ix-hidden: xdx2ixbrl1333">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Outstanding and exercisable, June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20230630_z8naV2NWGlqi" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Warrants, ending outstanding">456,080</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630_zTy9ihy2UkNh" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, ending outstanding">66.00</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_z327AyaFjLGk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 0.00001 47500 0 0 1.00 1-for-2 1-for-50 1-for-20 10000 200000000 1257000 2667 66.00 P2Y7M9D <p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zn3H4tA74qGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth common stock purchase warrants outstanding as of June 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zRIHExApm0hk" style="display: none">SCHEDULE OF WARRANT OUTSTANDING</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Warrants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in shares)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Outstanding, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20230630_zKytEZO8caz4" style="width: 16%; text-align: right" title="Number of Warrants, beginning balance">458,747</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630_zcrKr17NdQ57" style="width: 16%; text-align: right" title="Weighted Average Exercise Price, beginning balance">72.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Warrants granted, exercised, canceled, or expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20230101__20230630_zvNmQGO95ujj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Warrants, Warrants granted, exercised, canceled, or expired">(2,667</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630_zuMX5W0X6V4b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants granted, exercised, canceled, or expired"><span style="-sec-ix-hidden: xdx2ixbrl1333">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Outstanding and exercisable, June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20230630_z8naV2NWGlqi" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Warrants, ending outstanding">456,080</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630_zTy9ihy2UkNh" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, ending outstanding">66.00</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 458747 72.00 2667 456080 66.00 <p id="xdx_802_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zFzbSOpwtWO1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 — <span id="xdx_825_zQwj7DI4w59j">STOCK-BASED COMPENSATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Long-term stock incentive plan awards:</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s stock option plans provide options to purchase shares of common stock to officers, directors, other key employees, and consultants. The purchase price may be paid in cash or “net settled” in the Company’s common stock shares. In a net settlement of an option, the Company does not require payment of the exercise price from the holder but reduces the number of shares of common stock issued upon the exercise of the stock option by the smallest amount of whole shares that have an aggregate fair market value equal to or over the aggregate exercise price for the option shares covered by the option exercised. Options generally vest over three years from the grant date and expire ten years from the grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Inducement Awards:</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Time-vested options </span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company grants time-vested stock options to various employees in connection with their employment agreements. The equity awards are ten-year, non-statutory time-vested option inducement awards under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans (all subject to continued employment).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Performance-based stock options</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company grants performance-based stock options to various employees in connection with their employment agreements. The equity awards are ten-year, non-statutory performance-based stock option inducement awards under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans that will vest in three equal tranches upon achievement of applicable performance conditions for each tranche (all subject to continued employment).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted Stock Units (“RSUs”):</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Time-based awards</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company grants employees time-based restricted stock units (“RSUs”) subject to continued employment. <span id="xdx_90D_ecustom--DescriptionOfEquityAwardsVestingPercentageAndMaturityTerm_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z5FjDqbKrLBf" title="Description of equity awards vesting percentage and maturity term">The equity awards have an initial vesting between 25% and 33% on their one-year anniversary dates and will vest between 24 and 36 equal monthly periods thereafter.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Performance-based awards</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company grants employees performance-based restricted stock unit awards subject to performance vesting conditions and continued employment. The equity awards will vest in three equal tranches upon reaching performance conditions for each tranche.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_893_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_z0mEIPKZ0N69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As shown in the following table, stock-based compensation expense is included in general and administrative expenses under the following plans:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span><span id="xdx_8BC_ziakbW0Nyrr6" style="display: none">SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230401__20230630_zacgwP9oaoX7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220401__20220630_z9kGiib6HSgj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230101__20230630_zzSJ1olgFoYj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20220630_zJGibf2vuz66" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three months ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Equity-based plans:</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--PlanNameAxis__custom--LongTermStockIncentivePlanAwardsMember_zUAN8h6iiD8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Long-term stock incentive plan awards</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1345">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1346">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1347">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--PlanNameAxis__custom--TimeVestedOptionInducementAwardsMember_zrwLjl4rKuS2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Time-vested option inducement awards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">37,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">107,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--PlanNameAxis__custom--PerformanceBasedStockOptionInducementMember_zNCNy41w4T" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Performance-based stock option inducement award</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1355">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1356">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1357">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1358">-</span></span></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--PlanNameAxis__custom--TimeBasedRestrictedStockAwardsMember_zaQ1WogTHsml" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Time-based restricted stock awards <br/></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">299,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">898,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--PlanNameAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zKnXhswcQ9Cf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Performance-based restricted stock awards</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1365">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1366">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1367">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1368">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_zA9j4zXMdP48" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 0.1in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation expense</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">336,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">208,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,257,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">955,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zFpUPcUzkGb9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 — STOCK-BASED COMPENSATION (continued) </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_zxN9RWrGkkRk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates supplementary data under various equity compensation plans:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zAazxwEJBT2f" style="display: none">SCHEDULE OF EQUITY COMPENSATION PLANS</span></p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="14" style="font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Six months ended</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="14" style="font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Six months ended</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">June 30,</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">June 30,</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2023</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2022</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2023</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2022</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Quantity</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Weighted Average</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Quantity</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Weighted Average</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Quantity</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Weighted Average</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Quantity</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Weighted Average</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: italic 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Long-term stock incentive plan awards</span></td> <td style="font: italic 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: italic 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Time-vested option inducement awards</span></td> <td style="font: italic 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-January 1<sup>st</sup>, outstanding</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zEX5Z6DESCsl" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,250</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z2gLUNMTIWzh" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,756</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zZTThutecQC9" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,496</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zP1gbjXPyTfa" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,795.80</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zgkpaTGZISd1" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">24,721</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zpNl1TP3Na51" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zWxbou5RM138" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">24,721</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zHobp1obrIG7" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">20.20</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Granted, canceled, expired</span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zVJTw4SZsds8" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1393">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zJaa3pZHuCQa" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1395">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zyOquHt2cra1" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1397">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zQszhTB5fGN1" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1399">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zG18fLhC0xFb" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1401">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zP6Se7H7U0ij" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1403">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z5C3xHwQAWt2" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1405">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z0FSuhuKpkLe" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1407">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Forfeited</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zwyqQ22lOqTb" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(58</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zuV6aiiR1noh" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,166.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zeMgh1AhjvH5" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(171</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z0qodrhlJKy7" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,931.60</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zDFW1KxINfpl" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1417">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zKL3pBumflWj" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1419">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zStLN14fD1W2" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1421">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zlaE23TfRupi" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1423">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-June 30th, outstanding</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zdNpqjEEYR1d" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,192</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zWqWfeS2L2E2" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,771.40</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zjzLFHmGsFt9" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,325</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z6nLVzWFda73" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,754.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zpewKEsbfzK2" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">24,721</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zq6ke7G5aba8" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">10.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zBPKYnhmcUEh" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">24,721</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zSCvWaSfe3Of" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">17.80</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-June 30th, exercisable</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zvmat0FJCEMl" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,192</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z8l3XBq4eJQ8" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,771.40</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zRAiK0ntIT27" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,463</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zbkXFZb8Hbbi" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,802.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z9bKkuKSZfYe" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">24,721</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zUpFhf7n9g18" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">18.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z0kk8NzITXFe" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14,936</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z82TRol4ZrEk" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">29.60</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Remaining compensation expense</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_988_ecustom--RemainingStockCompensationExpenses_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zsYrFfY6yDTa" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1457">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_98C_ecustom--RemainingStockCompensationExpenses_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zveILjXaRLVb" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1459">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_981_ecustom--RemainingStockCompensationExpenses_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zTTjoLXUZjYg" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$212,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_980_ecustom--RemainingStockCompensationExpenses_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zpcWJsRRy91d" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$442,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Remaining amortization period</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_ecustom--AmortizationPeriod_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zoBqAg8s1pLi" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.0 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--AmortizationPeriod_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z9PSlDoGpiDb" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.0 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_ecustom--AmortizationPeriod_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zqYOKmmUEyDb" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--AmortizationPeriod_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zVu7WzRXLBK7" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Weighted average remaining contractual life – options outstanding and exercisable</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z08qzXnK7yc7" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.0 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zd6R1IXhdGE4">4.0 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zANJhKMDGOpg" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5.1 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zr2d34PG8ZC7">5.0 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zgpCaaeMfbte" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zedh3HKwktw9">6.6 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zPy4t7KDes71" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z5jOEHYSOr16">7.6 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Intrinsic value per share</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_980_ecustom--IntrinsicValuePerShare_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zgQMxrCTre67" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1477">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_981_ecustom--IntrinsicValuePerShare_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z60ltCop9374" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1479">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_980_ecustom--IntrinsicValuePerShare_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_ziLARwEqLxAi" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1481">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_98B_ecustom--IntrinsicValuePerShare_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zSZrYi3swgP4" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1483">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Range of exercise prices</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_900_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember__srt--RangeAxis__srt--MinimumMember_zOZhDSHtc2jg">139.20 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_902_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember__srt--RangeAxis__srt--MaximumMember_zNt7WnDCWqEi">1,944.00</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_90D_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember__srt--RangeAxis__srt--MinimumMember_z7qewSaaJIJi">139.20 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_90D_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember__srt--RangeAxis__srt--MaximumMember_zi0Vnu7EmP8e">23,472.00</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_90B_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember__srt--RangeAxis__srt--MinimumMember_zGzOBSjMracf">19.20 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_909_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember__srt--RangeAxis__srt--MaximumMember_zC0pnkrxrFs6">34.20</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_909_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember__srt--RangeAxis__srt--MinimumMember_zHqe00IdxmLd">19.20 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_905_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember__srt--RangeAxis__srt--MaximumMember_zyzt6gPfqC0h">34.20</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: italic 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="13" style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><i>Performance-based stock option inducement awards</i></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: italic 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="13" style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><i>Time-based restricted stock awards</i></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-January 1st, outstanding</span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zevgD7JYIed2" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,500</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zoFj1a05biF8" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">33.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z1wj681MoSu6" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,500</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zPmssUEYbvYd" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">33.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zg4BdQxKSXf9" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">140,736</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zWUNTSD06573" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">23.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zhR6dp8yr69i" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">39,933</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zrp60Ckak4j4" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">63.40</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Granted, canceled, expired</span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zJMtvg9dYIo7" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1509">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zrtz9xPLz65f" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1511">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zLry3Wz7PEmf" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1513">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zitvoxP01Q32" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1515">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zoJWlHprHx9e" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">41,250</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zxmFtbPRD307" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">9.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zXUUH0bYzxj" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">107,053</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zXfXETC6B944" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">20.80</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Forfeited</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z9avC8d2Asd2" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1525">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zIi5gBqnCRcg" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1527">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zvf6SaoZRRe4" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1529">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zfrVQQ45keqb" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1531">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zAcbtdPf02Q6" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(19,415</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zfon7nIWJ7vl" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(21.40</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">) </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zvmy4tofwQc4" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1537">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zfmquzMDKIFh" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1539">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-June 30th, outstanding</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zKNMU9DyMH16" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,500</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> $</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z9TGThftj3ib" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">33.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zpbvfaIku2a6" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,500</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> $</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zj0V6KpVQDyh" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">33.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zobsYVL14sjf" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">162,571</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> $</span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z5J1Ka4BKK8g" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12.60</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zZWYs2iaVDc5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">146,986</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zBKp5VWF2O94" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">26.20</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-June 30th, exercisable</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zd8OsXzROMeg" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1557">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zwQaqkHtj5R9" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1559">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zrZSWRoA6Aea" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1561">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zHluaTa7N3z5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1563">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z7ZUcWrr638b" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">63,098</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zuFOvf3qpAjg" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">40.20</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zrm18oUAsraj" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,472</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zh3PY9sHuPRh" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">100.80</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Remaining compensation expense</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_98D_ecustom--RemainingStockCompensationExpenses_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z2BRq6IsDMj3" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$414,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_98E_ecustom--RemainingStockCompensationExpenses_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zwwns5wJRvDj" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$414,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_982_ecustom--RemainingStockCompensationExpenses_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zHFd0xzq2knd" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$2,049,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_984_ecustom--RemainingStockCompensationExpenses_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z474K05j0ZH1" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$3,857,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Remaining amortization period</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--AmortizationPeriod_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z7bEz9cvlRPi" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_903_ecustom--AmortizationPeriod_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zIX2iLQtycF8" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_ecustom--AmortizationPeriod_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zx8tpbhDJHpj" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.7 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_ecustom--AmortizationPeriod_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zicpFxBnNRqc" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.0 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Weighted average remaining contractual life – options outstanding and exercisable</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_ztSAiAZQn7l3" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zY19QJCheCvl">0.0 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z9C06Xomxhej" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zTgUvp3TWTbe">7.6 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsOneMember_z9UJgPpZx5q3" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.1 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsTwoMember_zBsioUa2uTpd">1.8 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsOneMember_z6vmLBMiPDNe" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.0 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsTwoMember_ze9uXNxagRF9">4.0 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Intrinsic value per share</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_980_ecustom--IntrinsicValuePerShare_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z5rkRgmOmdm8" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1593">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_98A_ecustom--IntrinsicValuePerShare_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zwtCDRozImNc" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1595">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_98E_ecustom--IntrinsicValuePerShare_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zBMip5qx0GCd" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1597">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_988_ecustom--IntrinsicValuePerShare_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zo05KEo3Pd79" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1599">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Range of exercise prices</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_90E_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zARDfcSA9Uh6">34.20</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_90B_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z45cxakLtZ2l">34.20</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_908_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MinimumMember_z9O21jZkwA7j">8.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_90C_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MaximumMember_zs5eqpKRRMM1">72.00</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_902_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MinimumMember_zOptXce9uDXh">19.60 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_90D_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MaximumMember_zOdAgaDI5hi8">72.00</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: italic 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="13" style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><i>Performance-based restricted stock awards</i></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-January 1st, outstanding</span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zxxfBgm3ULge" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">71,303</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zbHXj9AmPhs4" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">58.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zaoXGmPOueVg" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">63,369</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z1AmiJDtTuh9" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">58.80</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Granted, canceled, expired</span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zAD3EFhAFTs" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1615">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zmrNjA5xfsV3" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1617">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zPUk8cl9Yxb1" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">71,303</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z4dS5cUjYS28" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">21.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Forfeited</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z7qQn6jBJXdk" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(19,649</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zh9jAD1Yzltf" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(21.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zZFpNWfqRvZg" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1627">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zAh5VI6p0A74" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1629">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-June 30th, outstanding</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zEqAEgWQ0qFh" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">51,654</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z4ThRVnktswd" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">22.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zADs0GWRIV4i" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">134,762</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zXBdidWEHoEg" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">38.80</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-June 30th, exercisable</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zNJqx6K5RyJ1" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1639">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z1ONL3u0mfHe" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1641">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zvQaYNBSPkla" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">63,369</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zUvCCYAq6OM6" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">82.40</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Remaining compensation expense</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_981_ecustom--RemainingStockCompensationExpenses_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zTK1ayZXWIj6" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$1,085,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_983_ecustom--RemainingStockCompensationExpenses_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z0jER2HZA1mb" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$1,498,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Remaining amortization period</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_ecustom--AmortizationPeriod_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z7b2U6FqtNUf" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.5 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_ecustom--AmortizationPeriod_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zS52kfJrkruk" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.7 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Weighted average remaining contractual life – options outstanding and exercisable</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsOneMember_znk38FGYxlhe" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.5 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsTwoMember_z1yzKsfdylUi">0.0 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsOneMember_z3EcKFA5cKbj" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.3 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsTwoMember_zrTypLgN77Z2">3.8 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Intrinsic value per share</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_986_ecustom--IntrinsicValuePerShare_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zZkqCgBbOyai" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1657">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_980_ecustom--IntrinsicValuePerShare_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zzHYRNKLOtda" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1659">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Range of exercise prices</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_90B_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MinimumMember_zbfOKdmfd45e">21.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_907_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MaximumMember_zcBGfi5pK39d">72.00</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_90D_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MinimumMember_zEVM8vurzUlb">21.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_902_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MaximumMember_zAxinKrDJIB8">72.00</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> </table> <p id="xdx_8A1_zNNapkXTl2X8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> The equity awards have an initial vesting between 25% and 33% on their one-year anniversary dates and will vest between 24 and 36 equal monthly periods thereafter. <p id="xdx_893_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_z0mEIPKZ0N69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As shown in the following table, stock-based compensation expense is included in general and administrative expenses under the following plans:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span><span id="xdx_8BC_ziakbW0Nyrr6" style="display: none">SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230401__20230630_zacgwP9oaoX7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220401__20220630_z9kGiib6HSgj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230101__20230630_zzSJ1olgFoYj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20220630_zJGibf2vuz66" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three months ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Equity-based plans:</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--PlanNameAxis__custom--LongTermStockIncentivePlanAwardsMember_zUAN8h6iiD8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Long-term stock incentive plan awards</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1345">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1346">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1347">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--PlanNameAxis__custom--TimeVestedOptionInducementAwardsMember_zrwLjl4rKuS2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Time-vested option inducement awards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">37,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">107,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--PlanNameAxis__custom--PerformanceBasedStockOptionInducementMember_zNCNy41w4T" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Performance-based stock option inducement award</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1355">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1356">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1357">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1358">-</span></span></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--PlanNameAxis__custom--TimeBasedRestrictedStockAwardsMember_zaQ1WogTHsml" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Time-based restricted stock awards <br/></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">299,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">898,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--PlanNameAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zKnXhswcQ9Cf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Performance-based restricted stock awards</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1365">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1366">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1367">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1368">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_zA9j4zXMdP48" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 0.1in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation expense</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">336,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">208,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,257,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">955,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1000000 37000000 28000000 107000000 56000000 299000000 180000000 1150000000 898000000 336000 208000 1257000 955000 <p id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_zxN9RWrGkkRk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates supplementary data under various equity compensation plans:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zAazxwEJBT2f" style="display: none">SCHEDULE OF EQUITY COMPENSATION PLANS</span></p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="14" style="font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Six months ended</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="14" style="font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Six months ended</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">June 30,</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">June 30,</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2023</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2022</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2023</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2022</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Quantity</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Weighted Average</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Quantity</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Weighted Average</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Quantity</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Weighted Average</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Quantity</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Weighted Average</span></td> <td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: italic 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Long-term stock incentive plan awards</span></td> <td style="font: italic 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: italic 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Time-vested option inducement awards</span></td> <td style="font: italic 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-January 1<sup>st</sup>, outstanding</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zEX5Z6DESCsl" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,250</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z2gLUNMTIWzh" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,756</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zZTThutecQC9" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,496</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zP1gbjXPyTfa" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,795.80</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zgkpaTGZISd1" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">24,721</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zpNl1TP3Na51" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zWxbou5RM138" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">24,721</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zHobp1obrIG7" style="font: 8pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">20.20</span></td> <td style="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Granted, canceled, expired</span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zVJTw4SZsds8" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1393">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zJaa3pZHuCQa" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1395">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zyOquHt2cra1" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1397">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zQszhTB5fGN1" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1399">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zG18fLhC0xFb" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1401">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zP6Se7H7U0ij" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1403">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z5C3xHwQAWt2" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1405">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z0FSuhuKpkLe" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1407">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Forfeited</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zwyqQ22lOqTb" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(58</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zuV6aiiR1noh" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,166.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zeMgh1AhjvH5" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(171</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z0qodrhlJKy7" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,931.60</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zDFW1KxINfpl" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1417">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zKL3pBumflWj" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1419">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zStLN14fD1W2" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1421">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zlaE23TfRupi" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1423">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-June 30th, outstanding</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zdNpqjEEYR1d" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,192</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zWqWfeS2L2E2" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,771.40</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zjzLFHmGsFt9" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,325</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z6nLVzWFda73" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,754.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zpewKEsbfzK2" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">24,721</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zq6ke7G5aba8" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">10.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zBPKYnhmcUEh" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">24,721</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zSCvWaSfe3Of" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">17.80</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-June 30th, exercisable</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zvmat0FJCEMl" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,192</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z8l3XBq4eJQ8" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,771.40</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zRAiK0ntIT27" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,463</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zbkXFZb8Hbbi" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,802.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z9bKkuKSZfYe" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">24,721</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zUpFhf7n9g18" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">18.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z0kk8NzITXFe" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14,936</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z82TRol4ZrEk" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">29.60</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Remaining compensation expense</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_988_ecustom--RemainingStockCompensationExpenses_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zsYrFfY6yDTa" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1457">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_98C_ecustom--RemainingStockCompensationExpenses_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zveILjXaRLVb" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1459">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_981_ecustom--RemainingStockCompensationExpenses_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zTTjoLXUZjYg" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$212,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_980_ecustom--RemainingStockCompensationExpenses_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zpcWJsRRy91d" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$442,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Remaining amortization period</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_ecustom--AmortizationPeriod_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zoBqAg8s1pLi" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.0 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--AmortizationPeriod_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z9PSlDoGpiDb" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.0 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_ecustom--AmortizationPeriod_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zqYOKmmUEyDb" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--AmortizationPeriod_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zVu7WzRXLBK7" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Weighted average remaining contractual life – options outstanding and exercisable</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z08qzXnK7yc7" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.0 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zd6R1IXhdGE4">4.0 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zANJhKMDGOpg" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5.1 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zr2d34PG8ZC7">5.0 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zgpCaaeMfbte" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zedh3HKwktw9">6.6 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zPy4t7KDes71" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z5jOEHYSOr16">7.6 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Intrinsic value per share</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_980_ecustom--IntrinsicValuePerShare_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zgQMxrCTre67" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1477">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_981_ecustom--IntrinsicValuePerShare_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z60ltCop9374" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1479">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_980_ecustom--IntrinsicValuePerShare_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_ziLARwEqLxAi" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1481">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_98B_ecustom--IntrinsicValuePerShare_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zSZrYi3swgP4" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1483">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Range of exercise prices</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_900_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember__srt--RangeAxis__srt--MinimumMember_zOZhDSHtc2jg">139.20 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_902_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember__srt--RangeAxis__srt--MaximumMember_zNt7WnDCWqEi">1,944.00</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_90D_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember__srt--RangeAxis__srt--MinimumMember_z7qewSaaJIJi">139.20 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_90D_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember__srt--RangeAxis__srt--MaximumMember_zi0Vnu7EmP8e">23,472.00</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_90B_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember__srt--RangeAxis__srt--MinimumMember_zGzOBSjMracf">19.20 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_909_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember__srt--RangeAxis__srt--MaximumMember_zC0pnkrxrFs6">34.20</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_909_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember__srt--RangeAxis__srt--MinimumMember_zHqe00IdxmLd">19.20 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_905_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember__srt--RangeAxis__srt--MaximumMember_zyzt6gPfqC0h">34.20</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: italic 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="13" style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><i>Performance-based stock option inducement awards</i></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: italic 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="13" style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><i>Time-based restricted stock awards</i></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-January 1st, outstanding</span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zevgD7JYIed2" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,500</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zoFj1a05biF8" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">33.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z1wj681MoSu6" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,500</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zPmssUEYbvYd" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">33.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zg4BdQxKSXf9" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">140,736</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zWUNTSD06573" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">23.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zhR6dp8yr69i" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">39,933</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zrp60Ckak4j4" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">63.40</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Granted, canceled, expired</span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zJMtvg9dYIo7" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1509">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zrtz9xPLz65f" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1511">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zLry3Wz7PEmf" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1513">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zitvoxP01Q32" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1515">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zoJWlHprHx9e" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">41,250</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zxmFtbPRD307" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">9.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zXUUH0bYzxj" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">107,053</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zXfXETC6B944" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">20.80</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Forfeited</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z9avC8d2Asd2" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1525">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zIi5gBqnCRcg" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1527">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zvf6SaoZRRe4" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1529">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zfrVQQ45keqb" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1531">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zAcbtdPf02Q6" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(19,415</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zfon7nIWJ7vl" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(21.40</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">) </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zvmy4tofwQc4" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1537">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zfmquzMDKIFh" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1539">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-June 30th, outstanding</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zKNMU9DyMH16" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,500</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> $</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z9TGThftj3ib" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">33.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zpbvfaIku2a6" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,500</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> $</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zj0V6KpVQDyh" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">33.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zobsYVL14sjf" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">162,571</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> $</span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z5J1Ka4BKK8g" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12.60</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zZWYs2iaVDc5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">146,986</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zBKp5VWF2O94" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">26.20</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-June 30th, exercisable</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zd8OsXzROMeg" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1557">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zwQaqkHtj5R9" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1559">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zrZSWRoA6Aea" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1561">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zHluaTa7N3z5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1563">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z7ZUcWrr638b" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">63,098</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zuFOvf3qpAjg" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">40.20</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zrm18oUAsraj" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,472</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zh3PY9sHuPRh" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">100.80</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Remaining compensation expense</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_98D_ecustom--RemainingStockCompensationExpenses_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z2BRq6IsDMj3" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$414,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_98E_ecustom--RemainingStockCompensationExpenses_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zwwns5wJRvDj" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$414,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_982_ecustom--RemainingStockCompensationExpenses_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zHFd0xzq2knd" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$2,049,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_984_ecustom--RemainingStockCompensationExpenses_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z474K05j0ZH1" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$3,857,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Remaining amortization period</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90A_ecustom--AmortizationPeriod_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z7bEz9cvlRPi" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_903_ecustom--AmortizationPeriod_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zIX2iLQtycF8" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_ecustom--AmortizationPeriod_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zx8tpbhDJHpj" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.7 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_ecustom--AmortizationPeriod_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zicpFxBnNRqc" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.0 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Weighted average remaining contractual life – options outstanding and exercisable</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_ztSAiAZQn7l3" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zY19QJCheCvl">0.0 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z9C06Xomxhej" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.6 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zTgUvp3TWTbe">7.6 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsOneMember_z9UJgPpZx5q3" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.1 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsTwoMember_zBsioUa2uTpd">1.8 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsOneMember_z6vmLBMiPDNe" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.0 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsTwoMember_ze9uXNxagRF9">4.0 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Intrinsic value per share</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_980_ecustom--IntrinsicValuePerShare_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z5rkRgmOmdm8" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1593">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_98A_ecustom--IntrinsicValuePerShare_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zwtCDRozImNc" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1595">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_98E_ecustom--IntrinsicValuePerShare_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zBMip5qx0GCd" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1597">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_988_ecustom--IntrinsicValuePerShare_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zo05KEo3Pd79" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1599">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Range of exercise prices</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_90E_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_zARDfcSA9Uh6">34.20</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_90B_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementAwardsMember_z45cxakLtZ2l">34.20</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_908_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MinimumMember_z9O21jZkwA7j">8.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_90C_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MaximumMember_zs5eqpKRRMM1">72.00</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_902_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MinimumMember_zOptXce9uDXh">19.60 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_90D_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MaximumMember_zOdAgaDI5hi8">72.00</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: italic 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="13" style="border-bottom: Black 1.5pt solid; font: italic 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><i>Performance-based restricted stock awards</i></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-January 1st, outstanding</span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zxxfBgm3ULge" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">71,303</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zbHXj9AmPhs4" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">58.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zaoXGmPOueVg" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">63,369</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z1AmiJDtTuh9" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">58.80</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Granted, canceled, expired</span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zAD3EFhAFTs" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1615">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zmrNjA5xfsV3" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1617">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zPUk8cl9Yxb1" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">71,303</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z4dS5cUjYS28" style="font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">21.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Forfeited</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z7qQn6jBJXdk" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(19,649</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zh9jAD1Yzltf" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(21.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zZFpNWfqRvZg" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1627">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zAh5VI6p0A74" style="border-bottom: Black 1.5pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1629">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-June 30th, outstanding</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zEqAEgWQ0qFh" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">51,654</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z4ThRVnktswd" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">22.00</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zADs0GWRIV4i" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">134,762</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zXBdidWEHoEg" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">38.80</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance-June 30th, exercisable</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zNJqx6K5RyJ1" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1639">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z1ONL3u0mfHe" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1641">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zvQaYNBSPkla" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">63,369</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zUvCCYAq6OM6" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">82.40</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Remaining compensation expense</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_981_ecustom--RemainingStockCompensationExpenses_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zTK1ayZXWIj6" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$1,085,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_983_ecustom--RemainingStockCompensationExpenses_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z0jER2HZA1mb" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$1,498,000</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Remaining amortization period</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_ecustom--AmortizationPeriod_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z7b2U6FqtNUf" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.5 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_ecustom--AmortizationPeriod_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zS52kfJrkruk" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.7 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Weighted average remaining contractual life – options outstanding and exercisable</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsOneMember_znk38FGYxlhe" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.5 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsTwoMember_z1yzKsfdylUi">0.0 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsOneMember_z3EcKFA5cKbj" style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.3 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years and <span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsTwoMember_zrTypLgN77Z2">3.8 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">years</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Intrinsic value per share</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_986_ecustom--IntrinsicValuePerShare_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zZkqCgBbOyai" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1657">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" id="xdx_980_ecustom--IntrinsicValuePerShare_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zzHYRNKLOtda" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span style="-sec-ix-hidden: xdx2ixbrl1659">—</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Range of exercise prices</span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Quantity, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_90B_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MinimumMember_zbfOKdmfd45e">21.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_907_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20230101__20230630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MaximumMember_zcBGfi5pK39d">72.00</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="5" style="border-bottom: Black 2.5pt double; font: 8pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$<span id="xdx_90D_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MinimumMember_zEVM8vurzUlb">21.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">to $<span id="xdx_902_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice_pid_c20220101__20220630__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember__srt--RangeAxis__srt--MaximumMember_zAxinKrDJIB8">72.00</span></span></td> <td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> </table> 2250 1756 2496 1795.80 24721 13.00 24721 20.20 58 1166.00 171 1931.60 2192 1771.40 2325 1754.00 24721 10.00 24721 17.80 2192 1771.40 2463 1802.00 24721 18.00 14936 29.60 212000000 442000000 P0Y P0Y P0Y7M6D P1Y7M6D P4Y P4Y P5Y1M6D P5Y P6Y7M6D P6Y7M6D P7Y7M6D P7Y7M6D 139.20 1944.00 139.20 23472.00 19.20 34.20 19.20 34.20 12500 33.00 12500 33.00 140736 23.00 39933 63.40 41250 9.00 107053 20.80 19415 21.40 12500 33.00 12500 33.00 162571 12.60 146986 26.20 63098 40.20 12472 100.80 414000000 414000000 2049000000 3857000000 P1Y7M6D P2Y7M6D P1Y8M12D P3Y P6Y7M6D P0Y P7Y7M6D P7Y7M6D P2Y1M6D P1Y9M18D P3Y P4Y 34.20 34.20 8.00 72.00 19.60 72.00 71303 58.00 63369 58.80 71303 21.00 19649 21.00 51654 22.00 134762 38.80 63369 82.40 1085000000 1498000000 P2Y6M P7Y8M12D P2Y6M P0Y P4Y3M18D P3Y9M18D 21.00 72.00 21.00 72.00 <p id="xdx_809_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zKnXJkWMFGMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 — <span id="xdx_820_zbJc97Figdw2">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pension:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may make a matching contribution to its employees’ 401(k) plan. Furthermore, Vislink operates a Group Personal Plan through its UK subsidiary, investing funds with Royal London. Employees of the Company in the United Kingdom are entitled to participate in the Company’s employee benefit plan, to which varying amounts are contributed according to their status. Additionally, the Company operates a stakeholder pension plan in the United Kingdom.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--DefinedContributionPlanDisclosuresTableTextBlock_zaiQs3Y350v4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below represents the Company’s matching contributions as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zzmcKn2URGY9" style="display: none">SCHEDULE OF MATCHING CONTRIBUTIONS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three months ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left; padding-bottom: 2.5pt">Company matching contributions - Group Personal Pension Plan</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20230401__20230630__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_zx45lAcVGXmg" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Company matching contributions">35,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20220401__20220630__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_znfskaRz5tfa" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Company matching contributions">48,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20230101__20230630__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_z0rUwoslcIE7" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Company matching contributions">68,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20220101__20220630__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_zTqcggVbh28d" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Company matching contributions">97,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zvBrhf23s73d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--DefinedContributionPlanDisclosuresTableTextBlock_zaiQs3Y350v4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below represents the Company’s matching contributions as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zzmcKn2URGY9" style="display: none">SCHEDULE OF MATCHING CONTRIBUTIONS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three months ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left; padding-bottom: 2.5pt">Company matching contributions - Group Personal Pension Plan</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20230401__20230630__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_zx45lAcVGXmg" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Company matching contributions">35,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20220401__20220630__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_znfskaRz5tfa" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Company matching contributions">48,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20230101__20230630__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_z0rUwoslcIE7" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Company matching contributions">68,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20220101__20220630__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_zTqcggVbh28d" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right" title="Company matching contributions">97,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 35000 48000 68000 97000 <p id="xdx_800_eus-gaap--ConcentrationRiskDisclosureTextBlock_zXTTCy5NrHC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 — <span id="xdx_820_zDv5KfTbmY1d">CONCENTRATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Customer concentration risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the three and six months ended June 30, 2023, no customers exceeded 10 percent of the Company’s consolidated sales. In the three and six months ending June 30, 2022, the Company derived revenue from two customers representing more than 10% of its total consolidated sales for approximately $<span id="xdx_906_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zD7geZKcO2Yb" title="Revenue, net">788,000</span> (<span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zTL3GjR7z1Qh" title="Concentration Risk, Percentage">12</span>%) and $<span id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zuUjmQu3fu7e" title="Revenue, net">1,467,000</span> (<span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zlLh5oqnDuIc" title="Concentration Risk, Percentage">11</span>%), respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two customers owed the Company approximately $<span id="xdx_901_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zMORdiDYlzH6" title="Revenue, net">925,000</span> and <span id="xdx_90F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z2NVMcUPUFN8" title="Revenue, net">688,000</span>, respectively, representing <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zhuoFPQsQRrf" title="Concentration risk, percentage">16</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zp7Dp14Z3cGd" title="Concentration risk, percentage">12</span>% of its consolidated net receivables on June 30, 2023. One customer owed the Company approximately $<span id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zNqIpRCLRS19">4,204,000</span>, representing <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zQRc4nr1q7Ti" title="Concentration risk, percentage">48</span>% of the Company’s consolidated net accounts receivable on June 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Vendor concentration risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the three months ending June 30, 2023, two vendors exceeded 10% of the Company’s consolidated purchases with approximately $<span id="xdx_90D_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--OneVendorMember_zEUAJWfMwp34" title="Accounts payable">465,000</span> and $<span id="xdx_908_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--VendorTwoMember_zaUzuNROUuOe" title="Accounts payable">323,000</span>, representing <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--VendorOneMember_zBwLCyWhGhV5" title="Concentration risk, percentage">15</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--VendorTwoMember_zfPod73JcXQh" title="Concentration risk, percentage">10</span>% of the Company’s consolidated inventory purchases, respectively. In the six months ending June 30, 2023, two vendors met the criteria beyond 10% of the Company’s consolidated purchases of approximately $<span id="xdx_907_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--VendorOneMember_zBEB34zYNUxb" title="Revenue, net">595,000</span> and $<span id="xdx_90C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--VendorTwoMember_zSmwZXPMSVwg" title="Revenue, net">587,000</span>, representing 10% of the Company’s consolidated inventory purchases, respectively. During the three and six months ended June 30, 2022, no vendor made purchases exceeding 10% of the Company’s total consolidated purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, one vendor exceeded 10% of the Company’s consolidated accounts payable of approximately $<span id="xdx_900_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--VendorOneMember_zUsAqqHmmp09" title="Accounts payable">610,000</span> (<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--VendorOneMember_zy6hmMRXpem4">18</span>%). As of June 30, 2022, no vendor represented more than 10% of the Company’s accounts payable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 788000 0.12 1467000 0.11 925000 688000 0.16 0.12 4204000 0.48 465000 323000 0.15 0.10 595000 587000 610000 0.18 <p id="xdx_800_eus-gaap--RevenueFromContractWithCustomerTextBlock_zKo2sfNrJldc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 – <span id="xdx_821_zJK9HC7EPTC1">REVENUE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_ze9uShsIQGF4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has one operating segment, with the senior executive management team as the decision-making group. In the following table, the Company has disaggregated revenue by the Company’s primary geographical markets and revenue sources:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zfK2ab2zgvf9" style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Primary geographical markets:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 36%; text-align: justify; padding-left: 10pt">North America</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zA2hGmMOMwYe" style="width: 12%; text-align: right" title="Revenue, net">1,721,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zcwAwPHECsp7" style="width: 12%; text-align: right" title="Revenue, net">3,472,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zHwl0OGG2LBf" style="width: 12%; text-align: right" title="Revenue, net">4,888,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zconspKtKVd9" style="width: 12%; text-align: right" title="Revenue, net">5,900,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">South America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__srt--StatementGeographicalAxis__srt--SouthAmericaMember_zs36T25miQq2" style="text-align: right" title="Revenue, net">38,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__srt--StatementGeographicalAxis__srt--SouthAmericaMember_zhugDSLGzyZi" style="text-align: right" title="Revenue, net">49,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__srt--StatementGeographicalAxis__srt--SouthAmericaMember_zOg6vp2H24P1" style="text-align: right" title="Revenue, net">227,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__srt--StatementGeographicalAxis__srt--SouthAmericaMember_z9jBsZ3BcWjb" style="text-align: right" title="Revenue, net">99,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__srt--StatementGeographicalAxis__srt--EuropeMember_zHEiBq6huBV5" style="text-align: right" title="Revenue, net">1,593,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__srt--StatementGeographicalAxis__srt--EuropeMember_zKhA2JMGqYQ7" style="text-align: right" title="Revenue, net">2,105,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__srt--StatementGeographicalAxis__srt--EuropeMember_znmazZW6xCn4" style="text-align: right" title="Revenue, net">3,436,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__srt--StatementGeographicalAxis__srt--EuropeMember_zVVIC5M0ljyb" style="text-align: right" title="Revenue, net">4,294,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Asia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__srt--StatementGeographicalAxis__srt--AsiaMember_zy8rz08qCEAb" style="text-align: right" title="Revenue, net">1,305,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__srt--StatementGeographicalAxis__srt--AsiaMember_zrDMSbsitrVe" style="text-align: right" title="Revenue, net">830,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__srt--StatementGeographicalAxis__srt--AsiaMember_zWC1MDqYVAMl" style="text-align: right" title="Revenue, net">2,024,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__srt--StatementGeographicalAxis__srt--AsiaMember_zDn51O6ZKPwk" style="text-align: right" title="Revenue, net">1,372,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Rest of World</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__srt--StatementGeographicalAxis__custom--RestOfWorldMember_zP9NFXRfA8r" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">386,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__srt--StatementGeographicalAxis__custom--RestOfWorldMember_z982NlaOitc8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">310,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__srt--StatementGeographicalAxis__custom--RestOfWorldMember_zglzjzInoiKl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">1,656,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__srt--StatementGeographicalAxis__custom--RestOfWorldMember_zdrxV1cURKpk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">1,961,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630_zB8JUfpgipNa" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">5,043,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630_zk3e273cXtqe" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">6,766,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630_zcedodn3HHD2" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">12,231,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630_zjLcbYaDQ2J1" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">13,626,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Primary revenue source:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Equipment sales</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_zFf98AyAq305" style="text-align: right" title="Revenue, net">4,279,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_zkdJm4fy8LI4" style="text-align: right" title="Revenue, net">6,194,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_zcVbn5VlMMOk" style="text-align: right" title="Revenue, net">10,673,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_z15h5mWJF3L2" style="text-align: right" title="Revenue, net">12,472,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">Installation, integration, and repairs</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zajEwxNSnyzl" style="text-align: right" title="Revenue, net">263,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zLke6XM8YP93" style="text-align: right" title="Revenue, net">330,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zc7uqpMz3MG8" style="text-align: right" title="Revenue, net">749,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zORw4otxWXsj" style="text-align: right" title="Revenue, net">573,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Warranties</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zy3IfnZvFESg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">501,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zvQBQhYZog1a" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">242,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zX2kQBB7EBmc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">809,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zEzR2CuAc9Bf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">581,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20230401__20230630_zGMEfBlvTp67" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">5,043,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20220401__20220630_zV1sFO5dPs58" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">6,766,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20230101__20230630_z0PRdmpS2stb" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">12,231,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20220101__20220630_znJCh50unHf7" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">13,626,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Long-Lived Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">United States</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__country--US_z29Qfrtvyona" style="text-align: right" title="Long-Lived Assets">2,174,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20220630__srt--StatementGeographicalAxis__country--US_znHj18Avo0oe" style="text-align: right" title="Long-Lived Assets">2,227,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Netherlands</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__country--NL_zlpwGKGT49o5" style="text-align: right" title="Long-Lived Assets">23,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20220630__srt--StatementGeographicalAxis__country--NL_zwtER3Sga0Ba" style="text-align: right" title="Long-Lived Assets">28,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">United Kingdom</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__country--GB_zMI1d8qyuJD4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Long-Lived Assets">4,397,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20220630__srt--StatementGeographicalAxis__country--GB_zlZPAs0XeWib" style="border-bottom: Black 1.5pt solid; text-align: right" title="Long-Lived Assets">5,471,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20230630_z8uVX8REMdvk" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Lived Assets">6,594,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20220630_zvcDzQyUM1Kb" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Lived Assets">7,726,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_z9uEMgJTxru4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_ze9uShsIQGF4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has one operating segment, with the senior executive management team as the decision-making group. In the following table, the Company has disaggregated revenue by the Company’s primary geographical markets and revenue sources:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zfK2ab2zgvf9" style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Primary geographical markets:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 36%; text-align: justify; padding-left: 10pt">North America</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zA2hGmMOMwYe" style="width: 12%; text-align: right" title="Revenue, net">1,721,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zcwAwPHECsp7" style="width: 12%; text-align: right" title="Revenue, net">3,472,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zHwl0OGG2LBf" style="width: 12%; text-align: right" title="Revenue, net">4,888,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zconspKtKVd9" style="width: 12%; text-align: right" title="Revenue, net">5,900,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">South America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__srt--StatementGeographicalAxis__srt--SouthAmericaMember_zs36T25miQq2" style="text-align: right" title="Revenue, net">38,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__srt--StatementGeographicalAxis__srt--SouthAmericaMember_zhugDSLGzyZi" style="text-align: right" title="Revenue, net">49,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__srt--StatementGeographicalAxis__srt--SouthAmericaMember_zOg6vp2H24P1" style="text-align: right" title="Revenue, net">227,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__srt--StatementGeographicalAxis__srt--SouthAmericaMember_z9jBsZ3BcWjb" style="text-align: right" title="Revenue, net">99,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">Europe</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__srt--StatementGeographicalAxis__srt--EuropeMember_zHEiBq6huBV5" style="text-align: right" title="Revenue, net">1,593,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__srt--StatementGeographicalAxis__srt--EuropeMember_zKhA2JMGqYQ7" style="text-align: right" title="Revenue, net">2,105,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__srt--StatementGeographicalAxis__srt--EuropeMember_znmazZW6xCn4" style="text-align: right" title="Revenue, net">3,436,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__srt--StatementGeographicalAxis__srt--EuropeMember_zVVIC5M0ljyb" style="text-align: right" title="Revenue, net">4,294,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Asia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__srt--StatementGeographicalAxis__srt--AsiaMember_zy8rz08qCEAb" style="text-align: right" title="Revenue, net">1,305,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__srt--StatementGeographicalAxis__srt--AsiaMember_zrDMSbsitrVe" style="text-align: right" title="Revenue, net">830,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__srt--StatementGeographicalAxis__srt--AsiaMember_zWC1MDqYVAMl" style="text-align: right" title="Revenue, net">2,024,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__srt--StatementGeographicalAxis__srt--AsiaMember_zDn51O6ZKPwk" style="text-align: right" title="Revenue, net">1,372,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Rest of World</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__srt--StatementGeographicalAxis__custom--RestOfWorldMember_zP9NFXRfA8r" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">386,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__srt--StatementGeographicalAxis__custom--RestOfWorldMember_z982NlaOitc8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">310,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__srt--StatementGeographicalAxis__custom--RestOfWorldMember_zglzjzInoiKl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">1,656,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__srt--StatementGeographicalAxis__custom--RestOfWorldMember_zdrxV1cURKpk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">1,961,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630_zB8JUfpgipNa" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">5,043,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630_zk3e273cXtqe" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">6,766,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630_zcedodn3HHD2" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">12,231,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630_zjLcbYaDQ2J1" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">13,626,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Primary revenue source:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Equipment sales</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_zFf98AyAq305" style="text-align: right" title="Revenue, net">4,279,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_zkdJm4fy8LI4" style="text-align: right" title="Revenue, net">6,194,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_zcVbn5VlMMOk" style="text-align: right" title="Revenue, net">10,673,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_z15h5mWJF3L2" style="text-align: right" title="Revenue, net">12,472,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">Installation, integration, and repairs</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zajEwxNSnyzl" style="text-align: right" title="Revenue, net">263,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zLke6XM8YP93" style="text-align: right" title="Revenue, net">330,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zc7uqpMz3MG8" style="text-align: right" title="Revenue, net">749,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zORw4otxWXsj" style="text-align: right" title="Revenue, net">573,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Warranties</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zy3IfnZvFESg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">501,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zvQBQhYZog1a" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">242,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230630__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zX2kQBB7EBmc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">809,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zEzR2CuAc9Bf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue, net">581,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20230401__20230630_zGMEfBlvTp67" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">5,043,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20220401__20220630_zV1sFO5dPs58" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">6,766,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20230101__20230630_z0PRdmpS2stb" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">12,231,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20220101__20220630_znJCh50unHf7" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue, net">13,626,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Long-Lived Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">United States</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__country--US_z29Qfrtvyona" style="text-align: right" title="Long-Lived Assets">2,174,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20220630__srt--StatementGeographicalAxis__country--US_znHj18Avo0oe" style="text-align: right" title="Long-Lived Assets">2,227,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Netherlands</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__country--NL_zlpwGKGT49o5" style="text-align: right" title="Long-Lived Assets">23,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20220630__srt--StatementGeographicalAxis__country--NL_zwtER3Sga0Ba" style="text-align: right" title="Long-Lived Assets">28,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">United Kingdom</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20230630__srt--StatementGeographicalAxis__country--GB_zMI1d8qyuJD4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Long-Lived Assets">4,397,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20220630__srt--StatementGeographicalAxis__country--GB_zlZPAs0XeWib" style="border-bottom: Black 1.5pt solid; text-align: right" title="Long-Lived Assets">5,471,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20230630_z8uVX8REMdvk" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Lived Assets">6,594,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20220630_zvcDzQyUM1Kb" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Lived Assets">7,726,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1721000 3472000 4888000 5900000 38000 49000 227000 99000 1593000 2105000 3436000 4294000 1305000 830000 2024000 1372000 386000 310000 1656000 1961000 5043000 6766000 12231000 13626000 4279000 6194000 10673000 12472000 263000 330000 749000 573000 501000 242000 809000 581000 5043000 6766000 12231000 13626000 2174000 2227000 23000 28000 4397000 5471000 6594000 7726000 <p id="xdx_80C_eus-gaap--InterestAndOtherIncomeTextBlock_zLnwBwOx5EH2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15 — <span id="xdx_828_zIDgZ4PR5NX1">OTHER INCOME (REBATES)</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--ScheduleOfTaxRebatesTableTextBlock_zrNp7YbGszNc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table represents tax rebates related to the research costs incurred by our U.K. subsidiary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_za2yWz6Ks6oj" style="display: none">SCHEDULE OF TAX REBATES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 36%; text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; font-weight: bold; text-align: center">2023</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; font-weight: bold; text-align: center">2022</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; font-weight: bold; text-align: center">2023</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; font-weight: bold; text-align: center">2022</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 10pt">Total tax rebates</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--IncreaseDecreaseInTaxRebates_c20230401__20230630__srt--StatementGeographicalAxis__custom--UKSubsidiaryMember_fKio___z5bWIhvchhL" style="border-bottom: Black 2.5pt double; text-align: right" title="Tax rebate">**5,000</td><td style="padding-bottom: 2.5pt; text-align: left"></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--IncreaseDecreaseInTaxRebates_c20220401__20220630__srt--StatementGeographicalAxis__custom--UKSubsidiaryMember_fKg_____z5T19KOv59O5" style="border-bottom: Black 2.5pt double; text-align: right" title="Tax rebate">*(10,000)</td><td style="padding-bottom: 2.5pt; text-align: left"></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--IncreaseDecreaseInTaxRebates_c20230101__20230630__srt--StatementGeographicalAxis__custom--UKSubsidiaryMember_zMgi6Q91583g" style="border-bottom: Black 2.5pt double; text-align: right" title="Tax rebate">329,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--IncreaseDecreaseInTaxRebates_c20220101__20220630__srt--StatementGeographicalAxis__custom--UKSubsidiaryMember_zFCIXqXTfkjb" style="border-bottom: Black 2.5pt double; text-align: right" title="Tax rebate">284,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: right"><span id="xdx_F02_zPtjD20aNXza" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: right"></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zMzqsF5w2OR2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An increase of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFRBWCBSRUJBVEVTIChQYXJlbnRoZXRpY2FsKSAoRGV0YWlscykA" id="xdx_902_ecustom--IncreaseDecreaseInTaxRebates_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_z5tY5YwkMcj" title="Increase (decrease) in tax rebates">5,000</span> represents a strengthening in the exchange rate from British Pounds to U.S. dollars, resulting in a gain from initial recognition of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFRBWCBSRUJBVEVTIChQYXJlbnRoZXRpY2FsKSAoRGV0YWlscykA" id="xdx_909_ecustom--GainLossFromInitialRecognitionOfExchangeRate_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_z4SY6jZ0c8Z9" title="Gain loss from initial recognition of exchange rate">324,000</span> in the first quarter of fiscal 2023.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_F03_zJ16eeLFNiDc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zYh90aefGV78" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of a weakening in the translation rate from British pounds to U.S. dollars, this $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFRBWCBSRUJBVEVTIChQYXJlbnRoZXRpY2FsKSAoRGV0YWlscykA" id="xdx_909_ecustom--IncreaseDecreaseInTaxRebates_dxL_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zx8ljAkvIPgl" title="Increase (decrease) in tax rebates::XDX::-10000"><span style="-sec-ix-hidden: xdx2ixbrl1831">10,000</span></span> decrease represents a loss compared to the initially recognized $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFRBWCBSRUJBVEVTIChQYXJlbnRoZXRpY2FsKSAoRGV0YWlscykA" id="xdx_906_ecustom--GainLossFromInitialRecognitionOfExchangeRate_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zfgRcIcZZfrl" title="Gain loss from initial recognition of exchange rate">294,000</span> in fiscal 2022.</span></td></tr> </table> <p id="xdx_8AD_zANi3Y11TV79" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While the Company plans to continue filing rebate forms for the 2023 fiscal year, it cannot guarantee that rebates will be available at a similar level or at all in future years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--ScheduleOfTaxRebatesTableTextBlock_zrNp7YbGszNc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table represents tax rebates related to the research costs incurred by our U.K. subsidiary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_za2yWz6Ks6oj" style="display: none">SCHEDULE OF TAX REBATES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 36%; text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; font-weight: bold; text-align: center">2023</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; font-weight: bold; text-align: center">2022</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; font-weight: bold; text-align: center">2023</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; font-weight: bold; text-align: center">2022</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 10pt">Total tax rebates</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--IncreaseDecreaseInTaxRebates_c20230401__20230630__srt--StatementGeographicalAxis__custom--UKSubsidiaryMember_fKio___z5bWIhvchhL" style="border-bottom: Black 2.5pt double; text-align: right" title="Tax rebate">**5,000</td><td style="padding-bottom: 2.5pt; text-align: left"></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--IncreaseDecreaseInTaxRebates_c20220401__20220630__srt--StatementGeographicalAxis__custom--UKSubsidiaryMember_fKg_____z5T19KOv59O5" style="border-bottom: Black 2.5pt double; text-align: right" title="Tax rebate">*(10,000)</td><td style="padding-bottom: 2.5pt; text-align: left"></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--IncreaseDecreaseInTaxRebates_c20230101__20230630__srt--StatementGeographicalAxis__custom--UKSubsidiaryMember_zMgi6Q91583g" style="border-bottom: Black 2.5pt double; text-align: right" title="Tax rebate">329,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--IncreaseDecreaseInTaxRebates_c20220101__20220630__srt--StatementGeographicalAxis__custom--UKSubsidiaryMember_zFCIXqXTfkjb" style="border-bottom: Black 2.5pt double; text-align: right" title="Tax rebate">284,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: right"><span id="xdx_F02_zPtjD20aNXza" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: right"></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zMzqsF5w2OR2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An increase of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFRBWCBSRUJBVEVTIChQYXJlbnRoZXRpY2FsKSAoRGV0YWlscykA" id="xdx_902_ecustom--IncreaseDecreaseInTaxRebates_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_z5tY5YwkMcj" title="Increase (decrease) in tax rebates">5,000</span> represents a strengthening in the exchange rate from British Pounds to U.S. dollars, resulting in a gain from initial recognition of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFRBWCBSRUJBVEVTIChQYXJlbnRoZXRpY2FsKSAoRGV0YWlscykA" id="xdx_909_ecustom--GainLossFromInitialRecognitionOfExchangeRate_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_z4SY6jZ0c8Z9" title="Gain loss from initial recognition of exchange rate">324,000</span> in the first quarter of fiscal 2023.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_F03_zJ16eeLFNiDc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zYh90aefGV78" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of a weakening in the translation rate from British pounds to U.S. dollars, this $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFRBWCBSRUJBVEVTIChQYXJlbnRoZXRpY2FsKSAoRGV0YWlscykA" id="xdx_909_ecustom--IncreaseDecreaseInTaxRebates_dxL_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zx8ljAkvIPgl" title="Increase (decrease) in tax rebates::XDX::-10000"><span style="-sec-ix-hidden: xdx2ixbrl1831">10,000</span></span> decrease represents a loss compared to the initially recognized $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFRBWCBSRUJBVEVTIChQYXJlbnRoZXRpY2FsKSAoRGV0YWlscykA" id="xdx_906_ecustom--GainLossFromInitialRecognitionOfExchangeRate_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zfgRcIcZZfrl" title="Gain loss from initial recognition of exchange rate">294,000</span> in fiscal 2022.</span></td></tr> </table> 5000000 -10000000 329000000 284000000 5000000 324000000 294000000 <p id="xdx_803_ecustom--ReclassificationOfPriorYearPresentationTextBlock_zo8vSeQ9KUZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 — <span id="xdx_820_zeVTU7XB89Zg">RECLASSIFICATION OF PRIOR YEAR PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: #F9F9F9">We reclassified other income amounts from the prior year to ensure consistency with the presentation of the current year’s condensed consolidated statement of operations. For the three and six months ended June 30, 2022, adjustments have been made to the condensed consolidated statements of operations and comprehensive loss. Tax rebates related to research costs incurred by our UK subsidiary were separated from other revenue to other income. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The reclassification did not affect the reported operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_80F_eus-gaap--SubsequentEventsTextBlock_z5R0uOx2q3d6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 17 — <span id="xdx_822_zWB6JFmWBMsl">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Office lease</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company renewed its lease for <span id="xdx_90B_eus-gaap--AreaOfLand_iI_uSquareFeet_c20230703__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--StatementGeographicalAxis__custom--DIFXMember_zI2E67U7oYeb" title="Area of land">976</span> square feet of administrative office space commencing on July 3, 2023, and terminating on July 2, 2024, in Dubai Studio City, UAE, for approximately $<span id="xdx_90A_eus-gaap--PaymentsForRent_pn3n3_c20230703__20230703__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--StatementGeographicalAxis__custom--DIFXMember_zfGP3FIFFeEg" title="Payments for rent">1,632</span> monthly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Relocation of United Kingdom manufacturing division</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following an ever-changing global business landscape, in July 2023, the Company strategically decided to consolidate its UK division and relocate its activities to the United States in September 2023. As a result of the move, management believes that operational efficiency will be optimized, productivity will be enhanced, and our position in the global market will be strengthened. Additionally, the move will:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">enhance our ability to meet future working capital requirements,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">eliminate obsolete inventory items,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduce the usage of our UK Colchester facility, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">simultaneously reduce miscellaneous operating costs.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our commitment to continuous improvement and growth has driven our decision to relocate our manufacturing division. The relocation of our manufacturing division to the United States will cost us approximately $<span id="xdx_90D_eus-gaap--SeveranceCosts1_pn5n6_c20230901__20230930__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zvwLlB4wNSr4" title="Severance costs over next six months">0.2</span> million in severance costs over the next six months. Our relocation process will be designed to ensure minimal disruption to our operations and employees.</span></p> 976 1632000 200000 In connection with the reverse stock split implemented by the Company on May 1, 2023, the company’s stock transfer agent calculated a de minimus adjustment to the opening quantity of shares issued. An increase of $5,000 represents a strengthening in the exchange rate from British Pounds to U.S. dollars, resulting in a gain from initial recognition of $324,000 in the first quarter of fiscal 2023. As a result of a weakening in the translation rate from British pounds to U.S. dollars, this $10,000 decrease represents a loss compared to the initially recognized $294,000 in fiscal 2022. EXCEL 78 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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�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end XML 79 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 80 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 81 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 309 279 1 true 78 0 false 8 false false R1.htm 00000001 - Document - Cover Sheet http://vislink.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://vislink.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://vislink.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) Sheet http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statement of Changes in Stockholders' Equity (Unaudited) Sheet http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity Consolidated Statement of Changes in Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://vislink.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://vislink.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 00000008 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION Sheet http://vislink.com/role/LiquidityAndFinancialCondition LIQUIDITY AND FINANCIAL CONDITION Notes 8 false false R9.htm 00000009 - Disclosure - LOSS PER SHARE Sheet http://vislink.com/role/LossPerShare LOSS PER SHARE Notes 9 false false R10.htm 00000010 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES Sheet http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLosses FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES Notes 10 false false R11.htm 00000011 - Disclosure - CASH AND CASH EQUIVALENTS Sheet http://vislink.com/role/CashAndCashEquivalents CASH AND CASH EQUIVALENTS Notes 11 false false R12.htm 00000012 - Disclosure - INVESTMENTS Sheet http://vislink.com/role/Investments INVESTMENTS Notes 12 false false R13.htm 00000013 - Disclosure - INTANGIBLE ASSETS Sheet http://vislink.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 13 false false R14.htm 00000014 - Disclosure - NOTES PAYABLE Notes http://vislink.com/role/NotesPayable NOTES PAYABLE Notes 14 false false R15.htm 00000015 - Disclosure - LEASES Sheet http://vislink.com/role/Leases LEASES Notes 15 false false R16.htm 00000016 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://vislink.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 16 false false R17.htm 00000017 - Disclosure - STOCK-BASED COMPENSATION Sheet http://vislink.com/role/Stock-basedCompensation STOCK-BASED COMPENSATION Notes 17 false false R18.htm 00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://vislink.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 18 false false R19.htm 00000019 - Disclosure - CONCENTRATIONS Sheet http://vislink.com/role/Concentrations CONCENTRATIONS Notes 19 false false R20.htm 00000020 - Disclosure - REVENUE Sheet http://vislink.com/role/Revenue REVENUE Notes 20 false false R21.htm 00000021 - Disclosure - OTHER INCOME (REBATES) Sheet http://vislink.com/role/OtherIncomeRebates OTHER INCOME (REBATES) Notes 21 false false R22.htm 00000022 - Disclosure - RECLASSIFICATION OF PRIOR YEAR PRESENTATION Sheet http://vislink.com/role/ReclassificationOfPriorYearPresentation RECLASSIFICATION OF PRIOR YEAR PRESENTATION Notes 22 false false R23.htm 00000023 - Disclosure - SUBSEQUENT EVENTS Sheet http://vislink.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 23 false false R24.htm 00000024 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://vislink.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 24 false false R25.htm 00000025 - Disclosure - LOSS PER SHARE (Tables) Sheet http://vislink.com/role/LossPerShareTables LOSS PER SHARE (Tables) Tables http://vislink.com/role/LossPerShare 25 false false R26.htm 00000026 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Tables) Sheet http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesTables FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Tables) Tables http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLosses 26 false false R27.htm 00000027 - Disclosure - CASH AND CASH EQUIVALENTS (Tables) Sheet http://vislink.com/role/CashAndCashEquivalentsTables CASH AND CASH EQUIVALENTS (Tables) Tables http://vislink.com/role/CashAndCashEquivalents 27 false false R28.htm 00000028 - Disclosure - INVESTMENTS (Tables) Sheet http://vislink.com/role/InvestmentsTables INVESTMENTS (Tables) Tables http://vislink.com/role/Investments 28 false false R29.htm 00000029 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://vislink.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://vislink.com/role/IntangibleAssets 29 false false R30.htm 00000030 - Disclosure - NOTES PAYABLE (Tables) Notes http://vislink.com/role/NotesPayableTables NOTES PAYABLE (Tables) Tables http://vislink.com/role/NotesPayable 30 false false R31.htm 00000031 - Disclosure - LEASES (Tables) Sheet http://vislink.com/role/LeasesTables LEASES (Tables) Tables http://vislink.com/role/Leases 31 false false R32.htm 00000032 - Disclosure - STOCKHOLDERS??? EQUITY (Tables) Sheet http://vislink.com/role/StockholdersEquityTables STOCKHOLDERS??? EQUITY (Tables) Tables http://vislink.com/role/StockholdersEquity 32 false false R33.htm 00000033 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://vislink.com/role/Stock-basedCompensationTables STOCK-BASED COMPENSATION (Tables) Tables http://vislink.com/role/Stock-basedCompensation 33 false false R34.htm 00000034 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://vislink.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://vislink.com/role/CommitmentsAndContingencies 34 false false R35.htm 00000035 - Disclosure - REVENUE (Tables) Sheet http://vislink.com/role/RevenueTables REVENUE (Tables) Tables http://vislink.com/role/Revenue 35 false false R36.htm 00000036 - Disclosure - OTHER INCOME (REBATES) (Tables) Sheet http://vislink.com/role/OtherIncomeRebatesTables OTHER INCOME (REBATES) (Tables) Tables http://vislink.com/role/OtherIncomeRebates 36 false false R37.htm 00000037 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION (Details Narrative) Sheet http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative LIQUIDITY AND FINANCIAL CONDITION (Details Narrative) Details http://vislink.com/role/LiquidityAndFinancialCondition 37 false false R38.htm 00000038 - Disclosure - SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE (Details) Sheet http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE (Details) Details 38 false false R39.htm 00000039 - Disclosure - SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details) Sheet http://vislink.com/role/ScheduleOfForeignExchangeAndChangeInAccumulatedComprehensiveIncomeDetails SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details) Details 39 false false R40.htm 00000040 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Details Narrative) Sheet http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Details Narrative) Details http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesTables 40 false false R41.htm 00000041 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) Sheet http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) Details 41 false false R42.htm 00000042 - Disclosure - SCHEDULE OF FAIR VALUE OF ITS INVESTMENTS (Details) Sheet http://vislink.com/role/ScheduleOfFairValueOfItsInvestmentsDetails SCHEDULE OF FAIR VALUE OF ITS INVESTMENTS (Details) Details 42 false false R43.htm 00000043 - Disclosure - SCHEDULE OF INVESTMENTS HELD TO MATURITY (Details) Sheet http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails SCHEDULE OF INVESTMENTS HELD TO MATURITY (Details) Details 43 false false R44.htm 00000044 - Disclosure - INVESTMENTS (Details Narrative) Sheet http://vislink.com/role/InvestmentsDetailsNarrative INVESTMENTS (Details Narrative) Details http://vislink.com/role/InvestmentsTables 44 false false R45.htm 00000045 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) Sheet http://vislink.com/role/ScheduleOfIntangibleAssetsDetails SCHEDULE OF INTANGIBLE ASSETS (Details) Details 45 false false R46.htm 00000046 - Disclosure - SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details) Sheet http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details) Details 46 false false R47.htm 00000047 - Disclosure - SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details) Sheet http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details) Details 47 false false R48.htm 00000048 - Disclosure - SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details) Sheet http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details) Details 48 false false R49.htm 00000049 - Disclosure - INTANGIBLE ASSETS (Details Narrative) Sheet http://vislink.com/role/IntangibleAssetsDetailsNarrative INTANGIBLE ASSETS (Details Narrative) Details http://vislink.com/role/IntangibleAssetsTables 49 false false R50.htm 00000050 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical) Notes http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical) Details 50 false false R51.htm 00000051 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) Notes http://vislink.com/role/ScheduleOfNotesPayableDetails SCHEDULE OF NOTES PAYABLE (Details) Details 51 false false R52.htm 00000052 - Disclosure - SCHEDULE OF OPERATING LEASE DATA (Details) Sheet http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails SCHEDULE OF OPERATING LEASE DATA (Details) Details 52 false false R53.htm 00000053 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) Sheet http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) Details 53 false false R54.htm 00000054 - Disclosure - SCHEDULE OF LEASE OBLIGATION ASSUMED (Details) Sheet http://vislink.com/role/ScheduleOfLeaseObligationAssumedDetails SCHEDULE OF LEASE OBLIGATION ASSUMED (Details) Details 54 false false R55.htm 00000055 - Disclosure - LEASES (Details Narrative) Sheet http://vislink.com/role/LeasesDetailsNarrative LEASES (Details Narrative) Details http://vislink.com/role/LeasesTables 55 false false R56.htm 00000056 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING (Details) Sheet http://vislink.com/role/ScheduleOfWarrantOutstandingDetails SCHEDULE OF WARRANT OUTSTANDING (Details) Details 56 false false R57.htm 00000057 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://vislink.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://vislink.com/role/StockholdersEquityTables 57 false false R58.htm 00000058 - Disclosure - SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE (Details) Sheet http://vislink.com/role/ScheduleOfStock-basedCompensationExpenseDetails SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE (Details) Details 58 false false R59.htm 00000059 - Disclosure - SCHEDULE OF EQUITY COMPENSATION PLANS (Details) Sheet http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails SCHEDULE OF EQUITY COMPENSATION PLANS (Details) Details 59 false false R60.htm 00000060 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative) Sheet http://vislink.com/role/Stock-basedCompensationDetailsNarrative STOCK-BASED COMPENSATION (Details Narrative) Details http://vislink.com/role/Stock-basedCompensationTables 60 false false R61.htm 00000061 - Disclosure - SCHEDULE OF MATCHING CONTRIBUTIONS (Details) Sheet http://vislink.com/role/ScheduleOfMatchingContributionsDetails SCHEDULE OF MATCHING CONTRIBUTIONS (Details) Details 61 false false R62.htm 00000062 - Disclosure - CONCENTRATIONS (Details Narrative) Sheet http://vislink.com/role/ConcentrationsDetailsNarrative CONCENTRATIONS (Details Narrative) Details http://vislink.com/role/Concentrations 62 false false R63.htm 00000063 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details) Sheet http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails SCHEDULE OF DISAGGREGATION OF REVENUE (Details) Details 63 false false R64.htm 00000064 - Disclosure - SCHEDULE OF TAX REBATES (Details) Sheet http://vislink.com/role/ScheduleOfTaxRebatesDetails SCHEDULE OF TAX REBATES (Details) Details 64 false false R65.htm 00000065 - Disclosure - SCHEDULE OF TAX REBATES (Parenthetical) (Details) Sheet http://vislink.com/role/ScheduleOfTaxRebatesParentheticalDetails SCHEDULE OF TAX REBATES (Parenthetical) (Details) Details 65 false false R66.htm 00000066 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://vislink.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://vislink.com/role/SubsequentEvents 66 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: VISL:IncreaseDecreaseInTaxRebates - form10-q.htm 268 form10-q.htm ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm visl-20230630.xsd visl-20230630_cal.xml visl-20230630_def.xml visl-20230630_lab.xml visl-20230630_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 84 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 20, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 883, "http://xbrl.sec.gov/dei/2023": 30 }, "contextCount": 309, "dts": { "calculationLink": { "local": [ "visl-20230630_cal.xml" ] }, "definitionLink": { "local": [ "visl-20230630_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "visl-20230630_lab.xml" ] }, "presentationLink": { "local": [ "visl-20230630_pre.xml" ] }, "schema": { "local": [ "visl-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 492, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 164, "http://vislink.com/20230630": 75, "http://xbrl.sec.gov/dei/2023": 4, "total": 243 }, "keyCustom": 50, "keyStandard": 229, "memberCustom": 43, "memberStandard": 31, "nsprefix": "VISL", "nsuri": "http://vislink.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://vislink.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ForeignCurrencyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES", "menuCat": "Notes", "order": "10", "role": "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLosses", "shortName": "FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ForeignCurrencyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - CASH AND CASH EQUIVALENTS", "menuCat": "Notes", "order": "11", "role": "http://vislink.com/role/CashAndCashEquivalents", "shortName": "CASH AND CASH EQUIVALENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - INVESTMENTS", "menuCat": "Notes", "order": "12", "role": "http://vislink.com/role/Investments", "shortName": "INVESTMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - INTANGIBLE ASSETS", "menuCat": "Notes", "order": "13", "role": "http://vislink.com/role/IntangibleAssets", "shortName": "INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - NOTES PAYABLE", "menuCat": "Notes", "order": "14", "role": "http://vislink.com/role/NotesPayable", "shortName": "NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - LEASES", "menuCat": "Notes", "order": "15", "role": "http://vislink.com/role/Leases", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "menuCat": "Notes", "order": "16", "role": "http://vislink.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - STOCK-BASED COMPENSATION", "menuCat": "Notes", "order": "17", "role": "http://vislink.com/role/Stock-basedCompensation", "shortName": "STOCK-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "18", "role": "http://vislink.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - CONCENTRATIONS", "menuCat": "Notes", "order": "19", "role": "http://vislink.com/role/Concentrations", "shortName": "CONCENTRATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://vislink.com/role/BalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - REVENUE", "menuCat": "Notes", "order": "20", "role": "http://vislink.com/role/Revenue", "shortName": "REVENUE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InterestAndOtherIncomeTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - OTHER INCOME (REBATES)", "menuCat": "Notes", "order": "21", "role": "http://vislink.com/role/OtherIncomeRebates", "shortName": "OTHER INCOME (REBATES)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InterestAndOtherIncomeTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:ReclassificationOfPriorYearPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - RECLASSIFICATION OF PRIOR YEAR PRESENTATION", "menuCat": "Notes", "order": "22", "role": "http://vislink.com/role/ReclassificationOfPriorYearPresentation", "shortName": "RECLASSIFICATION OF PRIOR YEAR PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:ReclassificationOfPriorYearPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "23", "role": "http://vislink.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:NatureOfOperationsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "24", "role": "http://vislink.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:NatureOfOperationsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - LOSS PER SHARE (Tables)", "menuCat": "Tables", "order": "25", "role": "http://vislink.com/role/LossPerShareTables", "shortName": "LOSS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:ForeignCurrencyDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Tables)", "menuCat": "Tables", "order": "26", "role": "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesTables", "shortName": "FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ForeignCurrencyDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - CASH AND CASH EQUIVALENTS (Tables)", "menuCat": "Tables", "order": "27", "role": "http://vislink.com/role/CashAndCashEquivalentsTables", "shortName": "CASH AND CASH EQUIVALENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - INVESTMENTS (Tables)", "menuCat": "Tables", "order": "28", "role": "http://vislink.com/role/InvestmentsTables", "shortName": "INVESTMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - INTANGIBLE ASSETS (Tables)", "menuCat": "Tables", "order": "29", "role": "http://vislink.com/role/IntangibleAssetsTables", "shortName": "INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://vislink.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - NOTES PAYABLE (Tables)", "menuCat": "Tables", "order": "30", "role": "http://vislink.com/role/NotesPayableTables", "shortName": "NOTES PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - LEASES (Tables)", "menuCat": "Tables", "order": "31", "role": "http://vislink.com/role/LeasesTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)", "menuCat": "Tables", "order": "32", "role": "http://vislink.com/role/StockholdersEquityTables", "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - STOCK-BASED COMPENSATION (Tables)", "menuCat": "Tables", "order": "33", "role": "http://vislink.com/role/Stock-basedCompensationTables", "shortName": "STOCK-BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "menuCat": "Tables", "order": "34", "role": "http://vislink.com/role/CommitmentsAndContingenciesTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - REVENUE (Tables)", "menuCat": "Tables", "order": "35", "role": "http://vislink.com/role/RevenueTables", "shortName": "REVENUE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:InterestAndOtherIncomeTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:ScheduleOfTaxRebatesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - OTHER INCOME (REBATES) (Tables)", "menuCat": "Tables", "order": "36", "role": "http://vislink.com/role/OtherIncomeRebatesTables", "shortName": "OTHER INCOME (REBATES) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InterestAndOtherIncomeTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:ScheduleOfTaxRebatesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION (Details Narrative)", "menuCat": "Details", "order": "37", "role": "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "shortName": "LIQUIDITY AND FINANCIAL CONDITION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "VISL:LiquidityAndFinancialConditionTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31_custom_FederalBondsMember", "decimals": "-5", "lang": null, "name": "us-gaap:HeldToMaturitySecuritiesFairValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE (Details)", "menuCat": "Details", "order": "38", "role": "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails", "shortName": "SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ForeignCurrencyDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details)", "menuCat": "Details", "order": "39", "role": "http://vislink.com/role/ScheduleOfForeignExchangeAndChangeInAccumulatedComprehensiveIncomeDetails", "shortName": "SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ForeignCurrencyDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss", "shortName": "Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "lang": null, "name": "us-gaap:LaborAndRelatedExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ForeignCurrencyDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_GBPToUSDMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Details Narrative)", "menuCat": "Details", "order": "40", "role": "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative", "shortName": "FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ForeignCurrencyDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_GBPToUSDMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Details)", "menuCat": "Details", "order": "41", "role": "http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails", "shortName": "SCHEDULE OF CASH AND CASH EQUIVALENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "us-gaap:InvestmentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - SCHEDULE OF FAIR VALUE OF ITS INVESTMENTS (Details)", "menuCat": "Details", "order": "42", "role": "http://vislink.com/role/ScheduleOfFairValueOfItsInvestmentsDetails", "shortName": "SCHEDULE OF FAIR VALUE OF ITS INVESTMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "us-gaap:InvestmentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_us-gaap_FairValueInputsLevel2Member", "decimals": "-3", "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:HeldToMaturitySecuritiesTextBlock", "us-gaap:InvestmentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - SCHEDULE OF INVESTMENTS HELD TO MATURITY (Details)", "menuCat": "Details", "order": "43", "role": "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails", "shortName": "SCHEDULE OF INVESTMENTS HELD TO MATURITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:HeldToMaturitySecuritiesTextBlock", "us-gaap:InvestmentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:InvestmentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-02-28", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - INVESTMENTS (Details Narrative)", "menuCat": "Details", "order": "44", "role": "http://vislink.com/role/InvestmentsDetailsNarrative", "shortName": "INVESTMENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:InvestmentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-02-01", "decimals": "0", "lang": null, "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "VISL:BeginningBalanceCostAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)", "menuCat": "Details", "order": "45", "role": "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails", "shortName": "SCHEDULE OF INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "VISL:BeginningBalanceCostAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details)", "menuCat": "Details", "order": "46", "role": "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "shortName": "SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_ProprietaryTechnologyMember", "decimals": "0", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details)", "menuCat": "Details", "order": "47", "role": "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "shortName": "SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details)", "menuCat": "Details", "order": "48", "role": "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails", "shortName": "SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - INTANGIBLE ASSETS (Details Narrative)", "menuCat": "Details", "order": "49", "role": "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "shortName": "INTANGIBLE ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statement of Changes in Stockholders' Equity (Unaudited)", "menuCat": "Statements", "order": "5", "role": "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity", "shortName": "Consolidated Statement of Changes in Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:InvestmentTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-02-28", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical)", "menuCat": "Details", "order": "50", "role": "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical", "shortName": "SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-04-05_custom_DAndOInsurancePolicyRenewedMember_custom_NotesPayableOneMember", "decimals": "0", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayableCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details)", "menuCat": "Details", "order": "51", "role": "http://vislink.com/role/ScheduleOfNotesPayableDetails", "shortName": "SCHEDULE OF NOTES PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_NotesPayableOneMember", "decimals": "0", "lang": null, "name": "us-gaap:NotesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - SCHEDULE OF OPERATING LEASE DATA (Details)", "menuCat": "Details", "order": "52", "role": "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails", "shortName": "SCHEDULE OF OPERATING LEASE DATA (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details)", "menuCat": "Details", "order": "53", "role": "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "shortName": "SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - SCHEDULE OF LEASE OBLIGATION ASSUMED (Details)", "menuCat": "Details", "order": "54", "role": "http://vislink.com/role/ScheduleOfLeaseObligationAssumedDetails", "shortName": "SCHEDULE OF LEASE OBLIGATION ASSUMED (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "VISL:ScheduleOfLeaseObligationsAssumedTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_ColchesterUKWatersideHouseMember", "decimals": "0", "lang": null, "name": "us-gaap:AreaOfLand", "reportCount": 1, "unique": true, "unitRef": "SquareFeet", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - LEASES (Details Narrative)", "menuCat": "Details", "order": "55", "role": "http://vislink.com/role/LeasesDetailsNarrative", "shortName": "LEASES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-5", "lang": null, "name": "VISL:OperatingLeaseRightOfUseAssetAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING (Details)", "menuCat": "Details", "order": "56", "role": "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails", "shortName": "SCHEDULE OF WARRANT OUTSTANDING (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "menuCat": "Details", "order": "57", "role": "http://vislink.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-05-20", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE (Details)", "menuCat": "Details", "order": "58", "role": "http://vislink.com/role/ScheduleOfStock-basedCompensationExpenseDetails", "shortName": "SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-06-30_custom_LongTermStockIncentivePlanAwardsMember", "decimals": "-3", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_LongTermStockIncentivePlanAwardsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - SCHEDULE OF EQUITY COMPENSATION PLANS (Details)", "menuCat": "Details", "order": "59", "role": "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails", "shortName": "SCHEDULE OF EQUITY COMPENSATION PLANS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_LongTermStockIncentivePlanAwardsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://vislink.com/role/StatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "lang": null, "name": "VISL:UnrealizedLossOnFairValueOfInvestmentInBondsHeldToMaturity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-06-30_us-gaap_RestrictedStockUnitsRSUMember", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:DescriptionOfEquityAwardsVestingPercentageAndMaturityTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)", "menuCat": "Details", "order": "60", "role": "http://vislink.com/role/Stock-basedCompensationDetailsNarrative", "shortName": "STOCK-BASED COMPENSATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-06-30_us-gaap_RestrictedStockUnitsRSUMember", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:DescriptionOfEquityAwardsVestingPercentageAndMaturityTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30_custom_GroupPersonalPensionPlanUKMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanCostRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - SCHEDULE OF MATCHING CONTRIBUTIONS (Details)", "menuCat": "Details", "order": "61", "role": "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "shortName": "SCHEDULE OF MATCHING CONTRIBUTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30_custom_GroupPersonalPensionPlanUKMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanCostRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - CONCENTRATIONS (Details Narrative)", "menuCat": "Details", "order": "62", "role": "http://vislink.com/role/ConcentrationsDetailsNarrative", "shortName": "CONCENTRATIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details)", "menuCat": "Details", "order": "63", "role": "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "shortName": "SCHEDULE OF DISAGGREGATION OF REVENUE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30_custom_EquipmentSalesMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "VISL:ScheduleOfTaxRebatesTableTextBlock", "us-gaap:InterestAndOtherIncomeTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30_custom_UKSubsidiaryMember", "decimals": "-3", "first": true, "lang": null, "name": "VISL:IncreaseDecreaseInTaxRebates", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - SCHEDULE OF TAX REBATES (Details)", "menuCat": "Details", "order": "64", "role": "http://vislink.com/role/ScheduleOfTaxRebatesDetails", "shortName": "SCHEDULE OF TAX REBATES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "VISL:ScheduleOfTaxRebatesTableTextBlock", "us-gaap:InterestAndOtherIncomeTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30_custom_UKSubsidiaryMember", "decimals": "-3", "first": true, "lang": null, "name": "VISL:IncreaseDecreaseInTaxRebates", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "VISL:ScheduleOfTaxRebatesTableTextBlock", "us-gaap:InterestAndOtherIncomeTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-03-31_custom_GBPToUSDMember", "decimals": "-3", "first": true, "lang": null, "name": "VISL:IncreaseDecreaseInTaxRebates", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - SCHEDULE OF TAX REBATES (Parenthetical) (Details)", "menuCat": "Details", "order": "65", "role": "http://vislink.com/role/ScheduleOfTaxRebatesParentheticalDetails", "shortName": "SCHEDULE OF TAX REBATES (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "VISL:ScheduleOfTaxRebatesTableTextBlock", "us-gaap:InterestAndOtherIncomeTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-03-31_custom_GBPToUSDMember", "decimals": "-3", "first": true, "lang": null, "name": "VISL:IncreaseDecreaseInTaxRebates", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-09-012023-09-30_srt_ScenarioForecastMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:SeveranceCosts1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "menuCat": "Details", "order": "66", "role": "http://vislink.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-09-012023-09-30_srt_ScenarioForecastMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:SeveranceCosts1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "7", "role": "http://vislink.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies", "shortName": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:LiquidityAndFinancialConditionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION", "menuCat": "Notes", "order": "8", "role": "http://vislink.com/role/LiquidityAndFinancialCondition", "shortName": "LIQUIDITY AND FINANCIAL CONDITION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:LiquidityAndFinancialConditionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - LOSS PER SHARE", "menuCat": "Notes", "order": "9", "role": "http://vislink.com/role/LossPerShare", "shortName": "LOSS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 78, "tag": { "VISL_AccretionOfBondDiscount": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accretion of bond discount.", "label": "AccretionOfBondDiscount", "negatedLabel": "Accretion of bond discount" } } }, "localname": "AccretionOfBondDiscount", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_AccumulatedComprehensiveIncomeUnrealizedLossOnCurrencyTranslationAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated comprehensive income unrealized loss on currency translation adjustment.", "label": "Unrealized (gains) losses on currency translation adjustment" } } }, "localname": "AccumulatedComprehensiveIncomeUnrealizedLossOnCurrencyTranslationAdjustment", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfForeignExchangeAndChangeInAccumulatedComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "VISL_AllowanceForCreditLossesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Allowance for Credit Losses [Policy Text Block]", "label": "Allowance for credit losses" } } }, "localname": "AllowanceForCreditLossesPolicyTextBlock", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "VISL_AmortizationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amortization period.", "label": "Services previously accrued" } } }, "localname": "AmortizationPeriod", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "durationItemType" }, "VISL_AreaOfLandDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land description.", "label": "Area of land description" } } }, "localname": "AreaOfLandDescription", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "VISL_BeginningBalanceCostAccumulatedAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Beginning balance cost accumulated amortization.", "label": "BeginningBalanceCostAccumulatedAmortization", "periodStartLabel": "Beginning balance net" } } }, "localname": "BeginningBalanceCostAccumulatedAmortization", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "VISL_BillericaMaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Billerica, MA [Member].", "label": "Billerica, MA [Member]" } } }, "localname": "BillericaMaMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfLeaseObligationAssumedDetails" ], "xbrltype": "domainItemType" }, "VISL_CashUsedForInvestmentInSecuritiesHeldToMaturity": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash used for investment in securities held to maturity.", "label": "CashUsedForInvestmentInSecuritiesHeldToMaturity", "negatedLabel": "Cash used for investments held to maturity" } } }, "localname": "CashUsedForInvestmentInSecuritiesHeldToMaturity", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_ColchesterUKWatersideHouseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Colchester, U.K. - Waterside House [Member].", "label": "Colchester, U.K. - Waterside House [Member]." } } }, "localname": "ColchesterUKWatersideHouseMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfLeaseObligationAssumedDetails" ], "xbrltype": "domainItemType" }, "VISL_CommonStockIssuedInConnectionWithAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock issued in connection with abstract.", "label": "Common stock issued in connection with:" } } }, "localname": "CommonStockIssuedInConnectionWithAbstract", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "VISL_CommonStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock Warrants [Member]", "label": "Common Stock Warrants [Member]" } } }, "localname": "CommonStockWarrantsMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_CompensationAwardsPreviouslyAccrued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Compensation awards previously accrued.", "label": "Compensation awards previously accrued" } } }, "localname": "CompensationAwardsPreviouslyAccrued", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One [Member]", "label": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Two [Member]", "label": "Customer Two [Member]" } } }, "localname": "CustomerTwoMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_DAndOInsurancePolicyRenewedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "D & O Insurance Policy Renewed [Member]", "label": "D & O Insurance Policy Renewed [Member]" } } }, "localname": "DAndOInsurancePolicyRenewedMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "domainItemType" }, "VISL_DIFXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DIFX [Member]", "label": "DIFX [Member]" } } }, "localname": "DIFXMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_DebtInstrumentDownPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt instrument down payment.", "label": "Debt instrument down payment" } } }, "localname": "DebtInstrumentDownPayment", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "monetaryItemType" }, "VISL_DescriptionOfEquityAwardsVestingPercentageAndMaturityTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of equity awards vesting percentage and maturity term.", "label": "Description of equity awards vesting percentage and maturity term" } } }, "localname": "DescriptionOfEquityAwardsVestingPercentageAndMaturityTerm", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "VISL_DisclosureLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases", "terseLabel": "Schedule Of Future Minimum Rental Payments For Operating Leases", "verboseLabel": "Schedule Of Operating Lease Data" } } }, "localname": "DisclosureLeasesAbstract", "nsuri": "http://vislink.com/20230630", "xbrltype": "stringItemType" }, "VISL_DisclosureLiquidityAndFinancialConditionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity And Financial Condition" } } }, "localname": "DisclosureLiquidityAndFinancialConditionAbstract", "nsuri": "http://vislink.com/20230630", "xbrltype": "stringItemType" }, "VISL_DisclosureReclassificationOfPriorYearPresentationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reclassification Of Prior Year Presentation" } } }, "localname": "DisclosureReclassificationOfPriorYearPresentationAbstract", "nsuri": "http://vislink.com/20230630", "xbrltype": "stringItemType" }, "VISL_EndingBalanceCostAccumulatedAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Ending Balance Cost Accumulated Amortization.", "label": "EndingBalanceCostAccumulatedAmortization", "periodEndLabel": "Ending balance net" } } }, "localname": "EndingBalanceCostAccumulatedAmortization", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "VISL_EquipmentSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment Sales [Member]", "label": "Equipment Sales [Member]" } } }, "localname": "EquipmentSalesMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "VISL_EuroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Euro [Member]", "label": "Euro [Member]" } } }, "localname": "EuroMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_EuroToGBPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Euro To GBP [Member]", "label": "Euro To GBP [Member]" } } }, "localname": "EuroToGBPMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_FederalBackedMutualFundMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Federal Backed Mutual Fund [Member]", "label": "Federal Backed Mutual Fund [Member]" } } }, "localname": "FederalBackedMutualFundMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "xbrltype": "domainItemType" }, "VISL_FederalBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Federal Bonds [Member]", "label": "Federal Bonds [Member]" } } }, "localname": "FederalBondsMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/ScheduleOfFairValueOfItsInvestmentsDetails" ], "xbrltype": "domainItemType" }, "VISL_FederalHomeLoanBanksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Federal Home Loan Banks [Member]", "label": "Federal Home Loan Banks [Member]" } } }, "localname": "FederalHomeLoanBanksMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_FederalNationalMortgageAssociationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Federal National Mortgage Association [Member]", "label": "Federal National Mortgage Association [Member]" } } }, "localname": "FederalNationalMortgageAssociationMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_FederallyInsuredMoneyMarketMutualFunds": { "auth_ref": [], "calculation": { "http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails": { "order": 2.0, "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Federally insured money market mutual funds.", "label": "Federally insured money market mutual funds" } } }, "localname": "FederallyInsuredMoneyMarketMutualFunds", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "VISL_GBPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "GBP [Member]", "label": "GBP [Member]" } } }, "localname": "GBPMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_GBPToUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "GBP To USD [Member]", "label": "GBP To USD [Member]" } } }, "localname": "GBPToUSDMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative", "http://vislink.com/role/ScheduleOfTaxRebatesParentheticalDetails" ], "xbrltype": "domainItemType" }, "VISL_GainLossFromInitialRecognitionOfExchangeRate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Gain loss from initial recognition of exchange rate" } } }, "localname": "GainLossFromInitialRecognitionOfExchangeRate", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfTaxRebatesParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "VISL_GroupPersonalPensionPlanUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Group Personal Pension Plan, UK [Member]", "label": "Group Personal Pension Plan, UK [Member]" } } }, "localname": "GroupPersonalPensionPlanUKMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails" ], "xbrltype": "domainItemType" }, "VISL_HemelUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hemel, UK [Member].", "label": "Hemel, UK [Member]" } } }, "localname": "HemelUKMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfLeaseObligationAssumedDetails" ], "xbrltype": "domainItemType" }, "VISL_IncreaseDecreaseInTaxRebates": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (decrease) in tax rebates.", "label": "Tax rebate", "verboseLabel": "Increase (decrease) in tax rebates" } } }, "localname": "IncreaseDecreaseInTaxRebates", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfTaxRebatesDetails", "http://vislink.com/role/ScheduleOfTaxRebatesParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "VISL_InstallationIntegrationAndRepairsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Installation, Integration and Repairs [Member]", "label": "Installation, Integration and Repairs [Member]" } } }, "localname": "InstallationIntegrationAndRepairsMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "VISL_IntrinsicValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intrinsic value per share.", "label": "Intrinsic value per share" } } }, "localname": "IntrinsicValuePerShare", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "perShareItemType" }, "VISL_InventoryValuationAdjustments": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventory valuation adjustments.", "label": "Inventory valuation adjustments" } } }, "localname": "InventoryValuationAdjustments", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "VISL_IssuanceOfCommonStockInConnectionWithAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock in connection with abstract.", "label": "Issuance of common stock in connection with:" } } }, "localname": "IssuanceOfCommonStockInConnectionWithAbstract", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "VISL_LeaseExpirationDateDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease expiration date description.", "label": "Lease-End Date" } } }, "localname": "LeaseExpirationDateDescription", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfLeaseObligationAssumedDetails" ], "xbrltype": "stringItemType" }, "VISL_LiquidityAndFinancialConditionTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liquidity and financial condition [Text block]", "label": "LIQUIDITY AND FINANCIAL CONDITION" } } }, "localname": "LiquidityAndFinancialConditionTextBlock", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialCondition" ], "xbrltype": "textBlockItemType" }, "VISL_LongTermStockIncentivePlanAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long Term Stock Incentive Plan Awards [Member]", "label": "Long Term Stock Incentive Plan Awards [Member]" } } }, "localname": "LongTermStockIncentivePlanAwardsMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails", "http://vislink.com/role/ScheduleOfStock-basedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "VISL_LutonUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Luton UK [Member]", "label": "Luton UK [Member]" } } }, "localname": "LutonUKMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_MountOliveNJMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mount Olive, NJ [Member]", "label": "Mount Olive, NJ [Member]" } } }, "localname": "MountOliveNJMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfLeaseObligationAssumedDetails" ], "xbrltype": "domainItemType" }, "VISL_NatureOfOperationsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nature of Operations [Policy Text Block]", "label": "Nature of Operations" } } }, "localname": "NatureOfOperationsPolicyTextBlock", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "VISL_NoncashChangesToOperatingLeaseLiabilitiesAccretion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Noncash changes to operating lease liabilities accretion.", "label": "Less: non-cash changes to operating lease liabilities accretion" } } }, "localname": "NoncashChangesToOperatingLeaseLiabilitiesAccretion", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_NoncashDisclosuresOfRouAssetsAndOperatingLeaseObligationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non cash disclosures of rou assets and operating lease obligation abstract.", "label": "ROU assets and operating lease obligations recognized (Note 6):" } } }, "localname": "NoncashDisclosuresOfRouAssetsAndOperatingLeaseObligationAbstract", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "VISL_NotesPayableOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes Payable One [Member]", "label": "Notes Payable One [Member]" } } }, "localname": "NotesPayableOneMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "domainItemType" }, "VISL_NotesPayableTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes Payable Two [Member]", "label": "Notes Payable Two [Member]" } } }, "localname": "NotesPayableTwoMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "domainItemType" }, "VISL_OneVendorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Vendor [Member]", "label": "One Vendor [Member]" } } }, "localname": "OneVendorMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_OperatingLeaseAssetAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating lease asset amortization.", "label": "OperatingLeaseAssetAmortization", "negatedLabel": "Less: non-cash changes to operating lease assets amortization" } } }, "localname": "OperatingLeaseAssetAmortization", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_OperatingLeaseAssetsRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating lease assets recognized.", "label": "Operating lease assets recognized" } } }, "localname": "OperatingLeaseAssetsRecognized", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_OperatingLeaseLiabilitiesRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating lease liabilities recognized.", "label": "Operating lease liabilities recognized" } } }, "localname": "OperatingLeaseLiabilitiesRecognized", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_OperatingLeaseRightOfUseAssetAccumulatedAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating lease accumulated amortization.", "label": "Right of use assets, accumulated depreciation" } } }, "localname": "OperatingLeaseRightOfUseAssetAccumulatedAmortization", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "VISL_PatentsAndLicensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Patents and Licenses [Member]", "label": "Patents and Licenses [Member]" } } }, "localname": "PatentsAndLicensesMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "VISL_PerformanceBasedRestrictedStockAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Based Restricted Stock Awards [Member]", "label": "Performance Based Restricted Stock Awards [Member]" } } }, "localname": "PerformanceBasedRestrictedStockAwardsMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails", "http://vislink.com/role/ScheduleOfStock-basedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "VISL_PerformanceBasedRestrictedStockAwardsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Based Restricted Stock Awards One [Member]", "label": "Performance Based Restricted Stock Awards One [Member]" } } }, "localname": "PerformanceBasedRestrictedStockAwardsOneMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "VISL_PerformanceBasedRestrictedStockAwardsTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Based Restricted Stock Awards Two [Member]", "label": "Performance Based Restricted Stock Awards Two [Member]" } } }, "localname": "PerformanceBasedRestrictedStockAwardsTwoMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "VISL_PerformanceBasedStockOptionInducementAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Based Stock Option Inducement Awards [Member]", "label": "Performance Based Stock Option Inducement Awards [Member]" } } }, "localname": "PerformanceBasedStockOptionInducementAwardsMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "VISL_PerformanceBasedStockOptionInducementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Based Stock Option Inducement [Member]", "label": "Performance Based Stock Option Inducement [Member]" } } }, "localname": "PerformanceBasedStockOptionInducementMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfStock-basedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "VISL_ProprietaryTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Proprietary Technology [Member]", "label": "Proprietary Technology [Member]" } } }, "localname": "ProprietaryTechnologyMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "VISL_PurchaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase [Member]", "label": "Purchase [Member]" } } }, "localname": "PurchaseMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_ROUAssetsAndOperatingLeaseObligationsRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "ROU assets and operating lease obligations recognized.", "label": "ROU assets and operating lease obligations recognized" } } }, "localname": "ROUAssetsAndOperatingLeaseObligationsRecognized", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_ReclassificationOfPriorYearPresentationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reclassification of Prior Year Presentation [Text Block]", "label": "RECLASSIFICATION OF PRIOR YEAR PRESENTATION" } } }, "localname": "ReclassificationOfPriorYearPresentationTextBlock", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ReclassificationOfPriorYearPresentation" ], "xbrltype": "textBlockItemType" }, "VISL_RecognizationOfOperatingLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating lease liabilities recognized.", "label": "Operating lease liabilities recognized [Default Label]", "verboseLabel": "Operating lease liabilities recognized" } } }, "localname": "RecognizationOfOperatingLeaseLiabilities", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_RecoveryOfBadDebt": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Recovery of bad debt.", "label": "RecoveryOfBadDebt", "negatedLabel": "Recovery of bad debt" } } }, "localname": "RecoveryOfBadDebt", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_RemainingStockCompensationExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining stock compensation expenses.", "label": "Remaining compensation expense" } } }, "localname": "RemainingStockCompensationExpenses", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "monetaryItemType" }, "VISL_RestOfWorldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rest of World [Member]", "label": "Rest of World [Member]" } } }, "localname": "RestOfWorldMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "VISL_SatisfactionOfAccountsPayableVendorBalance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Satisfaction of accounts payable vendor balance.", "label": "Satisfaction of accounts payable vendor balance" } } }, "localname": "SatisfactionOfAccountsPayableVendorBalance", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "VISL_SatisfactionOfAccountsPayableVendorBalanceShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Satisfaction of accounts payable vendor balance shares.", "label": "Satisfaction of accounts payable vendor balance, shares" } } }, "localname": "SatisfactionOfAccountsPayableVendorBalanceShares", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "VISL_SatisfactionOfWithholdingTaxUponConversionOfRestrictedStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Satisfaction of withholding tax upon conversion of restricted stock units.", "label": "Satisfaction of withholding tax upon conversion of restricted stock units" } } }, "localname": "SatisfactionOfWithholdingTaxUponConversionOfRestrictedStockUnits", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "VISL_SatisfactionOfWithholdingTaxUponConversionOfRestrictedStockUnitsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Satisfaction of withholding tax upon conversion of restricted stock units shares.", "label": "Satisfaction of withholding tax upon conversion of restricted stock units, shares" } } }, "localname": "SatisfactionOfWithholdingTaxUponConversionOfRestrictedStockUnitsShares", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "VISL_SatisfactionWithConversionOfRestrictedStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Satisfaction with conversion of restricted stock units.", "label": "Satisfaction with the conversion of restricted stock units" } } }, "localname": "SatisfactionWithConversionOfRestrictedStockUnits", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "VISL_SatisfactionWithTheConversionOfRestrictedStockUnitsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Satisfaction of withholding tax upon conversion.", "label": "Satisfaction with the conversion of restricted stock units, shares" } } }, "localname": "SatisfactionWithTheConversionOfRestrictedStockUnitsShares", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "VISL_ScheduleOfLeaseObligationsAssumedTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of lease obligations assumed [Table Text Block].", "label": "SCHEDULE OF LEASE OBLIGATION ASSUMED" } } }, "localname": "ScheduleOfLeaseObligationsAssumedTableTextBlock", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "VISL_ScheduleOfTaxRebatesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Tax Rebates [Table Text Block]", "label": "SCHEDULE OF TAX REBATES" } } }, "localname": "ScheduleOfTaxRebatesTableTextBlock", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/OtherIncomeRebatesTables" ], "xbrltype": "textBlockItemType" }, "VISL_SettlementOfAmountsDueAccountsPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Settlement of amounts due accounts payable.", "label": "Settlement of accounts payable" } } }, "localname": "SettlementOfAmountsDueAccountsPayable", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options outstanding and exercisable weighted average remaining contractual terms.", "label": "[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "durationItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Exercise Price.", "label": "Weighted average exercise price ending exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableOutstandingWeightedAverageExercisePrice", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Exercise Price.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice", "periodEndLabel": "Weighted Average Exercise Price, ending outstanding", "periodStartLabel": "Weighted Average Exercise Price, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails" ], "xbrltype": "perShareItemType" }, "VISL_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Exercise Price, cancelled/expired.", "label": "Weighted Average Exercise Price, Warrants granted, exercised, canceled, or expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails" ], "xbrltype": "perShareItemType" }, "VISL_ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation shares authorized under stock other than option plans exercise price.", "label": "Share based compensation shares authorized under stock other than option plans exercise price" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePrice", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "perShareItemType" }, "VISL_StockIssuanceCommitments": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock issuance commitments.", "label": "Stock issuance commitments" } } }, "localname": "StockIssuanceCommitments", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_StockIssuedDuringPeriodSharesCompensationAwardsForServicesPreviouslyAccrued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares compensation awards for services previously accrued.", "label": "Compensation awards for services previously accrued, shares" } } }, "localname": "StockIssuedDuringPeriodSharesCompensationAwardsForServicesPreviouslyAccrued", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "VISL_StockIssuedDuringPeriodSharesEliminationOfSeriesAPreferredStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares elimination of series A preferred stock.", "label": "Elimination of Series A Preferred Stock, shares" } } }, "localname": "StockIssuedDuringPeriodSharesEliminationOfSeriesAPreferredStock", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "VISL_StockIssuedDuringPeriodValueCompensationAwardsForServicesPreviouslyAccrued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value compensation awards for services previously accrued.", "label": "Compensation awards for services previously accrued" } } }, "localname": "StockIssuedDuringPeriodValueCompensationAwardsForServicesPreviouslyAccrued", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "VISL_StockIssuedDuringPeriodValueEliminationOfSeriesAPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value elimination of series A preferred stock.", "label": "Elimination of Series A Preferred Stock" } } }, "localname": "StockIssuedDuringPeriodValueEliminationOfSeriesAPreferredStock", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "VISL_TimeBasedRestrictedStockAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Time Based Restricted Stock Awards [Member]", "label": "Time Based Restricted Stock Awards [Member]" } } }, "localname": "TimeBasedRestrictedStockAwardsMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails", "http://vislink.com/role/ScheduleOfStock-basedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "VISL_TimeBasedRestrictedStockAwardsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Time Based Restricted Stock Awards One [Member]", "label": "Time Based Restricted Stock Awards One [Member]" } } }, "localname": "TimeBasedRestrictedStockAwardsOneMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "VISL_TimeBasedRestrictedStockAwardsTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Time Based Restricted Stock Awards Two [Member]", "label": "Time Based Restricted Stock Awards Two [Member]" } } }, "localname": "TimeBasedRestrictedStockAwardsTwoMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "VISL_TimeVestedOptionInducementAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Time Vested Option Inducement Awards [Member]", "label": "Time Vested Option Inducement Awards [Member]" } } }, "localname": "TimeVestedOptionInducementAwardsMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails", "http://vislink.com/role/ScheduleOfStock-basedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "VISL_TradeNamesAndTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trade Names And Technology [Member]", "label": "Trade Names And Technology [Member]" } } }, "localname": "TradeNamesAndTechnologyMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "VISL_UKSubsidiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "UK Subsidiary [Member]", "label": "UK Subsidiary [Member]" } } }, "localname": "UKSubsidiaryMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfTaxRebatesDetails" ], "xbrltype": "domainItemType" }, "VISL_UnrealizedLossOnFairValueOfInvestmentInBondsHeldToMaturity": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unrealized loss on fair value of investment in bonds held to maturity.", "label": "Unrealized loss on the fair value of investments in bonds held to maturity" } } }, "localname": "UnrealizedLossOnFairValueOfInvestmentInBondsHeldToMaturity", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_VendorOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor one [Member]", "label": "Vendor One [Member]" } } }, "localname": "VendorOneMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_VendorTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor two [Member]", "label": "Vendor Two [Member]" } } }, "localname": "VendorTwoMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_WarrantiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warranties [Member]", "label": "Warranties [Member]" } } }, "localname": "WarrantiesMember", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "VISL_WorkingCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital.", "label": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://vislink.com/20230630", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "country_GB": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED KINGDOM" } } }, "localname": "GB", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "country_NL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NETHERLANDS" } } }, "localname": "NL", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "country_SG": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SINGAPORE" } } }, "localname": "SG", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://vislink.com/role/ScheduleOfLeaseObligationAssumedDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r714" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r714" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r711", "r713", "r714" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r715" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r703" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r706" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r702" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r702" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r719" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r702" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r716" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r714" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r702" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r702" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r702" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r702" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r717" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r707" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r708" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r701" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r705" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r704" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r709" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r710" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r718" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_AsiaMember": { "auth_ref": [ "r847", "r848", "r849", "r850" ], "lang": { "en-us": { "role": { "label": "Asia [Member]" } } }, "localname": "AsiaMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [ "r847", "r848", "r849", "r850" ], "lang": { "en-us": { "role": { "label": "Europe [Member]" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r236", "r672", "r791", "r839", "r840" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r288", "r289", "r290", "r291", "r367", "r499", "r527", "r559", "r560", "r618", "r620", "r622", "r623", "r629", "r651", "r652", "r662", "r669", "r680", "r684", "r788", "r830", "r831", "r832", "r833", "r834", "r835" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r288", "r289", "r290", "r291", "r367", "r499", "r527", "r559", "r560", "r618", "r620", "r622", "r623", "r629", "r651", "r652", "r662", "r669", "r680", "r684", "r788", "r830", "r831", "r832", "r833", "r834", "r835" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r236", "r672", "r791", "r839", "r840" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [ "r847", "r848", "r849", "r850" ], "lang": { "en-us": { "role": { "label": "North America [Member]" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_PlatformOperatorCryptoAssetLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Platform Operator, Crypto-Asset [Line Items]" } } }, "localname": "PlatformOperatorCryptoAssetLineItems", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueOfItsInvestmentsDetails" ], "xbrltype": "stringItemType" }, "srt_PlatformOperatorCryptoAssetTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Platform Operator, Crypto-Asset [Table]" } } }, "localname": "PlatformOperatorCryptoAssetTable", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueOfItsInvestmentsDetails" ], "xbrltype": "stringItemType" }, "srt_RangeAxis": { "auth_ref": [ "r288", "r289", "r290", "r291", "r359", "r367", "r396", "r397", "r398", "r475", "r499", "r527", "r559", "r560", "r618", "r620", "r622", "r623", "r629", "r651", "r652", "r662", "r669", "r680", "r684", "r687", "r784", "r788", "r831", "r832", "r833", "r834", "r835" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r288", "r289", "r290", "r291", "r359", "r367", "r396", "r397", "r398", "r475", "r499", "r527", "r559", "r560", "r618", "r620", "r622", "r623", "r629", "r651", "r652", "r662", "r669", "r680", "r684", "r687", "r784", "r788", "r831", "r832", "r833", "r834", "r835" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r368", "r756" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r198", "r368", "r721", "r756" ], "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r234", "r235", "r555", "r556", "r557", "r619", "r621", "r624", "r632", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r653", "r671", "r687", "r791", "r839" ], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://vislink.com/role/ScheduleOfLeaseObligationAssumedDetails", "http://vislink.com/role/ScheduleOfTaxRebatesDetails", "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_SouthAmericaMember": { "auth_ref": [ "r847", "r848", "r849", "r850" ], "lang": { "en-us": { "role": { "label": "South America [Member]" } } }, "localname": "SouthAmericaMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r234", "r235", "r555", "r556", "r557", "r619", "r621", "r624", "r632", "r639", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r653", "r671", "r687", "r791", "r839" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://vislink.com/role/ScheduleOfLeaseObligationAssumedDetails", "http://vislink.com/role/ScheduleOfTaxRebatesDetails", "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r198", "r368", "r721", "r723", "r756" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r17", "r683" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableMember": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Obligations incurred and payable to vendors for goods and services received.", "label": "Accounts Payable [Member]" } } }, "localname": "AccountsPayableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r640" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r237", "r238" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r21" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r28", "r29", "r101", "r162", "r516", "r532", "r533" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.", "label": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r2", "r9", "r29", "r422", "r425", "r465", "r528", "r529", "r741", "r742", "r743", "r753", "r754", "r755" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r94", "r683", "r842" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r404", "r405", "r406", "r542", "r753", "r754", "r755", "r818", "r845" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r7", "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization", "negatedLabel": "Intangible assets, Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r70", "r71", "r371" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r400", "r408" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Stock compensation costs", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfStock-basedCompensationExpenseDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r7", "r46", "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of intangible assets", "negatedLabel": "Intangible assets, net Amortization" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Total" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AreaOfLand": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land held.", "label": "Area of land" } } }, "localname": "AreaOfLand", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfLeaseObligationAssumedDetails", "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "areaItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r130", "r158", "r183", "r215", "r227", "r231", "r270", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r417", "r419", "r435", "r509", "r582", "r683", "r695", "r786", "r787", "r828" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r153", "r164", "r183", "r270", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r417", "r419", "r435", "r683", "r786", "r787", "r828" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r183", "r270", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r417", "r419", "r435", "r786", "r787", "r828" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Long-Lived Assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative", "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails", "http://vislink.com/role/Stock-basedCompensationDetailsNarrative", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r142", "r512", "r553", "r577", "r683", "r695", "r736" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r32", "r155", "r654" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "totalLabel": "Total cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": { "auth_ref": [ "r155", "r512" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.", "label": "CASH AND CASH EQUIVALENTS" } } }, "localname": "CashAndCashEquivalentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/CashAndCashEquivalents" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r32", "r109", "r180" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and cash equivalents, end of the period", "periodStartLabel": "Cash and cash equivalents, beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r1", "r109" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r736", "r838" ], "calculation": { "http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash on hand" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r150", "r159", "r160", "r161", "r183", "r202", "r203", "r205", "r207", "r213", "r214", "r270", "r292", "r294", "r295", "r296", "r299", "r300", "r329", "r330", "r333", "r336", "r343", "r435", "r536", "r537", "r538", "r539", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r554", "r569", "r592", "r613", "r633", "r634", "r635", "r636", "r637", "r720", "r749", "r757" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [ "r159", "r160", "r161", "r213", "r329", "r330", "r331", "r333", "r336", "r341", "r343", "r536", "r537", "r538", "r539", "r669", "r720", "r749" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r25", "r86", "r511", "r568" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies (See Note 12)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r118", "r286", "r287", "r641", "r785" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r685", "r686", "r687", "r689", "r690", "r691", "r692", "r753", "r754", "r818", "r841", "r845" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value", "verboseLabel": "Common stock per share value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r93", "r569" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r10", "r93", "r569", "r588", "r845", "r846" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r93", "r514", "r683" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.00001 par value per share, 100,000,000 shares authorized on June 30, 2023, and December 31, 2022, respectively: Common stock, 2,377,362 and 2,370,966 were issued, and 2,377,229 and 2,370,833 were outstanding on June 30, 2023, and December 31, 2022, respectively." } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r30", "r166", "r168", "r173", "r504", "r523" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive loss:" } } }, "localname": "ComprehensiveIncomeNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r38", "r40", "r80", "r81", "r236", "r640" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r38", "r40", "r80", "r81", "r236", "r534", "r640" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r38", "r40", "r80", "r81", "r236", "r640", "r725" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/Concentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [ "r640" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r38", "r40", "r80", "r81", "r236" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r37", "r38", "r40", "r41", "r80", "r129", "r640" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r38", "r40", "r80", "r81", "r236", "r640" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r73", "r657" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r345", "r346", "r357" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Customer deposits and deferred revenue" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r104" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total cost of revenue and operating expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of revenue and operating expenses" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r39", "r236" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r119", "r181", "r301", "r307", "r308", "r309", "r310", "r311", "r312", "r317", "r324", "r325", "r327" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "NOTES PAYABLE" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/NotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r16", "r89", "r90", "r131", "r132", "r184", "r302", "r303", "r304", "r305", "r306", "r308", "r313", "r314", "r315", "r316", "r318", "r319", "r320", "r321", "r322", "r323", "r452", "r664", "r665", "r666", "r667", "r668", "r750" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r83", "r85", "r302", "r452", "r665", "r666" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt instrument face amount", "verboseLabel": "Debt instrument, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r315", "r434", "r665", "r666" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "verboseLabel": "Debt instrument face amount" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r750" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Debt instrument accrued interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r23", "r303" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt instrument interest rate", "verboseLabel": "Debt instrument, interest rate, stated percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r148", "r664", "r819" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt instrument maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r24", "r184", "r302", "r303", "r304", "r305", "r306", "r308", "r313", "r314", "r315", "r316", "r318", "r319", "r320", "r321", "r322", "r323", "r452", "r664", "r665", "r666", "r667", "r668", "r750" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPaymentInterest": { "auth_ref": [ "r24" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments applied to interest.", "label": "Debt instrument, periodic payment, interest" } } }, "localname": "DebtInstrumentPeriodicPaymentInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r82", "r85", "r789" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt instrument" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": { "auth_ref": [ "r82", "r85" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.", "label": "Debt instrument discount" } } }, "localname": "DebtInstrumentUnamortizedDiscountCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": { "auth_ref": [ "r783" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]" } } }, "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss": { "auth_ref": [ "r239", "r255", "r257", "r503" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).", "label": "Amortized Cost" } } }, "localname": "DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": { "auth_ref": [ "r783" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]" } } }, "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesRealizedGainLoss": { "auth_ref": [ "r525", "r744", "r745" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).", "label": "Unrealized Losses" } } }, "localname": "DebtSecuritiesRealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesUnrealizedGainLoss": { "auth_ref": [ "r526", "r744", "r745" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).", "label": "Unrealized loss on investments held to maturity" } } }, "localname": "DebtSecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r7", "r127", "r147", "r414", "r415", "r752" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred tax benefits", "negatedLabel": "Deferred tax benefits" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r410", "r411", "r510" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r366" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Company matching contributions" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanDisclosuresTableTextBlock": { "auth_ref": [ "r65" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.", "label": "SCHEDULE OF MATCHING CONTRIBUTIONS" } } }, "localname": "DefinedContributionPlanDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r7", "r52" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Amortization and depreciation", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [ "r558", "r560", "r574", "r575", "r576", "r578", "r579", "r580", "r581", "r583", "r584", "r585", "r586", "r600", "r601", "r602", "r603", "r606", "r607", "r608", "r609", "r625", "r626", "r627", "r628", "r685", "r687" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative", "http://vislink.com/role/ScheduleOfTaxRebatesParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r74", "r75", "r76", "r77", "r558", "r560", "r574", "r575", "r576", "r578", "r579", "r580", "r581", "r583", "r584", "r585", "r586", "r600", "r601", "r602", "r603", "r606", "r607", "r608", "r609", "r625", "r626", "r627", "r628", "r656", "r685", "r687" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative", "http://vislink.com/role/ScheduleOfTaxRebatesParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [ "r356", "r670", "r671", "r672", "r673", "r674", "r675", "r676" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r356", "r670", "r671", "r672", "r673", "r674", "r675", "r676" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r791" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "SCHEDULE OF DISAGGREGATION OF REVENUE" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r369", "r373", "r401", "r402", "r403", "r681" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "STOCK-BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/Stock-basedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DividendIncomeOperating": { "auth_ref": [ "r139", "r541", "r593", "r630", "r631", "r693", "r694", "r851" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating dividend income on securities.", "label": "Dividend income" } } }, "localname": "DividendIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r174", "r190", "r191", "r192", "r193", "r194", "r200", "r202", "r205", "r206", "r207", "r211", "r430", "r431", "r505", "r524", "r658" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic loss per share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r174", "r190", "r191", "r192", "r193", "r194", "r202", "r205", "r206", "r207", "r211", "r430", "r431", "r505", "r524", "r658" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted loss per share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:" } } }, "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r199", "r208", "r209", "r210" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "LOSS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r823" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r10", "r151", "r169", "r170", "r171", "r185", "r186", "r187", "r189", "r195", "r197", "r212", "r271", "r272", "r344", "r404", "r405", "r406", "r412", "r413", "r421", "r422", "r423", "r424", "r425", "r426", "r429", "r442", "r443", "r444", "r445", "r446", "r448", "r465", "r528", "r529", "r530", "r542", "r613" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": { "auth_ref": [ "r526", "r781" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Unrealized Gains" } } }, "localname": "EquitySecuritiesFvNiUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r78", "r79" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "SCHEDULE OF FAIR VALUE OF ITS INVESTMENTS" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r315", "r360", "r361", "r362", "r363", "r364", "r365", "r433", "r472", "r473", "r474", "r665", "r666", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueOfItsInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r315", "r360", "r365", "r433", "r472", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueOfItsInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r315", "r360", "r365", "r433", "r473", "r665", "r666", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueOfItsInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r315", "r360", "r361", "r362", "r363", "r364", "r365", "r433", "r474", "r665", "r666", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueOfItsInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r315", "r360", "r361", "r362", "r363", "r364", "r365", "r472", "r473", "r474", "r665", "r666", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueOfItsInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r273", "r274", "r276", "r277", "r278", "r279", "r280", "r281", "r326", "r341", "r427", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r522", "r663", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r777", "r778", "r779", "r780" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/ScheduleOfFairValueOfItsInvestmentsDetails", "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-lived intangible asset, useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r157", "r283" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "periodEndLabel": "Ending balance, accumulated Amortization", "periodStartLabel": "Beginning balance, accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r116" ], "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r116" ], "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2028" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r116" ], "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r116" ], "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r116" ], "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r115", "r502" ], "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible assets", "totalLabel": "Finite-Lived Intangible Assets, Net, Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-lived intangible assets, remaining amortization period" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ForeignCurrencyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Currency [Abstract]" } } }, "localname": "ForeignCurrencyAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_ForeignCurrencyDisclosureTextBlock": { "auth_ref": [ "r436", "r450", "r696", "r697", "r698", "r699", "r722" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for foreign currency transactions and translation. This may include description of foreign currency transactions, foreign currency gains and losses, explanation of change in cumulative translation adjustment, description of effect of subsequent foreign currency exchange rate change, cumulative translation adjustment movement, foreign currency translation adjustment by component movement, translation adjustment for net investment hedge movement, adjustment for long-term intercompany transactions, schedule of long-term intercompany balances and any other foreign currency transactions and translation related items.", "label": "FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES" } } }, "localname": "ForeignCurrencyDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLosses" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignCurrencyExchangeRateRemeasurement1": { "auth_ref": [ "r450" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to remeasure amounts denominated in a currency other than functional currency into functional currency.", "label": "Average foreign currency exchange rate remeasurement" } } }, "localname": "ForeignCurrencyExchangeRateRemeasurement1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "auth_ref": [ "r449", "r450" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.", "label": "Foreign currency exchange rate, translation" } } }, "localname": "ForeignCurrencyExchangeRateTranslation1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r437", "r438", "r439", "r441", "r610" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.", "label": "Net foreign exchange transactions: Losses" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfForeignExchangeAndChangeInAccumulatedComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "auth_ref": [ "r111", "r590", "r694", "r821", "r822", "r844" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction.", "label": "Unrealized gain on currency translation adjustment" } } }, "localname": "ForeignCurrencyTransactionGainLossUnrealized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r7", "r53", "r54" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain on settlement of debt", "negatedLabel": "Gain on settlement of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r105", "r595" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_HeldToMaturitySecuritiesFairValue": { "auth_ref": [ "r141", "r262", "r503", "r508" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity).", "label": "Held to maturity", "verboseLabel": "Fair Value" } } }, "localname": "HeldToMaturitySecuritiesFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesTextBlock": { "auth_ref": [ "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).", "label": "SCHEDULE OF INVESTMENTS HELD TO MATURITY" } } }, "localname": "HeldToMaturitySecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r0", "r102", "r136", "r215", "r226", "r230", "r232", "r506", "r520", "r660" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Net loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r284", "r285", "r596" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r285", "r596" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income taxes" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r6" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r6" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r6" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r500", "r747" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "verboseLabel": "Customer deposits and deferred revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r6" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r726", "r747" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease obligations" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r6" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "INTANGIBLE ASSETS" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [ "r156" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "periodEndLabel": "Ending balance cost", "periodStartLabel": "Beginning balance cost" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r45", "r48" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndOtherIncomeTextBlock": { "auth_ref": [ "r125" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for interest and other income.", "label": "OTHER INCOME (REBATES)" } } }, "localname": "InterestAndOtherIncomeTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/OtherIncomeRebates" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r84", "r140", "r172", "r218", "r451", "r597", "r694", "r843" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r138" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest income, net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r176", "r178", "r179" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid during the period for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLIFOReserveEffectOnIncomeNet": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The difference between the change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods and any LIFO decrement which have been reflected in the statement of income during the period.", "label": "Inventory, LIFO Reserve, Effect on Income, Net", "verboseLabel": "Inventory valuation adjustments" } } }, "localname": "InventoryLIFOReserveEffectOnIncomeNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r163", "r655", "r683" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTextBlock": { "auth_ref": [ "r727", "r728", "r758" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investment.", "label": "INVESTMENTS" } } }, "localname": "InvestmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/Investments" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]" } } }, "localname": "InvestmentsAllOtherInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r432" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, fair value disclosure", "verboseLabel": "Fair value of investments" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/ScheduleOfFairValueOfItsInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r746" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Cost of components and personnel" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r458", "r682" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r826" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "SCHEDULE OF OPERATING LEASE DATA" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseExpirationDate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.", "label": "Lease expiration" } } }, "localname": "LeaseExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r827" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r464" ], "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Approximate Future Payments", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "http://vislink.com/role/ScheduleOfLeaseObligationAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r464" ], "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "verboseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r464" ], "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "verboseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r464" ], "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "verboseLabel": "2028" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r464" ], "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "verboseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r464" ], "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "verboseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r464" ], "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "verboseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r464" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseOptionToTerminate": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Description of terms and conditions of option to terminate lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.", "label": "Lease maturity description" } } }, "localname": "LesseeOperatingLeaseOptionToTerminate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r453" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r20", "r183", "r270", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r418", "r419", "r420", "r435", "r567", "r659", "r695", "r786", "r828", "r829" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r98", "r133", "r518", "r683", "r751", "r782", "r820" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r22", "r154", "r183", "r270", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r418", "r419", "r420", "r435", "r683", "r786", "r828", "r829" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r177" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r177" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r109", "r110", "r111" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "negatedLabel": "Net cash provided by used in operating activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r103", "r111", "r137", "r152", "r165", "r167", "r171", "r183", "r188", "r190", "r191", "r192", "r193", "r196", "r197", "r204", "r215", "r226", "r230", "r232", "r270", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r431", "r435", "r521", "r591", "r611", "r612", "r660", "r694", "r786" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity", "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently Issued Accounting Principles" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of non-cash information:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r106" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_NotesIssued1": { "auth_ref": [ "r33", "r34", "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of notes issued in noncash investing and financing activities.", "label": "Notes Issued", "verboseLabel": "Notes payable" } } }, "localname": "NotesIssued1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r16", "r132", "r837" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Notes Payable", "verboseLabel": "Notes payable" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OffsettingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Offsetting Assets [Line Items]" } } }, "localname": "OffsettingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfTaxRebatesParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingAssetsTable": { "auth_ref": [ "r99", "r100" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.", "label": "Offsetting Assets [Table]" } } }, "localname": "OffsettingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfTaxRebatesParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r215", "r226", "r230", "r232", "r660" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "negatedLabel": "Operating income loss", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r459", "r682" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of lease liabilities", "verboseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r455" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease obligations, current", "terseLabel": "Current operating lease liabilities", "verboseLabel": "Less: Current lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r455" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease obligations, net of current portion", "terseLabel": "Non-current operating lease liabilities", "verboseLabel": "Non-current lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r456", "r461" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r454" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of use assets, operating leases", "verboseLabel": "Right of use of assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r748" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.", "label": "Amortization of right-of-use assets, operating assets" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r463", "r682" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Weighted-average discount rate-operating leases", "verboseLabel": "Weighted-average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r462", "r682" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted-average remaining lease term-operating leases", "verboseLabel": "Weighted-average remaining term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r88", "r112", "r113", "r128" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.", "label": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "auth_ref": [ "r3", "r4", "r440", "r447" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "negatedLabel": "Unrealized gain (loss) on currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r107" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other income" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r5" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Payments for rent" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r108" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Cash used for property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "http://vislink.com/role/ScheduleOfStock-basedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "http://vislink.com/role/ScheduleOfStock-basedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [ "r685", "r686", "r689", "r690", "r691", "r692", "r841", "r845" ], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r92", "r329" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value", "verboseLabel": "Preferred stock par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r92", "r569" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r92", "r329" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issed" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r92", "r569", "r588", "r845", "r846" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r92", "r513", "r683" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.00001 par value per share: 10,000,000 shares authorized on June 30, 2023, and December 31, 2022, respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r740" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r8", "r507", "r519", "r683" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r175", "r275" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision for bad debt" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfMediumTermNotes": { "auth_ref": [ "r31" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years.", "label": "Repayments of Medium-term Notes", "negatedLabel": "Principal payments made on notes payable" } } }, "localname": "RepaymentsOfMediumTermNotes", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r87", "r409", "r836" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/Stock-basedCompensationDetailsNarrative", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r95", "r123", "r517", "r531", "r533", "r540", "r570", "r683" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r151", "r185", "r186", "r187", "r189", "r195", "r197", "r271", "r272", "r404", "r405", "r406", "r412", "r413", "r421", "r423", "r424", "r426", "r429", "r528", "r530", "r542", "r845" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r216", "r217", "r225", "r228", "r229", "r233", "r234", "r236", "r355", "r356", "r501" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue, net" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r149", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r358" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "REVENUE" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r236", "r724" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r29", "r824", "r825" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "SCHEDULE OF CASH AND CASH EQUIVALENTS" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/CashAndCashEquivalentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r69" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "SCHEDULE OF NOTES PAYABLE" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r47", "r49", "r502" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r47", "r49" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "SCHEDULE OF INTANGIBLE ASSETS" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of impaired intangible assets excluding goodwill. This may include a description of the facts and circumstances leading to the recording of impairment charges of intangible assets in the period, the amount of the impairment charges, the methods of determining fair value of the associated assets, the caption in the income statement in which the impairment losses are aggregated, and the segment in which the impaired intangible assets are reported.", "label": "SCHEDULE OF CAPITALIZED INTANGIBLE COSTS" } } }, "localname": "ScheduleOfImpairedIntangibleAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r370", "r372", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative", "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails", "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "http://vislink.com/role/ScheduleOfStock-basedCompensationExpenseDetails", "http://vislink.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of employee stock purchase plan activity.", "label": "SCHEDULE OF EQUITY COMPENSATION PLANS" } } }, "localname": "ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r56", "r57", "r58", "r59", "r60", "r61", "r62", "r121", "r122", "r123", "r159", "r160", "r161", "r213", "r329", "r330", "r331", "r333", "r336", "r341", "r343", "r536", "r537", "r538", "r539", "r669", "r720", "r749" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "SCHEDULE OF WARRANT OUTSTANDING" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r219", "r220", "r221", "r222", "r223", "r224", "r234", "r661" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r737", "r738", "r790" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeveranceCosts1": { "auth_ref": [ "r7" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.", "label": "Severance costs over next six months" } } }, "localname": "SeveranceCosts1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r6" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "verboseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual life" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r392" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Restricted stock options, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [ "r370", "r372", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative", "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails", "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "http://vislink.com/role/ScheduleOfStock-basedCompensationExpenseDetails", "http://vislink.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.", "label": "Number of warrants cancelled/expired", "negatedLabel": "Number of Warrants, Warrants granted, exercised, canceled, or expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Number of Warrants, ending outstanding", "periodStartLabel": "Number of Warrants, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r379" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "periodEndLabel": "Quantity, outstanding beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r379" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average, outstanding beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r798" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Quantity, outstanding beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r798" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "negatedLabel": "Weighted Average, outstanding beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Quantity, outstanding beginning balance", "negatedLabel": "Quantity, outstanding beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r377", "r378" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Quantity, outstanding beginning balance", "periodStartLabel": "Quantity, outstanding beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r377", "r378" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average, outstanding beginning balance", "periodStartLabel": "Weighted Average, outstanding beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative", "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails", "http://vislink.com/role/Stock-basedCompensationDetailsNarrative", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted Average, outstanding beginning balance" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by supplier.", "label": "Supplier [Axis]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received." } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfEquityCompensationPlansDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Shares attributable to withholding tax" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r134", "r135", "r739" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Investments held to maturity" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r460", "r682" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r150", "r159", "r160", "r161", "r183", "r202", "r203", "r205", "r207", "r213", "r214", "r270", "r292", "r294", "r295", "r296", "r299", "r300", "r329", "r330", "r333", "r336", "r343", "r435", "r536", "r537", "r538", "r539", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r554", "r569", "r592", "r613", "r633", "r634", "r635", "r636", "r637", "r720", "r749", "r757" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r10", "r27", "r151", "r169", "r170", "r171", "r185", "r186", "r187", "r189", "r195", "r197", "r212", "r271", "r272", "r344", "r404", "r405", "r406", "r412", "r413", "r421", "r422", "r423", "r424", "r425", "r426", "r429", "r442", "r443", "r444", "r445", "r446", "r448", "r465", "r528", "r529", "r530", "r542", "r613" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r185", "r186", "r187", "r212", "r501", "r535", "r554", "r561", "r562", "r563", "r564", "r565", "r566", "r569", "r572", "r573", "r574", "r575", "r576", "r578", "r579", "r580", "r581", "r583", "r584", "r585", "r586", "r587", "r589", "r594", "r595", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r613", "r688" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity", "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfLeaseObligationAssumedDetails", "http://vislink.com/role/ScheduleOfTaxRebatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r185", "r186", "r187", "r212", "r501", "r535", "r554", "r561", "r562", "r563", "r564", "r565", "r566", "r569", "r572", "r573", "r574", "r575", "r576", "r578", "r579", "r580", "r581", "r583", "r584", "r585", "r586", "r587", "r589", "r594", "r595", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r613", "r688" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity", "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfLeaseObligationAssumedDetails", "http://vislink.com/role/ScheduleOfTaxRebatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r93", "r96", "r97", "r114", "r571", "r588", "r614", "r615", "r683", "r695", "r751", "r782", "r820", "r845" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r120", "r182", "r328", "r330", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r342", "r344", "r428", "r616", "r617", "r638" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Reverse split" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [ "r449", "r467" ], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r449", "r467" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r449", "r467" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r449", "r467" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r449", "r467" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r466", "r468" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r292", "r294", "r295", "r296", "r299", "r300", "r407", "r515" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Series A Preferred stock, $0.00001 par value per share: -0- shares authorized on June 30, 2023, and December 31, 2022, respectively; -0- and 47,419 shares issued and outstanding on June 30, 2023, and December 31, 2022, respectively." } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r15", "r55" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary equity, par value" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, shares authorized" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, shares issued" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r326", "r341", "r427", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r522", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r777", "r778", "r779", "r780" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/ScheduleOfFairValueOfItsInvestmentsDetails", "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonMember": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common [Member]" } } }, "localname": "TreasuryStockCommonMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury stock, shares" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r26", "r63", "r64" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost \u2013 133 shares as of June 30, 2023, and December 31, 2022, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r42", "r43", "r44", "r143", "r144", "r145", "r146" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r685", "r686", "r689", "r690", "r691", "r692" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r201", "r207" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r200", "r207" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndOtherComprehensiveLoss" ], "xbrltype": "stringItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org//470/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "610", "URI": "https://asc.fasb.org//610/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org//810/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.2)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(19)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org//606/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org//260/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(4)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//350-30/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org//718/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.E.Q2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "808", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org//830/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(d)(1))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(d)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "47", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "39", "Publisher": "FASB", "Section": "45", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-39", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-14", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-15", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-16", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r701": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r702": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r703": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r704": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r705": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r706": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r707": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r708": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r709": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r711": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r712": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r713": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r714": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r715": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r716": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r717": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r718": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r719": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r727": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "321", "URI": "https://asc.fasb.org//321/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r728": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "325", "URI": "https://asc.fasb.org//325/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r729": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r731": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r732": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r733": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r734": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r735": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(c))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(9)(a))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r758": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org//320/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(4)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r785": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 85 0001493152-23-027727-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-027727-xbrl.zip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